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Abstract
The goal of this thesis was to characterise a novel transmission detector in the
context of signal prediction. This was to eliminate the need to collect a base-
line signal for the device before treatment. This not only saves time, but, by
independently generating the baseline signal, the process is less prone to missing
errors.
A simple analytical algorithm was designed and was found to be capable of
detecting gross errors, however, it was shown not to be accurate enough to detect
MLC position errors that could have a clinical effect on the delivery. MU check
software was commissioned, however the fluence distribution it produced lacked
the complexity for accurate signal prediction. A Monte Carlo model of a linac was
built and validated then used to demonstrate that the detector could be modelled
as two slabs of Perspex; the signal being proportional to the dose measured in
the air between them. Two Monte Carlo models were then made using different
systems, these were both evaluated by comparing predicted signals to measured
signals for VMAT plans. Both models performed well and were capable of detecting
leaf errors ∼ 1mm; the merits of both are discussed with regard to error detection
and ease of use.
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Outline of thesis
The first chapter gives the reader a general introduction to radiotherapy and the
requirement for accuracy in its delivery. In-vivo dosimetry’s role in the QA frame-
work and how it gives the hospital physicist the confidence that this accuracy is
being achieved is discussed at the end of the chapter. Chapter 2 considers the
general case for IVD and the devices that are currently available. The research
question is posed and the novel work completed by the author for the purpose
of this thesis is presented in Chapters 3 to 6. The chapters are arranged chrono-
logically, a summary of each is included below. Presenting the material in this
manner is designed to assist the reader in understanding how decisions regarding
the direction of the work were reached. As with all research sometimes negative
results are recorded. For example, the work outlined in Appendix B did not yield
useful results, yet it helped inform decisions that led to the work in the subsequent
chapters hence its inclusion. Chapter 7 includes a discussion on this research, how
it sits with current radiotherapy practice and suggestions on future work.
• Chapter 1 Introduction to Radiotherapy External beam radiotherapy is in-
troduced. The basic radiobiology that underpins the subject is outlined
and the requirement for a high level of dosimetric certainty in the delivery
of treatments is demonstrated. The key components of the modern lin-
ear accelerator are outlined including the Multi-Leaf Collimator (MLC) and
how it has been used to develop Intensity Modulated Radiotherapy (IMRT).
While IMRT affords much more conformal dose distributions, small errors in
leaf position can lead to much larger dosimetric errors than traditional 3D
Conformal radiotherapy. MLC QA, pre-treatment verification and in-vivo
dosimetry can be used together to give the radiotherapy physicist confidence
that the linac is delivering treatments that maintain suitably high levels of
dosimetric accuracy to ensure that clinical objectives are realised.
• Chapter 2 Literature review In-Vivo Dosimetry (IVD) is reviewed. The
case is made for IVD by considering:
– The high level of accuracy required in advanced radiotherapy deliveries
– The unfortunate reality that gross errors have occurred
A synopsis of the current literature pertaining to IVD in the UK is given.
Techniques for performing IVD including point detectors, electronic portal
imaging and log file analysers are reviewed. Particular attention is given to
transmission detectors with individual products discussed. The Device for
Advanced Verification of IMRT Deliveries (DAVID) - a multi-wire transmis-
sion detector and the subject of this thesis - is introduced and the current
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literature on the device is reviewed. The requirement for an algorithm to
predict the DAVID signal for the purposes of efficiency and safety is demon-
strated leading to the research objective:
Investigate the characteristics of the DAVID device with
the intention of being able to predict the response to ad-
vanced deliveries in order to facilitate intra-fraction mon-
itoring of radiotherapy that is both efficient and safe.
• Chapter 3 Preliminary work for the predictive algorithms for the DAVID
The DAVID is shown to be a stable device with a response that is linear in
relation to both delivered Monitor Units (MUs) and field size. This demon-
strates that, in principle, it should be possible to predict the signal provided
enough is known about the field. Two algorithms are developed one relying
on a look-up table, the other using the linear response of the primary and
secondary response to leaf separation. These are tested using basic MLC
apertures with the linear-response algorithm predicting the signal more ac-
curately than the look-up table approach.
• Chapter 4 An analytical model for predicting the DAVID signal The linear-
response algorithm outlined in chapter 3 is developed to include the effects of
varying MU, asymmetric leaf separation, scatter, jaw position and penumbral
effects. The increased complexity of the algorithm allows it to predict the
response of the DAVID to clinical IMRT treatment deliveries. This work
was published during the course of the thesis (Johnson et al. 2014). It is
shown that the uncertainty associated with the out-of-field response is a
limiting factor in the algorithm’s ability to predict the DAVID response.
It is postulated that a dose or fluence map of the delivery would have the
potential to predict the response more accurately.
• Chapter 5 Monte Carlo Modelling of the DAVID An EGSnrc-based Monte
Carlo (MC) model of the Elekta MLCi2 head is developed and matched
to machines used clinically at Leeds Teaching Hospitals. At the time the
chapter was written, there was little published literature on MC modelling
of the MLCi2 head, so this work was novel as well as being necessary to
confirm an accurate model of the DAVID.
The linac model was used to show that the collection wires had a 3% impact
on the signal collected by the DAVID. This effect could, however, be ac-
counted for using a multiplicative correction factor. Using this information
a simple model of the DAVID - that did not include collection wires - was
created in EGSnrc. The combination of the DAVID model and the MLCi2
model were both calibrated and used to predict the response of five clinical
VMAT fields. Modelling of the DAVID in MC and the method used to cal-
ibrate a transmission detector are both novel, it is the authors intention to
publish this work in the near future.
An equivalent model of the DAVID was also constructed as a QA phantom in
the Monte Carlo-based treatment planning system Monaco. This was used
to predict the response of the same five VMAT fields.
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Both Monte Carlo approaches were shown to be capable of accurately pre-
dicting the DAVID response to a VMAT delivery. While the EGSnrc ap-
proach was slightly more accurate, this comes at the expense of both time
and effort if applied routinely in the clinic.
• Chapter 6 The performance of the models in detecting MLC errors using
the DAVID There is a review of the current literature regarding MLC er-
rors and their impact on the dosimetric accuracy of VMAT deliveries. The
general consensus is that leaf bank errors that either increase or decrease
leaf bank separation have the most severe impact on delivered dose. Five
VMAT plans were modified to include these errors with various magnitudes.
The analytical model devised in Chapter 4 and the two Monte Carlo models
developed in Chapter 6 were used to predict response of the original and
modified plans. These predictions were compared to measured signals to
give an indication of the algorithm’s sensitivity to the simulated errors. The
Monte Carlo approaches were shown to be almost equivalent and consider-
ably more sensitive than the analytical approach. Using Monaco to model a
transmission detector is novel as is the MLC error testing of the DAVID in
this context. The author intends to publish this work on the completion of
the thesis.
• Chapter 7 Discussion of findings, conclusions and suggestions for future
work.
A key contribution of the work to the field of radiotherapy physics is a robust
approach to implementing IVD that is not only efficient, but sensitive to gross
treatment errors and more subtle leaf errors that have been shown to have a
significant impact on the dose delivered by advanced (e.g VMAT) techniques.
Additionally, I developed two novel calibrated Monte Carlo models for transmission
detectors which could be used to predict the expected measurements.
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Chapter 1
Introduction to
Radiotherapy
In 2014 359,960 people were diagnosed with cancer in the UK (CRUK 2015).
Radiotherapy was used to treat approximately 50% of these cases. 40% of all cured
cancers are treated with radiotherapy, 16% of all cured cancers are treated with
radiotherapy alone (CRUK 2014). This chapter provides an outline of the biology
underpinning radiotherapy and how the response of tissue to radiation demands a
certain level of accuracy when delivering treatments. The basic principles of linear
accelerators are discussed and how modern advances are enabling more conformal
treatments. The chapter concludes by demonstrating that these new techniques
must be delivered accurately and then looks at the tools that are used to ensure
that this is the case.
1.1 Biological basis and accuracy requirements
for radiotherapy
1.1.1 Underlying principles
Radiotherapy is the treatment of cancer using ionising radiation. Exposure of
tissue to ionising radiation causes the production of free radicals, these are highly
unstable and react almost immediately (∼ milliseconds) with nearby molecules,
transferring chemical damage to them. In the context of radiotherapy, the energy
deposited by ionising radiation is referred to as dose and is given the unit of Gray,
defined as the absorption of one joule of radiation energy per kilogram of matter
(BIPM 2006). In the case of exposing tissue to ionising radiation, cells will be
damaged. If the damage is sufficient it will initiate a DNA Damage Response
(DDR) that can lead, through various mechanisms, to cell death.
The proportion of cells that are damaged as a function of dose is characterised
by the linear quadratic model:
L = αd+ βd2 (1.1)
Where L is the total number of cell deaths α and β are constants to be discussed
shortly. Using the Poisson model, the surviving fraction (S) can be considered as
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the probability of no cell deaths giving (Jones et al. 2001):
S = e−L (1.2)
Or:
S = e−(αd+βd
2) (1.3)
Radiobiological studies have shown (Joiner & Van der Kogel 2016) that each suc-
cessive fraction in a multidose schedule is equally effective, so the effect of n
fractions can be expressed as:
Sn = (e−(αd+βd
2))n (1.4)
Taking the natural logorithm of both sides leads to:
E = n(αd+ βd2) (1.5)
Where E is − lnS and is conventionally referred to as the ‘log cell-kill’ (Dale et al.
2007).
The linear quadratic model shown in Equation 1.1 was initially an empirical
fit to describe chromosome damage to cells as a consequence of irradiation (Lea
& Catcheside 1942). However, it has been shown to have solid bio-physical basis.
Damage to the cell’s DNA from the free radicals produced through exposure to
ionising radiation is regarded as the principle mechanism that brings about cell
death (Mayles et al. 2007). Single breaks in the DNA can normally be repaired by
intra-cellular enzymes, well-separated double breaks are repaired in a similar way;
double breaks close together are not easily repaired. Sufficiently damaged DNA
can trigger apoptosis - programmed cell death or check point activation - where
mitosis is inhibited (Dale et al. 2007, Joiner & Van der Kogel 2016). The α term
in the LQ model is associated with lethal damage caused by single-strand breaks
while the β term is associated with lethal damage caused by double-strand breaks
(Dale et al. 2007, Jones et al. 2001).
If we take Equation 1.5 and consider the situation when the total dose D is
delivered through a large number of very small fractions we see that the linear
term becomes dominant and the quadratic term can, essentially, be ignored:
E = nαd = αD as d→ 0 (1.6)
Here, dose D, is the dose required to give a specific effect; in this case D is defined
as the Biological Effective Dose (BED). While BED represents the physical dose
required for a given effect for the case where d → 0 it can be achieved through
more realistic dose / fractionation regimes (Dale et al. 2007). From Equation 1.6
we see that:
BED =
E
α
(1.7)
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Combining Equation 1.7 and Equation 1.5 it can be shown that:
BED = nd
(
1 +
d
α/β
)
(1.8)
Equation 1.6 demonstrates that a fractionated treatment regime that delivers a
higher total dose through a number of equally weighted fractions can have the
same biological effect as a single large-dose fraction given in one go. Fraction-
ating a treatment exploits inherent differences in the radiation response between
carcinogenic and normal tissue with beneficial consequences. When considering
fractionated treatments it is useful to consider the 5 Rs of radiobiology:
• Repair of sub-lethal damage - Typically much more active in normal tissue
and by limiting the dose to normal tissue the repair is more likely to work.
• Re-assortment of cells within the cell cycle - Cells have varying radiosensi-
tivities depending on where they are in the mitotic cycle. Fractionating the
treatments means that more cells will be exposed to radiation when they are
in their most vulnerable cell phases. This effect acts more strongly against
carcinogenic cells as they typically divide at a much higher rate than normal
tissue.
• Re-population - Cells that have undergone sub-lethal damage will go on to
proliferate and repopulate, this is the case for both normal and carcinogenic
tissues. In the case of treatments that continue for longer than the cell cycle
duration, it will be necessary to deliver a higher dose in order to maintain
the same level of tumour control.
• Re-oxygenation - Tumour tissues do not normally have particularly good
blood supplies to all of the cells. During the course of a radiotherapy
treatment the tumour shrinks, revascularisation occurs; previously hypoxic
regions of the tumour can be reoxygenated. Though this may help re-
population, the presence of oxygen also increases the potency of radiation.
Typically in more oxygenated areas there are more double strand breaks,
this is considered to be due to the production of highly-reactive oxygen
free radicals. The oxygen effect is thought to be one of the main reasons
why fractionated radiotherapy has better outcomes than high single-fraction
treatments (Dale et al. 2007).
• Radiosensitivity - how tissue responds to treatment depends on its radiosen-
sitvity. Some carcinogenic tissue is damaged more effectively with fraction-
ated treatment than others. At present there are a number of studies looking
at how dose fractionated regimes can be tailored to better suit specific cases
(Morrison et al. 2018, Lawless et al. 2017, Fisher & Rabinovitch 2014, Baker
et al. 2016). This remains an interesting and active area of research.
1.1.2 Accuracy and precision in radiotherapy
Recent work in the rapidly-developing field of immunotherapy has demonstrated
that the use of certain monoclonal antibodies can enhance the effect of radiother-
apy by inhibiting tumour repair pathways or by triggering an immune response
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(Farkona et al. 2016, Chalmers 2016). However, for simplicity, the classic target-
cell hypothesis of radiotherapy shall be used to illustrate the key concepts of frac-
tionated deliveries. This states that any single surviving cell has the capacity to
proliferate, therefore every clonogenic cell must be killed for the treatment to be
successful (Munro & Gilbert 1961, Mayles et al. 2007). Using Poisson statistics, it
can be shown that, given an average number of clonogenic cells N , the probability
of their being no surviving cells is:
TCP = e−N (1.9)
where TCP is the tumour control probability that is equal to 1 when there are
no remaining cancerous cells. Now taking the Equation 1.4 - that describes the
surviving fraction of cells for a fractionated treatment - it can be shown that:
N = −N0 × e−n(αd+βd2) (1.10)
Where N0 is the initial number of clonogenic cells. Combining Equation 1.9 with
Equation 1.10 generates Equation 1.11, describing the TCP. A plot of TCP as a
function of dose using typical values is shown in Figure 1.1.
TCP = e−N0×e
−n(αd+βd2)
(1.11)
The likelihood of inflicting damage to normal tissue depends on how much of the
Figure 1.1: TCP curve for a 2Gy per fraction (#) treatment regime using typical
values α = 0.286, β = 0.032 and N0 = 10
8 (Dale et al. 2007, Mayles et al. 2007,
Brahme 1984, Joiner & Van der Kogel 2016). The gradient of the curve around the
treatment dose determines the effect a dosimetric error would have on the TCP
organ is irradiated and whether the organ is more serial or parallel in character
(ICRU 1999), making the tissue more susceptible to point or average dose re-
spectively. There are a number of mathematical models describing Normal Tissue
Complication Probability (NTCP) (Adamus-Go´rka et al. 2011), the one by Lyman
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(1985) is the most widely cited (Equation 1.12)
P (D,V ) =
1√
2pi
∫ t
−∞
exp
{−t2/2} dt (1.12)
Where P (D,V ) is the NTCP and t is the upper limit of the normally distributed
probability function defined as:
t(D,V ) =
D −D50(V )
mD50(V )
(1.13)
and
D50(V ) =
D50(1)
V n
(1.14)
Where D50 is the dose associated with 50% probability of a response; D50(1) is
the tolerance dose for 50 % complications for uniform whole-organ irradiation;
V is the volume fraction being irradiated by dose D; n is specific to the organ
and associated with the gradient of its dose response. The Lyman response can be
plotted on a three axis graph with z, x and y being V , dose and NTCP respectively.
For a given V the NTCP relationship to dose is sigmoidal much like the TCP curve
shown in Figure 1.1 (Lyman 1985, Adamus-Go´rka et al. 2011).
While the Lynman model - and ones like it - are used frequently in research,
they are rarely used in the clinic. The model outlined here, for example, assumes
that the OAR sub volume receives a uniform dose - this is generally not observed in
practice. Furthermore, the complexity of various organs, the variety of responses
they can have to regional irradiation and the limited amount of of good clinical
data means that applying any mathematical model to determine NTCP will always
be difficult (Joiner & Van der Kogel 2016). What can be certain is that irradiating
healthy organs carries with it an associated risk, increased dose to larger volumes
increases this risk. Clinical decisions and tolerances associated with specific OARs
tend to be based on maximum doses, maximum volumes receiving certain doses
and interpretation of the Dose Volume Histogram (DVH) derived from experience
and/or national/international guidelines and/or clinical trials. With this approach
in place, minor unavoidable toxicities are frequent (eg. cataracts, erythema, rectal
bleeding). However, severe OAR radiation responses (eg organ failure, paralysis)
are rarely seen and when they are they are normally anticipated. In this instance
the patient is consented to this possibility to enable an informed decision on the
course of their treatment.
Tumour control is achieved by delivering dose to the tumour, however the
maximum dose delivered is limited by the risk to normal tissue. The necessary
dosimetric accuracy of these deliveries is determined by the gradient of the TCP
and/or NTCP curves around the dose that is being delivered. Deviation from the
anticipated dose will either lead to lower TCP or higher NTCP than anticipated,
in both cases resulting in poorer clinical outcome. Older (Brahme 1984) and more
recent (QUANTEC 2010) studies have agreed on the gradients associated with
TCP; consideration of these values by Brahme (1984) showed that the most critical
loss in tumour control was found when dosimetric inaccuracies were introduced at
the highest level of TCP. Given this mathematically rigorous analysis it is agreed
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that delivered dose should be accurate to within 3% (relative SD). Meaning that
there is a 95% chance that dosimetric changes at twice this level will be clinically
observable (Thwaites 2013, Brahme 1984)
1.2 The Linear Accelerator
1.2.1 Introduction
The most common energy band and modality in worldwide use for cancer treat-
ment is MV photon radiation as these beams can deposit dose at clinically-
appropriate depths. This is now almost exclusively generated by linear accel-
erators. The most common type of radiotherapy treatment unit is the c-arm style
linear accelerator (Figure 1.2). These are capable of generating MV radiation over
the range of 4-25MeV. Throughout the rest of this thesis the term radiotherapy
will be with regard to external beam radiotherapy delivered by a linac. The techni-
cal aspects associated with generating this radiation are discussed in the following
section.
Figure 1.2: An Elekta Versa HDTM
1.2.2 Generating Megavoltage (MV) radiation
To produce therapeutic electromagnetic radiation accelerator technology is used
– this is where electromagnetic waves with specific properties are generated and
utilised to accelerate the electrons to high speeds before crashing them in to a
target, producing electromagnetic radiation through the Bremsstrahlung process.
Throughout the generation of the therapeutic beam, there are a number of feed-
back and control mechanisms to ensure that the beam passing through the shaping
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apparatus is stable, symmetric and at the right energy (Waldron 2002) giving con-
fidence that that treatment is being delivered with appropriate accuracy. What
follows is brief discussion on the key components of a linac, summarised in Figure
1.4.
• The electron gun produces electrons through thermionic emission by using
a current to heat a filament. These electrons are then accelerated to speeds
∼0.5c using a voltage.
• At the same time as this is happening microwaves are produced by either a
magnetron or klystron.
• The microwaves are directed up to the accelerating waveguide.
• Shortly after the microwaves enter the waveguide the electrons are injected.
• The electrons are accelerated along the waveguide to speeds of ∼ c.
• Electromagnets are used to direct the electron beam on to a high-Z target.
• On hitting the target the electrons slow down and high energy photons are
produced through the Bremsstrahlung process, these pass through the linac
head (Section 1.2.3) before reaching the patient.
• In practice the radio-frequency power required to accelerate electrons to
such energies cannot be sustained, so linacs operate in a pulsed mode. This
pulsing is controlled by the modulator that distributes high voltages and
currents to the linac components.
Figure 1.3: Typical MLC-jaw set up. The MLC conforms the radiation to the
desired shape; the X jaws reduce transmission through the gaps between “closed”
leaf pairs, as there is a gap between the closed leaves the X jaws need to attenuate
the primary beam to acceptable levels before it hits the patient making them
necessarily thicker. The Y jaws back up the MLC reducing inter-leaf leakage.
Both X and Y jaws reduce leaf transmission.
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Electrons are created
through thermionic emis-
sion by heating a filament
The electrons are accelerated
using a potential difference
Electrons are accelerated to
velocities ∼ c using either
travelling or standing EM waves
Magnets direct the electron
beam towards the patient
Electron
Treatment
Scattering filter
Photon
Treatment
Electrons are directed at a
target, on hitting the target the
electrons slow down emitting
Bremsstrahlung radiation
The high-energy pho-
tons pass through a
conical flattening filter
The beam passes through
an ionisation chamber
The beam passes
through modality-specific
shaping apparatus
Patient
Figure 1.4: The process of generating therapeutic radiation. Although the whole
unit is typically called a linac, the accelerating part, held under vacuum is shown
in blue. The linac head, responsible for shaping the radiation, is shown in purple.
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1.2.3 The linac head
The linac head (Figure 1.5) shapes and monitors the radiation in accordance with
the radiotherapy plan and the linac’s own control system. The architecture of the
head is specific to both the model and vendor. Typically a modern treatment head
will contain the following:
• Primary collimator – attenuates peripheral, high angle scatter radiation pro-
duced in the target. Ultimately defines the maximum size of the radiation
field.
• Flattening filter – differentially attenuates the peaked radiation profile from
the target so that the dose distribution is approximately flat at 10cm deep
in water.
• Segmented ion chamber – checks the beam output, symmetry and flatness.
• Wedge – can be used to preferentially attenuate the radiation profile to better
improve conformity.
• Mirror and filament lamp – produces an optical field that matches the radia-
tion field to assist with patient setup and qualitative component assessment.
• Primary jaws – Set the extent of the field in the direction perpendicular to
the MLC movement.
• Backup jaws - Move in the same direction as the MLCs reducing leakage
(Figure 1.3).
• Multileaf collimator – shapes the beam exit aperture; adjusts the radiation
field shape to better conform to tumour dimensions.
Figure 1.5: An Elekta Versa HDTM treatment head with the covers removed
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1.2.4 The Multileaf Collimator
The Multileaf Collimator (MLC) was developed in the 1980s with Scanditronix
(Scanditronix AB, Uppsala, Sweden) (Brahme 1987, 1988a), Siemens (Siemens,
Concord, CA) (Boesecke et al. 1988), Varian (Varian Oncology Systems, Palo
Alto) (Moeller 1989, Galvin et al. 1993) and Philips (Philips Medical Systems,
Shelton) (Jordan & Williams 1991) releasing models with 32, 27, 26 and 40 leaf
pairs respectively (Jordan & Williams 1994). Initially the MLC allowed the radi-
ation beam to be conformed around target volumes (AAPM 2001), as shown in
Figure 1.6, but the technology paved the way for Intensity Modulated Radiother-
apy (IMRT) (Section 1.3). This approach to radiotherapy delivery led to highly
conformal dose distributions and new ways to utilise IMRT remain an exciting
area of research and development.
Figure 1.6: MLC used to conform the radiation field around the edge of a treatment
volume. Taken from Greene & Williams (1997)
Figure 1.7: A 80-leaf-pair MLC bank from an Elekta AgilityTM treatment head.
The view is along the beam axis looking up, through the MLC aperture, to the
target.
MLC banks consist of between 20 and 80 tungsten leaf pairs; each leaf can
move either forwards or backwards, but is restricted to a single plane. By moving
the leaf pairs, irregular apertures can be made for the radiation beam. As an
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example, for the Elekta Agility MLC, leaf velocities of 65 mm s-1 are possible with
the combined effect of leaf movement (35 mm s-1) and leaf-bank movement (30
mm s-1) (Thompson et al. 2014)
Radiation leakage and transmission through the leaf bank are key issues. Adja-
cent leaves can never be perfectly abutting, resulting in inter-leaf leakage; mechan-
ical reasons prevent leaf pairs from being completely shut, leading to transmission;
the leaves are of finite thickness so the beam can never be fully attenuated. There
are several methods for combating these various issues (Huq et al. 2002, AAPM
2001).
Inter leaf leakage. Leakage between the leaves is reduced to between 1 and
5% by stepping the leaf shape (Figure 1.8). In addition to stepping the MLCs
backup jaws are employed that move in the same direction as the MLCs, they are
set to be as far back as the most retracted leaf (Figure 1.3). When using this
method the interleaf leakage of the leaves that are not backed up by the jaws is
hard to avoid. Another method employed on the new Elekta Agility head is to
align the focus of the MLC divergence on a different point to the beam divergence
(Thompson et al. 2014).
Figure 1.8: Approaches taken by different manufacturers for reducing inter-leaf
leakage.
Leakage between the ends of closed leaves. To ensure a consistent penum-
bra over the range of leaf movement, MLC leaf ends are normally rounded; even
if the leaves were to shut, the point at which they touched would offer limited
shielding. This problem can be avoided if the closed leaves are not left in the
centre of the field but moved to the edge so they are under a jaw. Or a jaw that
moves perpendicular to the leaf movement can be used to cover the closed leaves.
Leaf transmission. Technical issues prevent the leaves being so thick that
they attenuate all the radiation, a typical leaf thickness is about 7cm; this is
sufficient to reduce the intensity of the primary beam to about 1%. This is still
not ideal for clinical treatments but the backup jaws serve to limit the overall
transmission.
Typically leaves project to between 0.25 and 1cm at the isocenter. The light
projection through a shape defined by MLC will have quite jagged edges leading
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one to think that the ability of the MLC to conform to the smooth edges normally
found in nature would be poor, however, the effect of scatter inside the patient
smooths the resulting dose distribution (Figure 1.9).
Figure 1.9: Isodose contours produced by a MLC that projects to 1cm leaf widths
at the isocenter. The smooth 90% isodose suggests that 1cm leaves are adequate
for accommodating for typical biological shapes. Taken from with permission
Brahme (1987)
1.3 Intensity Modulated Radiotherapy (IMRT)
1.3.1 Basic Principles
The MLC was initially used to conform the treatment fields to the shape of the
treatment site (Figure 1.9). However, the ability to generate small, irregular shapes
meant that beams could be built up through the superposition of a number of
smaller beams, or segments. The composite beams will have non-uniform fluence
distributions. With suitably advanced optimisation algorithms these beams can
be designed to have much higher levels of dose conformality and/or better sparing
of critical structures than could ever be achieved through 3DCRT planning, see
Figure 1.10 (Brahme et al. 1982, Bortfeld 2006, Webb 2003). This is expected
to lead to better treatment outcomes, despite generally coming at the expense
of an increased low-dose bath - though the benefits of high-dose conformality
typically out weigh the risks this brings (Chang 2015). On account of the varying
fluence across these beams this technique became known as Intensity Modulated
RadioTherapy (IMRT).
15
Figure 1.10: Five treatment beams treating a tumour with concave attributes
(right-hand picture). The varying intensities of the beams makes the resultant
dose conform in a way that would not be possible with conventional treatments
(left-hand picture) (Bortfeld 2006)
Using a MLC the intensity of a beam can be modulated two ways: Dynamic
modulation: the MLCs are moved while the beam is on or Step and Shoot: the
radiation is turned off while the leaves are moved.
Step and shoot The intensity of the beam is modulated by splitting it up in to
several segments. A segment is a small shape, defined by the MLCs, with some
fraction of the beam MUs being delivered through it. After the MUs are delivered,
the radiation is turned off and the MLCs are moved to define the next segment
shape before the next fraction of beam MUs are delivered. Any particular segment
shape is unlikely to bear much resemblance to the tumour outline but the resultant
dose distribution will match the shape of the tumour.
Dynamic IMRT: The beam aperture is changed while the beam is on (Convery
& Rosenbloom 1992, Mayles et al. 2007, Cho 2018). The dose is proportional to the
time in-between the leading edge of the MLC passing – exposing the volume – to
the trailing edge passing – blocking the volume and the dose rate during this time
(Figure 1.11). Intensity Modulated Arc Therapies (IMAT)(Palma et al. 2010) are
where IMRT is delivered while the gantry is rotating. There are a number of brand
names associated with this, but VMAT - initially an Elekta term - has become
the generic term. VMAT plans have been shown to have equivalent or superior
dose distributions to static arc IMRT techniques, with the main advantage being
a reduction in delivery time (Otto 2008, Palma et al. 2010, Ling et al. 2008).
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Figure 1.11: Generation of one-dimensional intensity-modulation with one leaf
pair in the unidirectional ‘sweep’ mode (from left to right), the intensity at every
point x is proportional to the difference between time tB(x) when the edge of the
leading (B) leaf crosses point x and starts the irradiation, and time tA(x) when
the trailing (A) leaf crosses over point x and stops the irradiation. Taken with
permission from Bortfeld (2006).
Inverse planning 3DCRT treatments are planned by first contouring the
CT scan. This involves delineating various features of the disease and organs
at risk, as discussed in ICRU (1994) and ICRU (1999). In conventional forward
planning, using a Treatment Planning System (TPS), beams are set at different
angles determined by a mix of protocol and experience. The planner modifies the
beam weighting, MLC shape and wedging in order to get the best dose distribution
possible. After each amendment to the set up the plan needs to be recalculated
for the new dose distribution evaluated. The plan can be visually assessed or a
more quantitative assessment can be performed by analysis of the DVH. IMRT
provides significantly increased degrees of freedom and enables inverse planning
to be used. Inverse planning involves the plan undergoing the same contouring
process, after this though the target doses or dose constraints are defined for
the clinical volumes. The TPS then uses iterative methods to achieve the most
suitable beam and segment choices so that the dose constraints are met. The
iterative process is unlikely to achieve all of the dose objectives and compromises
will have to made; what constraints are compromised is determined by clinical
importance and appropriate priority can assigned by attaching certain weights to
the different constraints. The TPS assesses the plan in terms of a cost function;
Equation 1.15 shows the cost function for n dose constraints where DD is the
delivered dose, DR is the required dose and W (n) is the weight - or importance
- of the constraint. The aim of the iterative planning process is to minimise the
cost function (Webb 2003, Brahme 1988b).
cost =
∑
n
W (n)× [DD(n)−DR(n)]2 (1.15)
Treatment volumes will be patient specific, yet the same treatment site in
different patients will, in most cases, require a similar planning paradigm. It
is this assumption that leads to the development of the class solution; this is a
starting point for the iteration. The use of the class solution not only speeds up
the computing process but reduces the likelihood of reaching a false optimisation.
It has been demonstrated that when plotting the cost function value as a function
of iterations, one can sometimes observe local minima, the planning algorithm may
perceive these as optimal and end the iterative process. In this way, the starting
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point of the iteration affects the finishing point and starting with a good guess
increases the chance of an optimal finish (Webb 2003).
The ability to increase the conformality of the treatment dose brings with it
obvious advantages. With this in mind, it is now recommended that any patient
with locally advanced head and neck (H&N) cancer should be treated with IMRT
(SCoR 2015). Following an investment of 23 million pounds by the government,
the percentage of patients in the UK receiving inverse-planned IMRT has risen
from fewer than 14% in 2012 (Cancer Research 2019) to over 40% nationally
with some centres delivering 100% of their radiotherapy with advanced techniques
(NATCANSAT 2019).
1.4 QA and Verification of IMRT Dose delivery
IMRT provides the opportunity to deliver more conformal treatments than 3DCRT
yet these advanced treatments are more susceptible to geometric errors which, in
radiotherapy, translate to dosimetric uncertainty (Thwaites 2013). Furthermore,
although delivery techniques may have changed, the dosimetric accuracy require-
ments discussed in Section 1.1.2 remain the same. It is the role of the multi-
disciplinary radiotherapy team to ensure the geometric uncertainties associated
with radiotherapy are minimised so that IMRT can be delivered with minimal
uncertainty, thus ensuring optimal clinical outcomes.
1.4.1 Patient and set-up uncertainty
The patient’s position needs to match the CT scan position used for the dose cal-
culation in order for the dose to go where it is intended. To account for variability
in patient position and patient size, set up uncertainty and machine variability
expansion margins are applied to treatment volumes (Van Herk 2004). However,
IMRT dose distributions can be much more conformal, so whereas a 3DCRT plan
might have less conformal dose distributions such that a movement of the patient
would still result in the CTV being covered by the treatment dose, movement of the
patient receiving a highly conformal IMRT delivery could cause the CTV to move
outside the treatment-dose volume. This will result in a loss of tumour control
and, if OARs are near the treatment volume, an increase in NTCP. X-ray Volume
Imaging (XVI) is now standard on new linacs and Image Guided Radiotherapy
(IGRT) is becoming increasingly common for radical treatments. The consequence
of improved imaging is increased certainty regarding the patient position and posi-
tion of the OARS and treatment volumes. This gives greater assurance for highly
conformal treatments and even allows a reduction in the expansion margins applied
to treatment volumes (RCR 2008b).
1.4.2 Beam shaping uncertainty
For 3DCRT deliveries, field shapes are roughly conformed with the projection of
the PTV at a specific gantry angle. Tolerances on leaf and jaw position were
built in to margin recipes so that the CTV was always covered by the beam.
Typically tolerances of 2mm (projection at isocentre) on leaf and jaw position were
recommended (AAPM 2009). IMRT deliveries typically contain small segments
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and will usually involve the MLC obscuring part of the treatment volume. In
the case of a 3DCRT plan, systematic errors in the position of the leaf bank -
modifying the position of all the leaves for all the treatment - would affect the
edge of the PTV. The same fault in a IMRT plan will affect the dose across the
whole target volume, discussed more in Section 6.1. Ultimately this means that, in
order to maintain dose certainty with IMRT deliveries, much higher, more stringent
tolerances are placed on MLC position accuracy with figures <1mm recommended
(IPEM 2018, AAPM 2009, Thwaites 2013). These tight tolerances demand a lot of
the linac’s leaf positioning equipment1. Ensuring this level of positional accuracy,
leading to confidence in dose delivery is one a key role of the radiotherapy physicist.
This is achieved through:
• MLC Quality Assurance (QA)
• Pre-treatment verification
• In-vivo dosimetry
MLC QA There are number of tests currently recommended to ensure that the
MLC is performing optimally (IPEM 2008, AAPM 2001, IPEM 2018). The tests
should be a part of a quality system ensuring that they are performed at appropri-
ate intervals and subject to locally-derived tolerances (Thwaites et al. 2005, Leer
et al. 1998, British Standards Institution 2000). These are designed to inspect the
following aspects of the system controlling the leaf positions:
• Independent movement of the individual leaves
• The relationship between leaf pairs
• Movement of the leaf banks
• Relationship between the leaves and collimators (IPEM 2018).
Patient-specific pre-treatment verification Pre-treatment verification is
recommended by a number of bodies (IPEM 2008, AAPM 2018). Generally the
process involves a recalculation of the treatment plan on a phantom, delivery to
that phantom then a comparison of the calculated and measured dose. Point
doses can be measured by a chamber but increasingly, the preferred method is
to use a detector array to measure and compare the dose in a plane or volume.
The results from these arrays are normally subjected to gamma index analysis
(See Appendix A); this approach has been shown to be capable of detecting small
offsets in leaf positions (Fredh et al. 2013). Increasingly, the measured signal is
processed and projected on the patient’s CT scan allowing a clinical evaluation of
the dose delivered by the linac. This is an improvement on an assessment based
metrics derived from the more-arbitrary gamma index analysis of the distribution
as it can be difficult to interpret what these mean with regard to the dose received
by the patient (Schreiner et al. 2013). Although it is not a widely adopted stance,
it is the opinion of the author that verification of a representative collection of
treatment plans with a array-style device represents a complete test of the linac
beam and and its ability to deliver a clinical dose distribution. Although sensitive
to errors it lacks specificity, but appropriate implementation could reduce the
11mm at the isocentre corresponds to about 0.3mm at the leaf edge
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monthly QA burden by allowing the omission of beam tests that have little direct
clinical relevance.
1.4.3 In-vivo dosimetry
A good QA program ensures that the MLC is working well. Pre-treatment verifi-
cation ensures that a plan is deliverable and that the TPS-generated dose matches
the dose delivered by the linac. However, these tests only imply that the dose
will be delivered correctly. With the sub-millimetre demand on the accuracy of
MLC necessary to maintain dose certainty to the level where clinical outcomes are
not compromised, measurement of the plan as it is delivered to the patient seems
prudent. Implementation of intra-fraction measurement, or In-Vivo Dosimetry
(IVD) is not simple and comes at considerable cost. The next chapter looks more
thoroughly at the case for IVD and reviews devices and methodologies for imple-
menting it. This leads to the objective of this work on the characterisation and
use of the DAVID transmission dosimeter.
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Chapter 2
Literature review
2.1 What is in-vivo dosimetry
In vivo is the Latin for within the living. Whilst some devices and techniques
do allow dose to be measured inside a patient, in radiotherapy the term generally
refers to the measurement of dose received by the patient during treatment. This
is in contrast to ex vivo or in vitro measurements that are made before or after the
treatment with a phantom as a surrogate for the patient (Mijnheer et al. 2013).
Whilst measuring the dose received by the patients seems a prudent step it is quite
difficult to implement. IVD measurements must either use detectors that do not
attenuate the treatment beam too much, or rely on the measurement of dose that
is exiting the patient.
2.2 The case for clinical IVD
2.2.1 Radiotherapy errors
Sadly there have been a number of radiotherapy errors; some of the errors discussed
in the following section appear in the Chief Medical Officer’s report that concluded
IVD should become routine in the UK (Donaldson 2007, Department of Health
2006)
North Staffordshire 1994
Radiotherapy treatments can be delivered isocentrically or with fixed Source to
Surface Distance (SSD). In the 1980s fixed SSD deliveries were prevalent mode of
delivery. At the North Staffordshire Royal Hospital (NSRH), when a patient was
treated with a fixed-SSD treatment that was not a metre, a MU scaling factor
was applied. In 1982 the centre acquired a new TPS that automatically applied
this correction for non-isocentric fields, unfortunately this was not known to the
staff. Between 1982 and 1991 all isocentric treatments delivered at NSRH had
an unnecessary scaling factor applied to them resulting in the under dosing of
over 1000 patients by between 5 and 35%. In cases where the sole modality of
treatment was radiotherapy, and the reduction of the dose was 20%, typically
bladder and prostate cases, the chance of these patients being disease free in 5
years was reduced by 50% (Ash & Bates 1994, Scottish Executive 2006).
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Leeds 2004
In 2004 Leeds Teaching Hospital (LTH) used Theraplan Plus as a TPS. Theraplan
lacked networking capabilities and the treatment field data was sent to the treat-
ment set on paper where it was manually entered into the treatment database.
As with all deliveries, multiple checks were performed on the database entry, but
none of these detected the initial data entry error. Unfortunately the error was a
failure to enter the planned use of a wedge. Elekta units use a physical wedge. The
wedge attenuates the field, so more monitor units are needed to deliver an equiv-
alent dose than would be delivered by an open field. Typically this is three times
as much. In this instance, the patient was subject to the MUs for a wedged field
that did not have a wedge in place, receiving 94 Gy compared to the prescribed
40 Gy (Toft 2004).
Glasgow 2006
In 2006 Lisa Norris, a patient at the Beatson Oncology Centre (BOC), received a
dose 58% higher than planned (Scottish Executive 2006). The patient had been
diagnosed with pineoblastoma and prescribed both chemotherapy and radiother-
apy. The radiotherapy prescription was 35 Gy in 20# (1.75Gy per #) to the whole
Central Nervous System (CNS) followed by 19.8 Gy in 11# (1.8Gy per #) to the
tumour bed.
The BOC had just upgraded their Treatment Planning System (TPS) so that
it was more integrated with the Record and Verify (R&V) system. Prior to the
upgrade the paper treatment form stated the Monitor Units (MUs) for the treat-
ment in terms of Normalised Monitor Units. If the TPS calculated that, to
deliver 2Gy (200cGy), 50MUs were required, then the treatment form would have
had on it:
MU
FractionDose
= NormalisedMU (2.1)
50MU
2Gy
= 25MU per 100 centiGray (2.2)
In order to get the daily treatment MU, the treatment radiographers would need
to multiply the normalised monitor units by the fractional dose (in centiGray) and
divide by 100.
DailyMU =
MU per 100 centiGray × Fractional Dose(cGy)
100
(2.3)
DailyMU =
25× 200
100
= 50MU (2.4)
After the upgrade this round-about process was streamlined. Paper forms were
no longer used and Normalised MU was replaced with MU. However, on
account of the complexity associated with entire CNS deliveries, the new system
was not adopted and the old, paper-based system with normalised monitor units
was kept in place. In the case where the error occurred, the planner wrote the
MU on the form, not the normalised MU. When the treatment radiographer
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applied the scaling factor, a larger MU was calculated and used for the treatment.
The patient was given almost 60% more dose for the treatment fields irradiating
the head. When another CNS patient was planned by the same planner and
the same mistake made, it was found out before treatment started; the internal
investigation it prompted uncovered the first error.
Panama 2000
In a centre in Panama, the TPS calculated the MUs for a treatment as if the beam
were attenuated by a complete lead sheet, not, as intended, a lead sheet with a
cut out. Consequently the MU calculated by the system was much higher, as was
the dose delivered. At the time the report was published in 2001, 5 people had
died as a direct consequence of this error (Vatnitsky et al. 2001). This is discussed
in greater detail in Appendix B.1.
Epinal 2004
At the Epinal Hospital in May 2004 the decision was made to replace the use
of physical wedges with dynamic wedges for prostate treatments. A failure to
understand the subtleties of the TPS user interface led some members of staff to
plan with physical wedges. The number of MU being calculated and transferred to
the treatment unit was, in these cases, much higher than intended for treatment
with dynamic wedges. Lack of proper checking software and procedures allowed
this practice to continue until new checking software, that lead to the discovery of
the problem, was installed in August 2005. During this time 23 patients had been
mistreated (Ash 2007, Wack et al. 2007).
2.2.2 New York 2005
At a New York Hospital in 2005 a patient was treated for H&N cancer; the first
four fractions were delivered as prescribed. On reviewing the plan the doctor
wanted to increase the shielding to the teeth, so the treatment was re-planned for
the fifth fraction. The TPS generated new optimal fluences and was in the process
of calculating the MLC positions and movement. However the computer crashed
and the MLC information was not saved, but, critically the fluence information
was. The plan was reopened on another computer, with the fluence information,
but not the MLC data. Dose can be and was calculated with just the fluence
information, the plan was reviewed and sent the the linac for delivery. The plan
was delivered with the jaws in a fixed position and the MLCs retracted - their
default position in the absence of MLC data in the treatment plan. 39Gy in 3
fractions was delivered to the patient’s neck, from the base of skull to the larynx
with life-threatening consequences (Bogdanich 2010).
Central to this treatment error was a computer failure that led to MLC data
transferred to the linac which did not correspond to MLC positions that would
generate the dose in the reviewed plan. Due to time pressures, the QA checks were
not followed that were in place to catch errors of this nature.
2.2.3 Arguments for and against IVD
Radiotherapy errors can be avoided by
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• Thorough and appropriate commissioning of radiotherapy equipment.
• A well thought out and implemented physics QA program.
• A high standard of patient care and treatment by radiographer staff.
• Appropriate use of up-to-date planning, checking and record and verify soft-
ware by properly trained staff.
• Comprehensive quality system.
It is not the intention to replace any of the above measures with IVD; personal
patient monitoring should be used to catch the very small fraction of cases that
manage to get through the system; on these points most agree (Feldman et al.
2001). Discussion on the subject tends to focus on whether implementing an IVD
system is the best use of typically limited resources.
Harrison & Morgan (2007) and Mackay & Williams (2009) question the cost
and effectiveness of implementing a IVD system. While neither suggest that IVD
is a bad idea they question its use for all patients and suggest that both the time
and money could, in a resource-limited environment, be better spent on the devel-
opment of advanced techniques to produce better patient outcomes. The author
suggests that, given the very low incidence of major radiotherapy errors, it may
be possible that development of advanced techniques that result in better treat-
ment outcomes, reduced toxicity and fewer cases of recurrence in large numbers
of patients could have a more positive impact on the population’s health than a
nation-wide implementation of of IVD that would only benefit a vanishingly-small
fraction. However, this proposition is almost impossible to prove.
Harrison & Morgan (2007) also point out that a lot of the radiotherapy inci-
dents that are used to justify IVD were brought about through transcription errors
and are, in modern radiotherapy centres, almost entirely eliminated through the
widespread uptake of electronic transfer of data with software to perform data-
transfer checks.
Harrison & Morgan (2007), Mackay & Williams (2009), Klein et al. (2005),
Munro (2007) question the effectiveness of IVD in its ability to detect clinically-
relevant treatment errors, however, their discussion is largely focussed on point
measurements made with a diode. The limitations of this approach are discussed
in Section 2.3.1 and newer technologies, discussed later in this chapter, have shown
to be better tools for IVD.
Mijnheer et al. (2013) recognise that a comprehensive QA program and addi-
tional patient-specific verification on IMRT deliveries should negate the necessity
for IVD and that there is, at present, limited hard evidence to show value in IVD.
However, with the increased complexity of modern IMRT treatment techniques
that have higher demand on the linac’s engineering, they recommend IVD be per-
formed. Mijnheer et al. (2013), Munro (2007), MacDougall et al. (2017) advocate
the implementation of IVD. Mijnheer et al. (2013) state that ideally IVD should be
performed on all radiotherapy fractions. Recognising this is not possible in most
radiotherapy centres, they recommend that IVD be performed, in some capacity,
on all patients receiving radiotherapy with radical intent and if this is not possible,
then, at the very least, the recommendations issued by IAEA (IAEA 2013) should
be followed. These state that IVD should be performed when:
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• Introducing new treatment protocols or irradiation techniques.
• Changing treatment equipment.
• Implementing new software, such as upgrades of planning systems, machine
controlling software, network communication, or patient management sys-
tems.
• Carrying out total body or total skin irradiations.
• Delivering single fraction treatments.
• Performing treatments with curative intent where the dose is close to normal
tissue tolerance.
Other international bodies to recommend the use of IVD include the World Health
Organisation (WHO 2008) and the International Commission on Radiological Pro-
tection (ICRP 2001).
Although economic advantages of delivering IVD have been discussed (Williams
& McKenzie 2008, IPEM 2006, Mackay & Williams 2009), for the author the key
motivations for performing IVD are:
• Assurance that advanced techniques are being delivered with the accuracy
necessary to be confident that planned dose distributions match delivered
doses so that clinical outcomes are not compromised.
• In the wake of a number of incidents, reassurance that patients being treated
with radiotherapy are safe.
2.2.4 Conclusion: IVD in the UK
The North Staffordshire, Leeds and Glasgow errors in Section 2.2.1 were discussed
in the annual report by the chief medical officer released 2006. Consideration of
these events and the rapidly advancing field of radiotherapy led the chief medical
officer to include in the report’s recommendations that: “IVD radiation checks
should be made routine” (Department of Health 2006).
This was followed by Towards Safer Radiotherapy (BIR 2007), released in 2007
this document contained official recommendations by radiotherapy professionals
based on the report by the chief medical officer. Among other things, it outlined
the need for departments to have a quality system and what to have in them;
it categorised errors and defined vernacular and systems for reporting them and
recommended the use of IVD.
For centres that did not have a quality system, implementing one takes time
but does not require any new equipment. Likewise for error-reporting protocol. On
the other hand, implementing IVD takes considerable resources in terms of physics
setting it up and radiographer training as well as the capital outlay necessary to
buy the equipment and software. These were the main reasons why the reaction
to the report was not entirely positive (Section 2.2.3). In response to the reaction
to the IVD recommendations in Towards safer radiotherapy a report came out in
2009 (RCR 2008a). This short document stated that implementing IVD should
be done taking into account the risk, potential benefit and cost associated with its
deployment. Risk, in this case, could be the diversion of resources away from other
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important duties. Echoing the statements made by IAEA (2013) and Mijnheer
et al. (2013) it also highlighted that priority should be given to new or more-
unusual treatments. Releasing this document took the pressure off radiotherapy
centres allowing radiotherapy professionals to consider options and not rush into
costly decisions to comply with Towards Safer Radiotherapy.
In 2014, supported by Public Health England, the Radiotherapy Board
comprising of representatives from the Institute of Physics and Engineering in
Medicine, Royal College of Radiologists and Society and College of Radiographers,
requested a review and update of the response to Towards Safer Radiotherapy (BIR
2007). In vivo dosimetry in UK external beam radiotherapy: current and future
usage was published in 2017 (MacDougall et al. 2017). In order to determine
the current IVD practices and make appropriate recommendations, it conducted
a nation-wide survey in the summer of 2014.
In summary, 73% of providers said that they were routinely using IVD, when
compared to 37% of providers performing routine IVD in 2008 (Edwards et al.
2007). The report demonstrated that although Department of Health (2006) had
provoked some debate, the response was, on the whole a more widespread uptake
of routine IVD. Of the 27% not routinely performing IVD, only a small fraction
said that they had no intention of doing so. Of the centres routinely performing
IVD, 85% were using diodes with 15% using EPIDS. It was noted that the large
percentage associated with diode usage reflects historical practice with the report
commenting that diodes were not appropriate for IVD of highly modulated fields
or arc deliveries.
The first recommendation made by MacDougall et al. (2017) was that: “RT
providers should implement local protocols for verifying therapeutic radiation dose
is delivered as prescribed.” Some of the other recommendations suggested that
emphasis should be placed on the development of the still-emerging EPID-based
approach. However, MacDougall et al. (2017), like the other UK recommenda-
tions (Department of Health 2006, BIR 2007, RCR 2008a) and the international
recommendations (IAEA 2013, ICRP 2001, WHO 2008), did not state what ap-
proach should be taken by radiotherapy providers to implement IVD. The rest of
this review is concerned with looking at the devices and techniques for performing
IVD in the radiotherapy clinic.
2.3 Devices for IVD
2.3.1 Point detectors
Diodes
Diodes are small semi-conductor devices that typically lie on the skin of the pa-
tient during treatment and give a real time reading of dose. In addition to these
favourable properties, they are mechanically robust and have no need for an ex-
ternal voltage. These properties are probably why, until recently, diodes were the
most commonly used in vivo dosimeter in the UK (MacDougall et al. 2017) and
US (AAPM 2005). Unfortunately, the diode’s response is a function of field size,
dose rate, temperature and accumulated dose; as a consequence they need regular
calibration. Higgins et al. (2003) perform monthly calibration; Mijnheer (2008)
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and Huyskens et al. (2001) report an accuracy of 1.5% and 1.6% (1sd) respectively
if the devices are well calibrated. Even with good calibration, the response of
diodes depends on the angle of the beam; the response can change by as little as
2% for angles 45o but can be as high as 8% for angles above 60o (depending on
the manufacturer (Higgins et al. 2003)) This makes them less than ideal for use
as an in-vivo dosimeter.
Also, despite not requiring an external voltage, most diodes must be attached
to a cable during acquisition meaning that it is impractical to place the device
at the treatment site. Some wireless systems do exist but these have yet to have
widespread uptake.
Despite these shortcomings (Huyskens et al. 2001) implemented an in-vivo
program that was able to detect both major (>10%) and minor errors (<10%) in
therapy delivery. They concluded that a “5% action level was appropriate” though
in some cases (tangential or wedged beams) a higher 6-7% action level might be
more practical.
TLDs
Thermoluminescent Devices (TLDs) are small (∼ 1mm) detectors; the response
has little dependence on temperature, dose rate or therapeutic energy. They do
not require an external voltage and have the major advantage over diodes in that
they do not require cabling during acquisition, making them useful for intra-cavity
applications. Though it should be noted that the heating process required to
extract the signal is time-consuming and work intensive (Izewska & Andreo 2000).
The fact that TLDS do not require a wire is probably the main advantage over
diodes, but this facet also highlights their biggest shortcoming: the inability to
produce real-time readings (Mijnheer 2008).
2.3.2 Discussion
At the time when Towards Safer Radiotherapy (BIR 2007) was released, diodes
and TLDs were the most common technology appropriate for the role of in-vivo
dosimeter. International reports released around the same time (IAEA 2013) rec-
ommended them for this purpose. In the case of diodes, this led them to be
the most widely-used device for performing IVD (MacDougall et al. 2017, AAPM
2005). However the point-like nature of these devices has rendered them increas-
ingly obsolete as radiotherapy delivery techniques have advanced. While it is
possible to place TLDs internally (Azor´ın 2004) and perform in-vivo dosimetry in
the truest sense of the phrase, this resource-heavy invasive procedure comes with
its own risks and is rarely performed in practice. Typically both TLDs and diodes
are placed on the skin surface. The measured dose is then compared to the dose
calculated at the same point in the TPS. There are a number of problems with
this approach. Firstly the detectors are sensitive to back scatter and must be
placed flush with the patients skin; in the case of TLDs bolus material is normally
necessary. Also with wedged and IMRT fields, that can create high dose gradients
across the field, the position of the detector is critical. With scope to get the set up
wrong, the tolerances on point measurements tend to be quite high, often 5% and
sometimes, as high as 10%. Assuming the diode is perfectly placed, a tolerance of
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10% equates to a difference in SSD of 5cm. So it might be stated that as the diode
is on the patient, it’s sensitive to patient set up (Edwards & Mountford 2009), but
it is the opinion of the author that a detector that is not sensitive to a difference
in SSD of 5cm does not adequately verify the patient set up.
The most significant limitation of point detectors in the context of modern
radiotherapy was brought about through the advent, and widespread uptake, of
arc therapy. Typical use of diodes requires them to be placed on the surface
where the beam enters. In the case of a seven-field step-and-shoot IMRT delivery,
treatment staff will have to enter the room several times to re-site the diode.
For a VMAT deliveries, it is not possible to get a meaningful result. It is now
recommended that “diode-based point dose measurements are not appropriate for
verification of dose delivered when treating with highly modulated, rotational or
adaptive techniques” (MacDougall et al. 2017).
2.3.3 Electronic Portal Imaging Devices
Electronic Portal Imaging Devices (EPIDs) are MV imaging panels initially devised
for verification of patient set up. The amorphous-silicon-flat-panel EPID now
comes as standard with every linac install (MacDougall et al. 2017). These devices
are comprised of a method to convert radiation dose deposition into a light signal, a
light detector and a readout system (Van Elmpt et al. 2008). The X-ray converter
is constructed from amorphous silicon which also gives the device its name. The
silicon is, at an atomic level, inherently disorganised meaning that the panel,
which images in the main beam, is less susceptible to radiation damage. The
fast sampling time, high resolution, digital output and linear dose response that
is independent of dose rate proved to be an effective MV-energy imaging device
(Van Elmpt et al. 2008). A combination of the a-Si EPID’s attributes and its
increasing ubiquity make it a strong candidate for performing in-vivo dosimetry.
EPIDs as IVD devices have a number of advantages:
• They are included as standard on all modern linacs making hardware costs
low.
• They are sensitive to patient set up.
• They do not perturb the beam or affect the delivery in any way.
In many ways, EPIDs represent the ideal IVD device. However, they were not orig-
inally intended to be used as dosimeters, the fact that they are not in widespread
use for IVD reflects the complexity in managing this limitation. Turning the EPID
signal in to a patient dose is non-trivial, this is largely down to the tendency for
amorphous silicon EPIDs to over respond to low energy scatter. There has been
some success in using EPIDs to determine a point dose in a patient (Piermattei
et al. 2007, Celi et al. 2016), but it is only recently that the use of the EPID to
back project a 2/3D dose in the patient CT has been turned in to a commercial
product (Delaby et al. 2017). The NKI solution has been implemented in the
clinic and an initial report given of its use on 4337 patients. 17 serious errors were
found, 9 of these would not have been discovered without EPID-based IVD (Mans
et al. 2010). Wider-spread implementation is under way (Ricketts et al. 2016) and
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investing resources in the development of this technology is recommended (Mac-
Dougall et al. 2017). Time will tell if this iteration of the software is feasible in
the typical clinic.
2.3.4 Log File analysers
Linacs record the position of the MLCs, Jaws, gantry and collimator during treat-
ment and save them in a log file that is available to the user. It has been shown
that analysis of these log files can detect delivery errors in Elekta (Tyagi et al.
2012, Fontenot 2014) and Varian (Litzenberg et al. 2002, Rangaraj et al. 2013,
Vazquez-Quino et al. 2017) machines. Mobius3D (Mobius Medical Systems, Hus-
ton, TX, USA) is a commercial system that uses the beam shaping positions in
the log file and plan file to calculate the dose on the patient CT using a collapsed
cone algorithm (Childress et al. 2012). The dose calculated using the plan file acts
as a secondary MU check (see Appendix B.1), the dose calculated using the log
file is described as the delivered dose and serves as a check of the dose actually
received by the patient (Fontenot 2014, Mobius3D 2019). The system has been
commissioned on both Elekta (Nelson et al. 2016) and Varian (McDonald et al.
2017).
There are a number of advantages to log file analysis:
• The process can be automated and performed on each delivery saving con-
siderable time.
• It has been suggested that this sort of analysis is more sensitive to errors
than planer or point dose measurement (Rangaraj et al. 2013, Childress et al.
2015)
• The analysis can be very specific. Unlike the gamma assessment, the analysis
performed by the Mobius software allows the dosimetric impact the error
has made on the plan to be determined. The exact cause is also identified,
reducing the time it takes to remedy a machine-based error (Childress et al.
2015).
There are two key shortcomings with log file analysis. The first is that the beam
profile and energy are generally not reported; the processing software assumes that
the beam matches the beam model data exactly. Although the machine should in-
terlock if the beam energy or profile changes significantly, there is scope inside the
tolerance values for the beam to be asymmetric and have slightly different energy
values bringing in to question the accuracy of the “delivered dose” calculation per-
formed by the software. Furthermore, any error that results in beam instabilities
not causing an interlock will go undetected. This leads in to the second, and, for
the author, the key problem with log file analysis as a form of in-vivo monitor-
ing: the lack of independence. It is quite possible that the information in the log
file might not reflect a delivery error - if a significant error was detected by the
machine, then it should interlock anyway. One purpose of IVD is to detect errors
when these interlocks have failed. Although machines are subject to strict protocol
that dictates the accurate calibration of beam shaping apparatus (AAPM 2009,
Childress et al. 2015) there have been cases where these values have been reported
incorrectly and only detected via a QA measurement. (Agnew et al. 2014).
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Log file analysis is currently being implemented by both Elekta and Varian
users in a number of centres for treatment delivery validation (Tyagi et al. 2012,
Fontenot 2014, Litzenberg et al. 2002, Rangaraj et al. 2013, Vazquez-Quino et al.
2017, Nelson et al. 2016, McDonald et al. 2017). The debate regarding its effec-
tiveness continues (Childress et al. 2015).
2.4 Transmission detectors
2.4.1 Introduction to transmission detectors
Transmission detectors are flat-panel detectors that can be attached to the head
of the linac - normally using the fixtures that hold the accessory tray or electron
applicators. Transmission detectors can accurately monitor the linac output and
can, in some cases, interrupt the beam in the event that the output deviates from
the baseline by more than pre-determined presents (Islam et al. 2009, Pasler et al.
2017). In this way, unlike IVD devices previously discussed, transmission detectors
have the potential to actually prevent a fault or error causing serious harm.
In the case of an EPID measurement, the radiation has passed through the
patient allowing it to assess the patient set up. The upstream nature of trans-
mission detectors mean that they have no way of reviewing the patient set-up.
Furthermore, by necessarily obscuring the whole field, they will, to varying de-
grees, attenuate the beam. This can be accommodated for by applying a scaling
factor to the treatment MU, however this does introduce an element of risk. By
interacting with the beam prior to the patient they also act as a secondary electron
source and have been shown to increase the number of contamination electrons at
the surface by up to 18% (Asuni et al. 2011).
MacDougall et al. (2017) describe transmission detectors as an emerging tech-
nology with potential for use as a daily treatment monitoring tool. However, on
account of the limited clinical experience or published works on the subject, the
discussion was limited to little more than an acknowledgement that transmission
detectors existed and could be used for IVD. What follows is a more in-depth
review on specific models of transmission detector.
2.4.2 Slanted-plate transmission detector
Design
Islam et al. (2009) developed a large-area, transmission-style ionisation detector.
The detector is made up of three, 22cm square, plate electrodes. Two polarising
electrodes sandwich the collecting electrode. The polarising plates and inner col-
lecting plate are 3.18mm and 1.59mm thick respectively; with a PMMA frame the
total thickness of the detector is 4cm.
A particularly novel aspect of this design is that polarising plates are placed
at an angle to the collecting plate (Figure 2.1). The collection efficiency is propor-
tional to the plate separation so, in having a varying plate separation, the chamber
is made spatially sensitive in one dimension. If the chamber were to be irradiated
with a small square field towards the end where the plates are closer then the sig-
nal would be larger than if the plate were to be irradiated by the same field where
the plates are further apart. The gradient of the polarising plates is subject to a
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compromise between the sensitivity to spatial change; the plate separation varies
linearly from 2 to 20mm corresponding in a signal change of approximately 0.5%
per mm. The operation of large-plate like ionisation chambers is often hindered
Figure 2.1: Transmission detector relying on varying sensitivity, brought about
by varying proximity of the collection electrode and polarising electrode, to give a
spatially sensitive signal (Islam et al. 2009)
by the fact that electrometers can saturate in normal usage due to the amount of
charge collected. Electrometers that are capable of integrating the large amounts
of charge generated normally do so at the expense of the resolution of small charge
readings. Islam et al. (2009) have overcome this problem by using two electrom-
eters“operating in a switching configuration”; this allows currents over the range
of 0.5nA – 0.5mA to be collected accurately. The details of the system are not
important here, but while one electrometer is set to collect the other is set to rest,
the roles are changed when the collecting electrometer nears saturation.
Islam et al. (2009) also came up with a way of predicting the signal based on
the characteristics of the detector, the MUs to be delivered and the geometry of
the MLCs as shown in Equation 2.5.
Scalc = MU × k ×AOF (X,Y )×
∫
A1
F (x, y)b(x, y)dxdy
+
∫
A−A1
TMLC(x, y)F (x, y)b(x, y)dxdy
+
∫
R−A
TJaw(x, y)TMLC(x, y)F (x, y)b(x, y)dxdy
(2.5)
WhereMU is the monitor units, k is a system constant, AOF(XY) is the integrated
output factor for the jaw settings (this was found empirically), F dictates the
fluence distribution (including penumbra) and b is the detector response. The later
two integrals in Equation 2.5 refer to leakage with T corresponding to transmission
through either the MLCs or the Jaw. A is the open aperture, A1 is the active
area covered by the MLCs and R the active area covered by the jaws.
Testing and discussion
Islam et al. (2009) found the electrometer system to be “stable and reproducible”
with a linear dose response in the range of 1-2000 MU. The observed dependence
on dose rate was a variation of 0.2% over the range 100 – 600MU min-1. An 11
segment prostate treatment was delivered and the average agreement was 0.5%
with a maximum deviation of 3.5% per segment. This was repeated with a H&N
treatment with an average agreement of 0.9% and maximum standard deviation of
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5%. In both cases the largest discrepancies were seen in the smaller-area segments.
Most of the results were lower than 1% and it was thought by (Islam et al. 2009)
that the errors could be reduced if the smaller segments were combined with a
larger adjacent segment. However, the difference signal from the total delivery
when compared with predicted responses was found to be <1%.
Further testing was completed by artificially introducing probable errors to
square fields. A 15cm2 field was reduced by 1mm in width simulating a leaf bank
error; the result was a 0.7% disagreement with the result from a true 15cm2 field.
This was repeated with a square field of 3cm2 the disparity was seen to increase
to 3%. The movement of a single leaf by 5mm in a 3cm2 field generated a 2%
difference to the signal (Islam et al. 2009). Variations in machine output were
matched by equivalent variations in the device and a change in energy from 6 to
10MeV reduced the signal by 6.3 +/- 1.5% (Pasler et al. 2017).
More realistic scenarios were tested by artificially introducing leaf bank errors.
15 clinical treatment plans were used; 5 prostate, 5 H&N and 5 partial-arc breast
VMAT plans, planned on Pinnacle (V.14 Philips Radiation Oncology Systems,
Milpitas, CA) and delivered on an Elekta Synergy linac (MLCi2). The plans with
the errors in were delivered to the device and compared to the signal generated
from the delivery of the unmodified plans. 2mm and 1mm unidirectional leaf bank
shifts were seen to have a limited (<1%) effect on the signal. This was deemed
by the authors to be of little consequence as recalculating the modified plans on
in the planning system showed that these shifts made negligible differences to the
calculated dose distribution. Leaf bank shifts toward and away from the central
axis resulted on average in a +/- 17.9% difference and 5.4% difference from the
unmodified signal for 2mm and 1mm respectively with positive increases in dose
for movement away from the axis and negative for toward (Pasler et al. 2017).
The effect of the device on the beam characteristics was generally negligible
with the most significant difference being a 3% rise in surface dose (Islam et al.
2009). The reproducibility of signal generated from VMAT plans was ∼ 1% (Pasler
et al. 2017).
This detector has an interesting design with a novel approach to incorporating
spatial sensitivity in the direction of leaf movement. The aluminium composition
makes the device opaque to visible light which means that the Optical Distance
Indicator (ODI)1 cannot be used and optical field matching cannot be performed.
This could be compensated for by making the finished product easy to slide in and
out of position, but this solution is far from ideal in a working environment.
Unfortunately, sensitivity in the direction of leaf travel is gained at the expense
of spatial sensitivity in the direction perpendicular to the leaf movement. So, while
the device is able to detect single leaf errors, it is not able to pinpoint their origin
(Islam et al. 2009). Also, though the leaf-direction sensitivity is one of the key
selling points of the design, it is shown that 2mm unilateral moves in the leaf bank
do not generate a deviation from the baseline that is above the uncertainty in
the measurement of 1% (Pasler et al. 2017). Furthermore, even if the device were
sensitive to these errors, DVH analysis of unilateral shifts demonstrated that they
have limited clinical impact. Leaf errors and their effects are discussed more in
Section 6.1.
1Beam of light shone through a calibrated graticule so a projected image displaying the SSD
is visible on the patient’s surface
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The method of predicting the signal (Equation 2.5) was applied to 1 prostate
and 1 H&N and was seen to agree with the total signal generated by the delivery
of the plans to within 1% (Islam et al. 2009). This promising result does not seem
to have been followed up in subsequent work.
2.4.3 COMPASS
IBA Dosimetry (Germany,Schwarzenbruck) have created a patient-specific QA
system that consists of three parts: The MatrixX detector (Godart et al. 2011,
Nithiyanantham et al. 2015), The Dolphin Transmission Detector (DTD) (Thoelk-
ing et al. 2016a) and the COMPASS software. The COMPASS software can per-
form several functions (Thoelking et al. 2016b):
1. Import patient images, structures and DICOM plans from the TPS and
calculate the dose in the patient with a collapsed cone algorithm. In this
way it acts as independent check of the TPS dose calculation (See Appendix
B.1).
2. Import and analyse the measurement from the MatrixX detector array for
the purposes of patient-specific pre-treatment verification.
3. Import the measurements from the DTD for plan verification during the
patient’s treatment.
The DTD is a 2D array consisting of 1513 vented parallel-plate ionisation cham-
bers2 that cover an active area of 24 cm2. This projects to a 40 cm2 at 100cm SSD
when measuring at SDD 60 cm. The centre-to-centre distances of the chambers
range from 0.5cm to 1cm. The height and diameter of the individual chambers are
0.2cm and 0.32cm respectively (Thoelking et al. 2016a). With the DTD in posi-
tion there is an increase in surface dose that is field size and SSD dependent. A
maximum of 11% higher than without the DTD in place for a 30cm2 field at 80cm
SSD, this was however deemed clinically acceptable. The PDD below DMAX was
observed to vary by less than 1% with the DTD in place. Although the MU factor,
to correct for the attenuation of the beam by the device, was seen to vary slightly
by field size, a generic value was used for all IMRT plans assessed in the study.
When subject to 2%/2mm gamma index analysis, no significant differences were
seen between the IMRT distributions with and without the DTD in place (Thoelk-
ing et al. 2016a) similar results were found through Monte Carlo techniques by
Nakaguchi et al. (2017).
The device was tested in more realistic clinical scenarios by delivering 18 clin-
ical step-and-shoot IMRT and VMAT plans for various sites with the DTD in
place. The previously-evaluated (Godart et al. 2011, Nithiyanantham et al. 2015)
MatrixX was also used to asses the delivery at the same time. Both recorded
equivalent gamma scores for all of the plans.
It would appear that the strongest attribute of the IBA system is the facility
to use the DTD signal to reconstruct the delivered dose inside the patient’s CT
data set. This allows a three-way comparison between the delivered dose, the dose
2IBA seem to have abandoned a similar design that used diodes (Stasi et al. 2010), this is
because of the effect that it was having on the treatment beam (Asuni et al. 2011, Venkataraman
et al. 2009, Thoelking et al. 2016a).
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calculated by the Collapsed Cone (CC) algorithm (Ahnesjo¨ 1989) in COMPASS
and the planned dose distribution from the TPS (Thoelking et al. 2016b). This
feature was tested by making such a comparison between the aforementioned 18
plans. The subsequent distributions were then subject to 3D gamma index analysis
as outlined by Stock et al. (2005) and Visser et al. (2013) with evaluation criteria
of γ < 0.4 = pass, 0.4< γ < 0.5 = evaluate, γ > 0.5 = fail. When comparing
the CC dose, the dose generated from the DTD and the TPS dose, 16 of the
18 plans passed with 2 falling in to the evaluate criteria. As the dose has been
reconstructed inside the patient data set, in theory, a clinician could evaluate the
delivered dose. However the study chose to quantify the clinical assessment by
comparing DVH parameters on target and OAR structures. The average dose to
the target and 95% coverage dose calculated from the DTD signal were compared
to the CC-calculated dose; averaged over all plans the differences were found to
be found to be -0.8 +/- 0.5% and -1.3 +/- 0.6% respectively. Dose to OARs was
overestimated by 2%, but most of the specific indices were < 2%. These results
demonstrate that the dose reconstruction inside the patient based on the delivered
signal captured by the DTD is good enough to be used clinically (Thoelking et al.
2016b), the same conclusion was reached by Monseux et al. (2016)
In a method similar to that used by Pasler et al. (2017) the ability of the
DTD to detect errors was assessed by intentionally introducing errors in to RTP
files, delivering them to the detector and comparing the reconstructed dose by
means of 3D gamma index analysis and DVH-evaluation. 3%/3mm gamma values
increased from 0.29 +/- 0.03 for the unmodified plans to 1.03+/-0.32 for the plans
with a 1mm shift of the leaf banks toward the central axis. This implies that these
errors, according to the passing criteria already discussed, would be detected by
the system. Like Pasler et al. (2017) unidirectional shifts were more difficult to
detect and were not evident in the gamma assessment. However, the authors
claimed that the errors were evident when the dose distribution was compared to
the unmodified dose as there was a significant difference around the edge of the
treatment volumes. Output errors of -2 and +3% resulted in gamma values of 0.79
and 0.61 respectively demonstrating that they would both be detected.
Interestingly, although DVH analysis highlighted the output errors by showing
an equivalent increase / decrease in dose, the leaf bank errors were not evident
(Thoelking et al. 2016b). This is unexpected as errors of this magnitude have been
shown to have clinical impact (Zhen et al. 2013, Rangel & Dunscombe 2009, Oliver
et al. 2010). It would have been useful to see the modified plans calculated in the
TPS and compared to the unmodified plans also calculated in the TPS. This way
difference in dose calculation could have been ruled out and the difference, or lack
of difference, between the plans could have been attributed to the characteristics
(eg modulation) of the plans.
The Dolphin-Compass combination provides a complete patient-specific system
for IMRT QA. The equivalence between the results from the MatrixX and the DTD
show that pre-treatment QA with just the Dolphin array is possible. It is the intra-
treatment monitoring where the solution excels. While 3D gamma index analysis
is possible, it is often difficult to relate gamma values to clinical consequence and in
some cases, errors with clinical effects can pass gamma criteria (Appendix A). The
ability to reconstruct the delivered dose in the patient CT provides the opportunity
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for well informed clinical decisions to be made in the event of a delivery error.
2.4.4 The DAVID
Construction and design
The Device for Advanced Verification of IMRT Deliveries (DAVID) is a transmis-
sion detector consisting of two Perspex blocks that sandwich a vented air gap;
inside the air gap are thin wires that line up with MLC pairs (Figure 2.2). Incom-
ing radiation scatters inside the Perspex blocks, the electrons move into the air
gap and are influenced by the potential between the aluminium (evaporated on
to the surface of the Perspex and held at a +ve voltage) and the collection wires
held at ground (Figure 2.3). Consequently, a charge builds up on the collection
wires that is proportional to the radiation incident on the detector. By making
the device out of clear Perspex and ensuring that the aluminium layer is very thin,
the device is transparent; allowing the ODI to be used with the DAVID in place
(Poppe et al. 2006).
Figure 2.2: The DAVID
The DAVID device is specific to the linac head model as each detection wire
needs to line up with a MLC pair: more MLCs – more wires. As a result, the
cross-field resolution of the DAVID depends on the MLC head in use (Figure 2.4).
Poppe et al. (2010) point out that in moving from a DAVID with 37 wires to one
with 80 as a consequence of a new head; the resolution went from 10mm to 5mm.
Error detection capability and clinical implementation of the DAVID
Poppe et al. (2010) performed pre-clinical testing on the DAVID for its error
detecting capabilities by purposefully introducing errors to a 25 fraction treatment
with a fraction taking place daily. These artificial errors included:
• The mis-positioning of three leaves of the MLC – leaves 14, 17 and 20 were
displaced by 2mm in the 15th fraction.
35
Figure 2.3: Primary and Compton-scatter events contributing to the signal mea-
sured at the central wire.
Figure 2.4: Beams-eye view of an IMRT segment showing the MLCs (green) and
the collection wires - each lining up with a leaf pair, in the direction of leaf travel.
• The omission of a single segment – during the 19th fraction a segment was
omitted
• The sudden change of the photon fluence simulated by removing the cross
hair reticule
• The change of photon energy – the 25th fraction was irradiated with a 10MV
beam instead of a 15MV beam.
The record and display system employed by Poppe et al. (2006) was designed
so that the integrated signal for the whole fraction was displayed on the screen;
the individual columns – indicative of the signal received by each wire – were
subdivided by horizontal lines indicative of a segment. For each of the artificially-
introduced errors, the DAVID system detected the fault. Poppe et al. (2006) also
showed that the “relative deviations remained below 1% of the mean signal except
for very low signals” indicating that the normal fluctuations of the DAVID are
below the signal changes caused by errors. In another test of the devices’ stability,
the fluctuations of all the wires in an 8 fraction H&N treatment were never found
to deviate outside 3% alert threshold.
The DAVID was used over an 8 month period during which 35 IMRT plans were
subject to daily verification the results reported in Poppe et al. (2010). In this time
the device performed well exhibiting good levels of stability and detecting three
clinically relevant errors. The first one demonstrated the DAVID’s sensitivity,
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detecting a 1% change in the linac output. The dose per MU was changed due to
the findings of a monthly QC session; the treatment continued but a new reference
measurement was taken with the DAVID to account for the change. The DAVID
consistently detected a fault at the field border, when this was investigated it was
found that a collimator block was incorrectly calibrated. The final case involved
a plan modified midway through a treatment. When the new field was imported
the MLC information was lost and the linac irradiated the patient with a square
field that was instantly picked up by the DAVID.
When Poppe et al. (2010) was published the DAVID system had verified over
50,000 segments.
Origin of DAVID signal
The signal measured at any wire is made up of three components (Poppe et al.
2006) (Figure 2.5):
• The fluence of radiation above that particular wire.
• The scatter radiation formed in the Perspex by radiation incident on other
parts of the surface.
• The leaf and inter-leaf leakage.
Poppe et al. (2006) quantifies these signals empirically. The main signal is charac-
terised by opening the leaf pair associated with the test wire. The scatter signal
is analysed by keeping the test-wire leaf pair closed and varying the square field
size with all the other MLCs and jaws. The leakage radiation was found by col-
lecting a signal with the MLCs closed – this was deducted from the other results.
The analysis consisted of plotting the signal as a function of leaf separation and
then as a function of square field length - both exhibited a near-linear fit. The
non-linearity manifested itself, in both cases, as a slight curvature of the response
- this was attributed to the effect of the flattening filter.
The current paradigm for using the DAVID to perform in-vivo dosimetry in-
volves planning the treatment and verifying the treatment plan with the DAVID
in place; if the plan passes the verification then the DAVID signal recorded during
the verification is used as a baseline for the treatment. Subsequent treatments are
then performed with the DAVID in place and the resulting signal compared with
the baseline acquired during verification.
Looe et al. (2010) went a step further by demonstrating that the signal can be
described mathematically as the convolution of the photon fluence with the lateral
response function (Equation 2.6).
S(x) =
D∑
ζ=1
P (ζ)fζ(x) (2.6)
Where P (ζ) is the photon fluence, ζ is the number pertaining to the leaf pair,
fζ(x) is the lateral response function (LRF ), x is the wire associated with the
response and D is the total amount of wires.
The LRF describes the fractional contribution to the signal at any wire (posi-
tion denoted by x) as a result of the fluence through any leaf pair (position denoted
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Figure 2.5: Lateral response function. Signal as a consequence of one open leaf
pair is recorded at a number of wires. The signal reduces as the distance from the
open leaf pair increases.
by ζ) and is normalised as shown in Equation 2.7
D∑
x=1
fζ(x) = 1 (2.7)
The LRF can be characterised by closing all the MLC leaves apart from one, irra-
diating the DAVID and recording the response from all the wires. Although only
one wire will be irradiated by primary radiation the wires next to the wire asso-
ciated with the open leaf pair will measure considerable scatter radiation (Figure
2.5) (Looe et al. 2010). Poppe et al. (2006) observed that the sum of the signals
from the adjacent wires was approximately equal to the response from the wire
under the open leaf.
The DAVID Conclusion
Out of the devices discussed in this section, the DAVID is the only one that is
transparent, meaning that it can be in place whilst the ODI is used. Unlike the
COMPASS solution (Section 2.4.3) the DAVID lacks the ability to translate the
signal into patient dose. However, it has been shown to be sensitive to small
changes in leaf and jaw position (Poppe et al. 2006) and has even been used in
practice to detect such errors (Poppe et al. 2010).
The detector array discussed in Section 2.4.2 has been designed to be spatially
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sensitive to errors in the leaves in the direction of leaf travel, in contrast, the
DAVID has been designed to be spatially sensitive to errors in the direction per-
pendicular to leaf travel. Unilateral leaf-bank errors will not be detected by the
DAVID, however unilateral errors of 2mm were not detected by the slanted trans-
mission detector and it has been shown (Section 6.1) these have limited clinical
impact. The DAVID, like the slanted array and COMPASS system, is sensitive to
leaf bank shifts towards and away from the isocentre (Poppe et al. 2010, 2006).
Although all the detectors are sensitive to individual leaf errors the DAVID can
detect very small miscalibrations (∼1mm) and isolate the associated leaf pair.
The DAVID, though lacking the complex analysis of the COMPASS detector
is sensitive to clinically relevant leaf and jaw errors. The device is easy to use and
produces a real-time output allowing the treatment to be interrupted in the case
of serious errors. Poppe et al. (2010) have shown the device to be appropriate and
useful for routine clinical monitoring of radiotherapy treatments.
Discussion on Transmission detectors
Is it in-vivo? Transmission detectors, by virtue of their position, have the poten-
tial to accurately describe the characteristics of the radiation beam. Their major
shortcoming, at least with regard to in-vivo dosimetry, is that the response will
contain no information about the patient (Edwards & Mountford 2009). Post-
patient transmission dosimeters and ones that lie on the patient’s skin will have
a response that is dependent on the position of the patient while, with upstream
transmission detectors, it would be possible to deliver the treatment and verify it
even if there was not a patient on the couch.
Electron contamination and the effect on the beam Any transmission de-
tector will, to some extent, attenuate the beam. There are two methods of com-
pensating for the attenuation: increase the monitor units delivered or recollect
commissioning data for the TPS with the device in place. The first method is a
similar method to that used to compensate for the Perspex tray that was used to
hold lead blocks in early conformal treatments. Increasing the monitor units has
the advantage of being simple to implement but lacks the sophistication to deal
with potential beam hardening effects, resulting in the behaviour of the radiation
inside the patient not being correctly modelled in the TPS. Measuring the TPS
commissioning data with the device in places offers a complete solution to the
beam hardening problem, however any treatment planned with the software using
the data collected from the detector must be delivered with the detector in place.
This could have practical issues in a department where not every machine is using
a detector all the time, meaning two sets of treatment planning data would need
to exist for each linac. This over complication increases the likelihood of an error,
treatments being delivered with/without the detector in place when the detector
should not/ should be in place. The DAVID system addresses this by having an
accessory coding system so the treatment beam will not deliver if the DAVID is/is
not in place and it should not/ should be (Poppe et al. 2010).
Electron contamination is present in any external beam radiotherapy treat-
ment. Electrons will be produced by the interaction of the radiation with the air,
ionisation chamber, head shielding etc. Contaminant electrons are undesirable as,
if they hit the patient, they increase the surface dose which can cause or contribute
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to conditions like erythema, fibrosis, necrosis and epilation (Asuni et al. 2011).
In the case of the beam being blocked by a material with thickness greater than
the range of secondary electrons, the majority of the secondary electrons created
in the head apparatus are stopped and the material itself becomes the primary
source of electron contamination (Asuni et al. 2011, Venkataraman et al. 2009).
So, transmission detectors, by their very nature, will change the characteristics of
the electron contamination when compared to an open field.
Asuni et al. (2011) examined the effect the COMPASS detector (Section 2.4.3)
has on the electron contamination. They state that specific information such as
energy spectra, angular distribution and fluence distribution of the contaminant
electrons are required to understand the effects fully. Acknowledging that this
information is difficult to determine experimentally Asuni et al. (2011) quantify
it with Monte Carlo modelling using the EGSnrc distribution (Kawrakow et al.
2000). It was shown that modifications needed to be made to the electron contam-
ination models of commercial treatment planning software to accurately model the
beam with the COMPASS detector in place. In the case of the Eclipse anisotropic
analytic algorithm (AAA) (Varian Medical Systems, Palo Alto, CA) this modifica-
tion was a 12% and 15% increase in the Gaussian widths used in the contaminant
electron source model. In the case of the Collapsed Cone algorithm used by Pinna-
cle, the off-axis coefficients needed to be reduced to accurately model the device.
It was concluded that modifying the treatment planning dose-calculation algo-
rithm was “a necessary step for accurate beam modelling when using the device”.
Though its analysis is limited to surface effects, no attention is given to clinical
target doses or OARs other than the skin. Without this information, it would
appear that drawing such strong conclusions is a little premature.
The findings in Asuni et al. (2011) match those of Venkataraman et al. (2009)
and Stasi et al. (2010) who found experimentally that the presence of the COM-
PASS detector affected surface dose and the dose in the build up region; the effect
beyond dmax was found to be negligible. Venkataraman et al. (2009) showed that
the attenuation was about 3.3% (they conclude a transmission factor of 96.7%)
and Stasi et al. (2010) show that the beam is attenuated by between 3.5 and 4%.
Venkataraman et al. (2009) and Stasi et al. (2010) differ from Asuni et al. (2011)
in that they suggest that the problem can be dealt with by introducing a trans-
mission factor for deliveries with the COMPASS attached as opposed to modifying
TPS variables.
The DAVID is 10mm thick (Figure 2.3); the section that the beam passes
through is almost entirely Perspex - the metal wires used for signal collection are
thin enough to have a negligible effect on the dose once scatter and beam divergence
have been taken in to account. Despite the thin Perspex some attenuation will
occur; transmission factors of 0.953 +/- 0.001 and 0.968 +/- 0.001 have been
measured at energies of 6 MV and 10 MV respectively Poppe et al. (2006). A
surface dose increase when the DAVID was attached was also described by Poppe
et al. (2010) who found that it was proportional to field size. Interestingly, Poppe
et al. (2010) also showed a surface dose decrease for very small field sizes and noted
no significant difference in transmission factor observed for different SSDs.
Poppe et al. (2010) states that the MU delivery was altered “by a correction
factor applied at the end of the treatment planning procedure” to compensate for
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the DAVID detector but admits that “another option would be the commissioning
of the planning system in the presence of the DAVID system in the beam”.
For the purposes of comparison, Poppe et al. (2010) includes a table of the
normalised dose enhancements to tissues at two depths as a result of transmission
detectors (Table 2.1)
SSD 70 SSD 150
Energy D = 1.5cm D = 3.5cm D = 1.5cm D = 3.5cm
DAVID 10 1.13 1.08 1.05 1.03
DAVID 6 1.06 1.04 1.02 1.01
COMPASS 6 1.37 1.16 1.1 1.04
Table 2.1: Dose enhancement as a result of two different transmission detectors at
two depths (D) copied from (Poppe et al. 2010)
2.5 Conclusion and discussion of intended work
In-vivo dosimetry is now a recommendation for all centres providing radiother-
apy treatment in the UK (BIR 2007). There is growing demand for an affordable
device that will perform accurate IVD on many-field/arc treatments. Point detec-
tors, although a viable option for traditional treatment regimes, are not practical
for advanced treatment. EPIDs present a viable solution and there are currently
several projects under way to realise the EPIDs potential. Transmission detec-
tors are quite a new concept in the in-vivo field and at present this developing
technology lacks large-scale uptake and investigation. The DAVID detector has
been shown to be a stable and reliable device, sensitive to small errors in leaf
position and is less costly than other array-like detectors. However, the DAVID
still needs a baseline, acquired on the linac, to compare subsequent on-treatment
measurements to. This is a time-consuming procedure as it not only requires that
DAVID to be in place, but the linac delivery, while the DAVID is recording the
baseline, needs to be verified by another device - otherwise, the baseline signal
could be incorrect (maybe as a result of a transfer error) and subsequent treat-
ments could be verified against this incorrect measurement. Furthermore, with
the increasing prevalence of Online Adaptive Radiotherapy (OART) (Franks &
McNair 2012, Roussakis 2016), where there is limited time between plan creation
and plan delivery, the need for an accurate baseline reading without the use of a
linac is desirable.
In this work I intend to investigate the characteristics of the DAVID device
with the intention of being able to predict the response of advanced deliveries in
order to facilitate intra-fraction monitoring of radiotherapy that is both efficient
and safe.
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Chapter 3
Preliminary work for
predictive algorithms
3.1 Introduction
At the time of writing, published work on the DAVID has been limited to descrip-
tion of its design (Poppe et al. 2006), manipulation of its recorded signal (Looe
et al. 2010) and discussions about its use and implementation (Poppe et al. 2010,
Chandraraj et al. 2010, Karagoz et al. 2014). In the absence of published work
on the topic, this chapter is concerned with ascertaining if the device behaves in
a predictable fashion. Initially acting as a proof of principle by showing that the
DAVID’s response can be predicted in limiting cases, this chapter is a precursor
to developing a predictive algorithm for the more general case in Chapter 4.
3.1.1 Simple Deliveries
Preliminary tests were performed that related the response of the DAVID to the
machine output and the field size. While maintaining a square field size of 10cm
10, 50, 100 and 200 MUs were delivered by the linac, the response from the two
central wires was averaged and plotted as a function of MU (Figure 3.1). Then
100 MU was delivered through square field sizes of 2.5, 5, 10 and 20cm2, again the
average response of the two central wires were plotted as a function of field size
(Figure 3.2)
The linear relationship of the DAVID response between machine output (Figure
3.1) and radiation field size (Figure 3.2) implies that it should be possible to predict
the response of the DAVID if sufficient information is provided about the radiation
field.
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Figure 3.1: DAVID response (average of the two central wires) as a function of
delivered MU for a 10cm square field
Figure 3.2: DAVID response (average of the two central wires) as a function of
field size
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The DAVID response at a single wire is a consequence of primary and scatter
radiation. The radiation incident on the detector from the aperture created by
the leaf pair associated with the wire (leaf separation), is defined as the primary
radiation. Radiation incident on the detector elsewhere, but scattering inside the
Perspex plate to the collection volume of the wire is defined as the scatter radiation
(Figure 3.3). Figure 3.4 shows the response of the DAVID for the case where one
leaf pair is open and the others are closed.
Figure 3.3: Primary and Compton-scatter events contributing to the signal mea-
sured in the central wire.
Figure 3.4: Response of all DAVID wires for a single leaf pair opening of 10cm (a
leaf pair with each leaf separated from the central axis by 5cm)
The wire associated with the open leaf pair is obviously distinguished by having
the largest response (wire 16). The wires adjacent to it (15 and 17) show a response
that is clearly above background, and the wires adjacent to these (14 and 18)
also show a response that is higher than the background. Apart from wire 16,
the signal recorded in this plot is the result of scatter, leakage and penumbral
radiation. Although these will contribute to the signal seen in wire 16, the main
source is primary radiation.
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3.2 Two basic predictive algorithms
A DICOM plan was created that moved equivalent leaves in opposite banks. All
leaves started off closed 1; there was a 10MU delivery then a leaf pair was moved so
that the separation was 5mm; after a 10MU delivery each leaf was moved 2.5mm
so that the separation was 1cm and another 10MUs were delivered. This process
was repeated until each leaf had moved 5cm and the separation was 10cm, all
leaves were closed and the process started again. This was performed for each of
the 10 central leaf pairs (leaf pairs 16 to 25), the results were sorted into an array
referred to hence forth as the R-matrix (Figure 3.8). Figure 3.5 shows the response
of the wire associated with leaf pair 20 during the deliveries through leaf pairs 18
to 22. The scatter signal associated with the opening of adjacent leaf pairs can be
seen both before and after the primary response.
The response of wire 20 in Figure 3.5 to the opening of leaf pair 20 demonstrates
what shall now be referred to as the primary response - the response of a wire as
a consequence of the leaf pair above it opening. The response of wire 20 to the
opening of leaves 19 or 21 is the adjacent response. The response of wire 20 to the
opening of leaves 18 or 22 is the second adjacent response. As described earlier
in this chapter, leaf pairs 16 to 25 were sequentially opened and 10MUs delivered
through each leaf separation, the data shown in Figure 3.5 for wire 20 was collected
for wires 16 to 25. The primary, adjacent and second adjacent responses for each
of these wires were collected and averaged to give a general relationship between
these responses and the leaf separation (Figure 3.6). The collected responses and
the relationships shown in Figure 3.6 were used to create two algorithms that
would predict the response of the DAVID to simple fields that only used the 10
central leaves for 10MU deliveries.
Figure 3.5: The response of the wire associated with leaf pair 20 during deliveries
through leaf pairs 18 to 22
1Closed leaf positions corresponds to a separation of 2.5mm to avoid crashing the leaves into
each other due to uncertainties in the linac control systems
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Figure 3.6: Primary, adjacent and second-adjacent responses to a leaf pair opening
with deliveries of 10MU. Errors represent +/- 2 standard deviations of the results
associated with the response. The second adjacent response was not used in the
linear fit algorithm as its inclusion did not improve the accuracy of the predicted
signal. This is likely to be because the second adjacent signal is small and the un-
certainty associated with it is higher when compared to the primary and adjacent
relationships.
3.2.1 Method
Two different approaches were used to write two different algorithms, both with
the intention of predicting the DAVID’s response. The programs were tested with
basic field shapes shown in Figure 3.7. The results are shown in Figures 3.11 to
3.14.
Figure 3.7: Leaf apertures used to test the algorithms
Algorithm A: look-up method
The raw data used to generate Figures 3.5 and 3.6 were sorted into an array
(Figure 3.8). A program was written to use this array - the R-matrix - to predict
the DAVID response. The algorithm worked by first defining the S-matrix. This
is a 1×10 matrix where each element corresponds to the predicted response of
wires 16 to 25; initially all these values are 0 but the matrix was populated as the
algorithm generated a response due to each open leaf. Then, the algorithm scanned
through the MLC positions to identify the leaves that were open and calculate their
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separations. For each open leaf pair there was a row in the R-matrix that gave the
response for each wire, these values were extracted, the background subtracted
and added to elements 1 - 10 in the S-matrix. This process was repeated for
each open leaf pair and a background signal added to each of the final S-matrix
values. The R-matrix was populated using steps of 5mm. For instances where the
leaf separation in the test field was not a multiple of 5mm a linear interpolation
was performed between the two nearest values. A flow-chart outlining the whole
process is shown in Figure 3.9.
Figure 3.8: The R-matrix. How the data used to create Figures 3.5 and 3.6 was
stored to be interpreted by the look-up algorithm.
Algorithm B: Linear-fit method
This approach uses the fact that the primary and adjacent responses of the DAVID
are linear when plotted as a function of the leaf separation (Figure 3.5). The
gradients used to predict the response were found by averaging all the gradients
of the main and lateral responses for all the MLC openings (Figure 3.6). Like the
look-up algorithm the linear-fit approach started by first identifying the position
of the open leaves and calculating their separation. Assuming that a position of
an open leaf pair was above wire 19, the predicted signal of wire 19 could be
calculated using the linear relationship between primary response and the leaf
separation shown in (Figure 3.6). The predicted signal of wires 18 and 20 could
be calculated using the relationship between leaf separation and adjacent response
again shown in (Figure 3.6). The predicted signals of wires 18, 19 and 20 as a
result of the leaf pair above wire 19 would be added to the elements 3, 4 and 5
in the S-matrix. This process is repeated for each open leaf pair (Figure 3.10).
The S-matrix is a 1×10 matrix where each element corresponds to the predicted
response of wires 16 to 25. Initially all these values are 0; the matrix is populated
as the algorithm predicts the response of the DAVID to the open leaf pairs.
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Results
Four different test patterns (Figure 3.7) were used to compare the two algorithms.
In all four cases, the DAVID was attached to the head and exposed to the four
fields dictated by the MLC shape. In each instance, a 10MU delivery was used.
The results for algorithms A and B are shown in Figures 3.11 to 3.14.
Figure 3.11: Measured DAVID response and signal predicted by the linear fit and
look up algorithms for test shape 1
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Figure 3.12: Measured DAVID response and signal predicted by the linear fit and
look up algorithms for test shape 2
Figure 3.13: Measured DAVID response and signal predicted by the linear fit and
look up algorithms for test shape 3
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Figure 3.14: Measured DAVID response and signal predicted by the linear fit and
look up algorithms for test shape 4
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3.3 Discussion
Qualitatively it is clear, even through visual inspection, that algorithm B (linear
fit) predicts the DAVID response more accurately than algorithm A (look up).
The results shown in Table 3.1, where the sum of the absolute differences for each
wire between the predicted and measured signal are shown as a percentage of the
total measured signal, show this quantitatively. The difference is thought to be a
result of the way the background signal is handled. In the case of algorithm A,
the background is subtracted from each wire’s response associated with that leaf
opening; all these signals are then placed at their allocated position in the 10×10
matrix. The net signal is found by summing the columns and adding, to the
resulting line matrix, the background. Poor estimation of the background signal
will have a cumulative impact on this calculation. The effect of the background
value is less for algorithm B as this only uses the background value once for each
wire (as opposed to 10 times with algorithm A).
Algorithm Test shape 1 Test shape 2 Test shape 3 Test shape 4
Look up 23% 41% 9% 34%
Linear fit 4% 9% 1% 9%
Table 3.1: Sum of the absolute differences between measured and predicted signals
displayed as a percentage of the total measured signal.
This exercise has acted as a proof of principle, showing that it is possible
to anticipate the DAVID response. The lack of accuracy reflects the simplistic
methodology. By increasing the complexity and rigour when defining the variables,
the accuracy of the algorithm should improve.
The algorithms, as well as being quite simplistic, are only designed to handle
very limited cases. These include:
• Symmetrical displacement of the leaf pairs around the y-axis
• No MLC displacement outside the central 10 MLCs
• 10MU deliveries
For the project to move from a basic proof of principle to something with clinical
applications, it will be necessary to improve both the accuracy and the capability
of subsequent algorithms. This will be the subject of the next section.
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Chapter 4
An analytical model for
predicting the DAVID signal
4.1 Introduction
In chapter 3, it was shown that the DAVID response at a wire could be predicted
in limited cases. In this chapter, the complexity of the algorithm is increased to
include the effects of penumbra, jaw attenuation and varying MUs so that it can
be applied more generally. The more advanced algorithm is tested by comparing
the predicted response to the response measured by the DAVID for 10 clinical,
H&N, step-and-shoot IMRT plans. A methodology for the DAVID that includes
the predictive algorithm is proposed. The methodology’s ability to detect known
radiotherapy errors is discussed. Shortcomings in the algorithm, leading to a loss
in accuracy, are shown and suggestions for developments are made. The work and
findings discussed in this chapter were published during the writing of this thesis
Johnson et al. (2014).
4.2 Increasing the complexity of the algorithm
4.2.1 Introduction
In chapter 3, two algorithms were devised that predicted the response of the
DAVID for 10MU deliveries through basic, static, symmetric fields. In this section,
the previous work is expanded on to allow the prediction of any field. Work was
done to model the effects of:
• Varying MUs
• Scatter (more thoroughly)
• Jaw attenuation
• Penumbra
These are discussed in turn.
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4.2.2 Varying monitor units and leaf separation
Introduction and Method
In chapter 3, only deliveries of 10 MU were modelled. This represents a typical
IMRT segment; in practice however, there will be a range of MUs delivered per
segment (Qi & Xia 2013, Stieler et al. 2011). This section is concerned with
devising a scheme to accommodate varying MU deliveries.
A beam sequence was devised where 5, 10, 25, 50 and 100 MUs were delivered
through leaf separations of 20, 40, 70, 100, 150, 200, 300, 350 and 400mm. The
response measured by the collection wire associated with leaf pair 20 is shown in
Figure 4.1. The response of the DAVID for a specific leaf separation is linear. The
gradient associated with the response was calculated for each leaf separation, the
results were collected and plotted in Figure 4.2 .
Results
Figure 4.1: Signal as a function of MU for a variety of leaf separations (shown in
the key).
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Figure 4.2: A graph showing the gradients of the MU response to different leaf
openings (Figure 4.1)
Discussion
Figures 4.1 and 4.2 show that the response of the wire associated with an opening
leaf pair (primary response) is linearly proportional to both the MU and leaf
separation. So, for a given MU and leaf separation, Figure 4.2 shows that the
gradient (G) of the MU response can be determined (Equation 4.1) and given
the MU response Figure 4.1 shows that the primary response can be calculated
(Equation 4.2).
G = C × LS (4.1)
Primary Response = G×MU (4.2)
or:
Primary Response = C ×MU × LS (4.3)
Where C = 0.0004 (Figure 4.2) , MU is Monitor units and LS is the leaf separation.
4.2.3 Scatter
Using the data collected in Section 4.2.2, it was possible to anticipate the signal
output from the wire associated with an open leaf pair for any separation and for
any amount of MUs delivered. However, leaf arrangements used in clinical practice
will have more than one leaf open, meaning that the signal at any one wire will be
a result of the primary fluence above the wire and the scatter caused by radiation
incident on other parts of the detector. The scatter effect is seen in Figure 4.3.
In the algorithms devised in Chapter 3, this effect was modelled very basically,
neglecting the scatter from points further away than the wire immediately adjacent
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to the primary wire.
Figure 4.3: lateral response of 100MU being delivered through 100mm leaf sep-
aration with the jaws open. Taken from the data collected in the experiment
performed in Section 4.2.2
The data collected in Section 4.2.2 were used to model the effect of scatter. The
response of the four wires either side of the primary wire were normalised to the
main wire for each exposure. This was repeated for all the MU deliveries at this
leaf separation (10,20,50 MU etc.). Then, the average of these results was taken
for equivalent wires. This procedure was repeated for each leaf separation and
the results collected. Finally, an average was taken for the results at equivalent
distances. The normalised and averaged results were plotted as a function of
distance from the primary wire; the response was seen to be exponential (Figure
4.4 ). The lateral response shown in Figure 4.4 is characterised by equation 4.4.
L(d,w) = e(−1.447×D(d,w)) (4.4)
Where:
L is the response of the wire w as a fraction of the signal at wire d.
D(d,w) is the distance between wire w and wire d
Knowing from Equation 4.3 that the primary response of a wire is the
product of some constant, the leaf separation and the delivered monitor units, it
can now be said that:
Rw = C ×MU × Sepd × L(d,w) (4.5)
Where:
Rw is the scatter response at wire w from the radiation incident on the device at
wire d
Sepd is the separation of the MLCs above wire d - where the scatter response is
measured from.
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Figure 4.4: lateral response of 100MU being delivered through 400mm slit separa-
tion taken from the data collected in the experiment performed in Section 4.2.2,
the errors represent 2 standard deviations of the measured data.
L is the lateral response function (equation 4.4)
C is a constant
MU is the delivered monitor units
So the total response at a wire can now be described as:
Total =
∑
d
C ×MU × Sepd × L(d,w) (4.6)
Where d is the number of wires, in this case, 40.
Note that when the equation is calculating the response from the leaf pair imme-
diately above wire w, the distance (D(d,w)) becomes 0 so L(d,w) becomes 1 and
the response is determined by:
Total = C ×MU × Sepd (4.7)
This was shown earlier (equation 4.3).
Looking at this result, it can be seen that the total response to an IMRT segment
can be estimated through the convolution of the lateral response with the leaf
separation matrix with the result multiplied by the MU and the gradient factor
(C):
SegmentResponse = [LSmat ∗ L(d,w)]× C ×MU (4.8)
Where LSmat is a 1×n matrix where n is the number of leaf pairs. Each element
LSmat contains the separation distance of the corresponding leaf pair. L(dw)
is the lateral response function, C is the MU response gradient and MU is the
monitor units.
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4.2.4 Leaf leakage
In Chapter 3, all the calculations were performed with the jaws fully retracted.
This will not be the case for clinical deliveries where the jaws are used to reduce
unnecessary dose to the patient as a consequence of leaf and inter-leaf leakage.
The consequence of this is that leaves inside the field will have a different leakage
contribution to the signal than those outside the field.
Initial tests were done using a test field where leaves 10 and 31 were opened
(Figure 4.5) and 10, 20, 30 and 40MU were delivered through the set up. The
DAVID response was predicted using equation 4.8. The predicted response was
compared with the measured signal; the results can be seen in Figure 4.5. Figure
.
Figure 4.5: Convolution and measured results from the delivery of 20MU through
two open leaves (field shape in top right).
4.5 shows a reasonable agreement between the predicted and measured results at
the points where the leaves are open (sections b), but there is poor agreement in
sections A and C. Despite wires 5 and 15 both being equally displaced from wire
10, wire 5 records no signal whereas wire 15 does. Initially it was thought that
the signal at wire 15 could be a consequence of the scatter from both of the open
leaves. Wire 5, although the same distance from wire 10, is much further from
wire 31 than wire 15; this would suggest a shortcoming with the convolution. It
was noticed, however, that the signal recorded in section C is much more than
double the lowest signal recorded outside the field (wires 6 and 34). And, wire
20 is further from the open leaves than either of these low values are from the
primary response. The key difference between the field in section C compared
to that in section A is that, in section C, the leaves are not backed up by the
jaws. To accommodate this, a MU-dependent leaf-leakage factor was added to
each convolution result that was inside the open jaws. For plans where the jaws
are fixed throughout the delivery, this factor will be applied to the same wires for
each segment. Where the jaws do move, the wires having this factor applied will
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differ from segment to segment.
It is also evident from Figure 4.5 that the DAVID does not detect low fluence
scatter as no signal is recorded in the wires at the edges. The exponential nature
of the lateral response function meant that the algorithm will always get some
results outside the field. To stop this happening, thresholding is used to set the
signal at the wires more than four wires from the field edge to zero.
4.2.5 Penumbra
Introduction
As a consequence of geometry and the finite attenuation of the beam, the edge of
the radiation field is not completely distinct. The fluence drops from 80% of the
main beam to 20% at the edge of the field over a finite distance. This region is
termed the penumbra (Khan 2010).
The finite size of the source is responsible for the geometric penumbra – this
is the region with a partially blocked view of the source. As shown in equation
4.9, the width of the geometric penumbra (PGeo) is a function of the width of the
source (dsource), the distance from the source (F ) and the distance between the
source and the end of the collimator (S ) see Figure 4.6
PGeo = dsource × F − S
S
(4.9)
The transmission penumbra, a consequence of photons from the distal end of
a source passing through the collimator, will increase the width of the overall
penumbra still further. Efforts are made to ensure that the focal spot in a linac are
small (∼mm), however the flattening filter also acts as a secondary photon source,
broadening the apparent focal spot. The scattering of high-energy photons and the
scatter of secondary electrons outside the beam edge (without being compensated
for by electrons being scattered back in to the beam) also increases the penumbra
(Mayles et al. 2007).
Effect on the DAVID signal
As a consequence of the penumbra, the DAVID signal is seen to drop outside
the treatment field. Modelling this, however, poses a challenge as the signal is a
consequence of:
• Scatter radiation - from the radiation incident on the device in the treatment
segment
• Primary radiation from the segment’s penumbra
• Scatter from the segment’s penumbral radiation.
With the intention of making a simple algorithm that will be quick and easy
to use, it is desirable to have limited input variables allowing easy set-up and
implementation. With this in mind, an assumption was made that the out-of-field
signal was proportional to the signal of the last in-field wire. This is justified,
at least qualitatively, by looking at the components of both signals. The signal
recorded at the last in-field wire will be proportional to the scatter as a result
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.Figure 4.6: Diagram showing the origin of the penumbra; dimensions have been ex-
aggerated to illustrate the effect. Geometric penumbra (GP), transmission penum-
bra (TP) and full penumbra (FP)
of radiation incident elsewhere on the device, and the primary radiation from
the leaf pair associated with the wire. The penumbral radiation is made up of
scatter radiation from elsewhere in the device and some component of the primary
radiation from the last, open, in-field leaf pair. To test this assumption, the out-of-
field responses for 16 segments of an IMRT treatment beam were measured. These
were normalised to the last in-field signal. Results are shown in Figure 4.7; the
error bars are two standard deviation of the normalised results for the respective
points. This was implemented in the code by first calculating the in-field responses
then the out-of-field responses by multiplying the last in-field response by the
fractional values shown in Figure 4.7. For example, in the case of a 10×10 square
field symmetric about the beam centre, the signal associated with the five leaves
either side of the centre would be calculated using the lateral response function
and multiplying by the delivered MU and MU factor. The penumbral component
of the predicted signal for the wires associated with leaves 6, 7, 8 and 9 would
be calculated by multiplying the signal calculated at the wire associated with leaf
pair 5 by 0.82, 0.22, 0.05 and 0.01 respectively. The uncertainty associated with
the penumbral signal is much higher than the in-field signal. This is due to the
spread in the results that determined the size of the error bars in Figure 4.7.
This uncertainty was summed in the algorithm to calculate the total uncertainty
associated with the predicted signal for each wire, this is discussed in Section 4.4.
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.Figure 4.7: Average penumbral response as a fraction of the last in-field response
for 16 segments of an IMRT field.
4.3 Iterative assessment
The preceding sections in this chapter have outlined several parameters that, given
a treatment plan (that includes MU/seg and each segment’s leaf positions), are
able to anticipate the DAVID response. To summarise, the factors are: MU factor
(Section 4.2.2), lateral response exponent (Section 4.2.3), leaf leakage (Section
4.2.4) and 4 penumbral factors (Section 4.2.5). The values for each of these factors
were used in a MATLAB algorithm and applied to an imported treatment plan.
The subsequent predicted signals were compared with treatment plans delivered
on the linac. H&N plans are typically highly modulated making them a good
choice for use in this development work as they provide of more rigorous test of
the algorithm. 10 clinical H&N plans were selected and delivered three times; the
average for each beam and entire delivery (5 beams) were taken to reduce any
variability in linac output or DAVID response (the difference was never seen to
be >1%). Initial results were disappointing; Figure 4.8 shows the response for an
entire H&N IMRT delivery (5 beams ∼70 segments).
To try and improve the predicted response, a program was written that pro-
duced a predicted response and compared it to the measured DAVID signal. For
each of the algorithm factors listed above (lateral response exponent, 4 penumbral
fitting factors and the MU constant, C), the iterative process used a value lower
than the original as a starting point - this meant that if the optimal value was less
than the original it would not be missed by the stepping process. The difference
between the predicted and measured signal was calculated using the starting value,
then a single unit was added to the starting value and the difference between the
predicted and measured signal calculated again. If the result was better using the
second value another unit was added on and the process repeated until the results
starting getting worse. Then the unit was divided by 10 and was subtracted from
the test value and the process repeated - this way each decimal place was dealt
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.Figure 4.8: Predicted and measured signals for an entire H&N IMRT delivery
(5 beams ∼70 segments). Average local percentage difference = 23.4% Average
global (when the absolute difference was compared with the smallest of either the
maximum predicted signal or measured signal) percentage difference = 5.3%
with in turn, Figure 4.10 outlines the process. Let us assume that the original
value for a parameter was 2 and the optimal value 2.82. 1 would be used as a
starting value and this would be compared to the result gained using 2. The result
with 2 would be better so then 3 would be used, this would be better than 2 so
4 would be used however, this would be worse than 3. This process demonstrates
that the optimal value is somewhere between 2 and 3, to determine the second
decimal the order of precision was increase by a factor of 10 the results were calcu-
lated using 2.9, then 2.8 then 2.81 and ultimately 2.82 (Figure 4.9). This process
was done for each factor in turn and could go on for as many orders of precision
it was necessary until the impact the changes were making on the results were
negligible.
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Figure 4.9: The stepping process associated with achieving optimal value for each
model factor. The local minima - where the difference between the measured and
predicted values is smallest is found by changing the value for each factor involved
in the predictive algorithm by increasing levels of precision
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Import DICOM
plan; calculate
predicted response
Import mea-
sured DAVID
response
Compare predicted and
measured response - cal-
culate total difference (d1)
Add Xn to target vari-
able and recalculate
predicted response
Compare predicted and
measured response - cal-
culate total difference (d2)
Is d2 < d1
Yes
Have number
of iterations
exceeded limit?
No
No
Is n at re-
quired level
of precision?
No
Break - solution
reached at
desired precision
No
n = n + 1
Xn = (−1) × Xn−110
Yes
Break - No solution
reached. Review
input variables
Figure 4.10: Flow diagram outlining the iterative process for tuning the variables
associated with the predictive algorithm
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Although the iterative correction produced good results (Figure 4.11), are the
values it produced still sensible and valid in the context of the work that has
been done? If the values produced through the iterative method were wildly
different from expected values, it would suggest a shortcoming in the theory. The
values that were seen to change significantly were the lateral-response exponent
and the penumbral factors. The predictive algorithm was modified to include the
iteratively-optimised values. The MU response factor (C from Equation 4.8) was
not seen to vary with the optimisation, so kept the same. A summary of the
factors used in the algorithm can be found in Table 4.1.
.
Figure 4.11: Predicted and measured signals for an entire H&N IMRT delivery
(5 beams ∼70 segments). Average local percentage difference = 10.9% Average
global (when the absolute difference was compared to the smallest of either the
maximum predicted signal or measured signal) percentage difference = 3.1%
Factor Original Iterative result
Penumbra 1 0.821 0.932
Penumbra 2 0.219 0.347
Penumbra 3 0.052 0.106
Penumbra 4 0.009 0.039
C (MU constant) 0.0004 NA
Lateral response Exponent 1.447 1.404
Table 4.1: Original and iteratively-derived values for the factors in the algorithm
To ensure that the new values were in line with the theory discussed in this
chapter, they were compared with the values derived from measured data. The
lateral response derived from incrementally opening leaf pairs 1, 5 and 10 was plot-
ted against the lateral response derived through the iterative process. They were
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found to be consistent (Figure 4.12). These results also highlighted that the same
lateral response function is valid across the whole detector. The penumbral values,
derived through iteration, were also plotted against the ones found experimentally;
they were found to be consistent (Figure 4.13).
.
Figure 4.12: The lateral response derived through experiment by sequentially
opening leaf pair 1 2 and 5 plotted against the lateral response derived through
iteration.
The iterative correction worked well and, should a commercial piece of software
ever be made, including this would make implementation quite easy. The user
would need to get some approximate values for the predictive algorithm’s variables
and then the software, given a verified test plan, could tune itself.
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.Figure 4.13: Measured penumbral values (blue points and line, from Figure 4.7)
plotted against those derived through iteration.
4.4 Errors and assessment
4.4.1 Introduction
There needed to be a way of assessing the signals that was stringent enough to
highlight an error, while at the same time, not triggering when minor discrepancies
were detected. The percentage difference between two wires seems a sensible place
to start. However, in the case of out-of-field signals, that have small values – and
little clinical impact – the percentage difference can often be quite high (>50%)
(Figure 4.14) and not indicative of a fault in the machine’s output or delivery.
One possibility would be to ignore the out-of-field signals, although this approach
might miss some machine errors – eg leaves/jaws staying open outside the field
throughout the delivery. With this in mind, it was necessary to design a form of
assessment other than absolute percentage differences in the measured signals.
Normal distribution method
One idea was to look at the normal distribution of the difference in the results
– any distribution not centred on zero or with a high standard deviation would
indicate an error in the delivery. While this is an attractive idea in principle, the
fact that there are <40 results means that creating the normal distribution is not
always statistically justified (Figure 4.15).
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.Figure 4.14: Beam 4 of a five-field H&N IMRT delivery (top left) and a close-up
of the measured and predicted signals from wires 35–37 (bottom right). Despite
having large relative percentage differences, the absolute differences will have neg-
ligible clinical impact. Alerting the user to this error would be pointless
.
Figure 4.15: The measured and predicted response for an entire fraction are shown
on the left, the corresponding histogram of the differences between the two is
shown on the right. Although Matlab was able to fit a normal distribution, visual
assessment is less than convincing. This is typical of both the beams and fractions
for ten treatments.
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Global assessment
Although the local percentage difference in out-of-field signals might be large,
the absolute difference is quite small. Assessing this in the context of the entire
delivery proved a sensible approach. X% of the smallest maximum was used to set
a tolerance on the difference between the measured and predicted values for each
wire. What is meant by the smallest maximum? Both predicted and measured
signal sets have a maximum signal – it is the smaller of these two maxima that
is used to define the assessment metric. The reasoning behind this being that, if
there was a calibration error with the linac that resulted in a grossly increased
output, the higher maximum could potentially be large, thus increasing the size
of the assessment metric and, possibly passing the gross error. Using the lower
maximum avoids this possibility and makes a tighter tolerance overall.
Position-dependent errors
Both the measured and predicted results need to presented with a level of confi-
dence. Repeat measurements of the same plan on different days on different linacs
(three sets of data, two different linacs) showed that the uncertainty on the mea-
sured DAVID response to be of the order 1% which is consistent with the results
found by Poppe et al. (2006).
For the predicted signals, due to the variability in the penumbral signal (Figure
4.7), the uncertainty associated with these values was much greater. Uncertainties
of 1% and 3%, respectively, were given to the in-field and penumbral regions for
each segment. These values were summed in quadrature so that, in the case of
the final beam, the regions of the field primarily made up of in-field radiation had
a smaller uncertainty than those primarily made up of penumbral beam (Figure
4.16)
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Figure 4.16: Position-dependent uncertainties on a full beam (∼ 10 segments).
The error bars in region “F” are lower as the response in the section was largely
made up of in-field signals; the response in region “P” was made up of mainly
penumbral signals. More penumbral regions will results in higher levels of uncer-
tainty - because each beam is made up of a number of differently-shaped segments,
these levels of uncertainty are unlikely to be symmetrical.
4.5 Implementation
The signals of ten, five-field H&N treatments were measured with the DAVID and
compared to predicted values using the workflow outlined in Figure 4.17 . Each
plan was delivered three times and the average taken. The DAVID had some
difficulty resolving individual segments – some low-MU deliveries were often not
recorded as distinct segments. These were included in the signal for the next or
previous segment. Even if this only happens once, subsequent segments will no
longer be associated with the right position in the delivery order, making compar-
ison difficult. With this in mind, comparisons were made between measured and
predicted beams (about 15 segments) and whole fraction (5 beams) (Figure 4.18).
A tolerance (X% in Section 4.4.1) of 5% of the maximum was used for the beams
and 2.5% for the whole fraction (Figure 4.17).
In order to test the sensitivity of the algorithm, a calibration error was simu-
lated by both increasing and decreasing the MU of the imported plans by various
percentages. In addition to this, to asses the algorithm’s ability to detect more
coarse delivery errors, predicted results were compared to the incorrect measured
signals for beams and whole deliveries.
4.5.1 Results
The algorithm successfully predicted all the DAVID response for all ten plans, for
the whole fraction and for each beam in accordance with the tolerances discussed
in Section 4.5.
Where the predicted results were compared to the measured results from a
different beam or whole delivery the major difference between the two was obvious
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Figure 4.17: Pass/Fail workflow for the comparison algorithm.
and easily detected each time.
The simulated calibration error resulted in all of the plans failing when at both
plus and minus 5% errors were introduced.
The algorithm provides a quick way of predicting the DAVID signal and the tol-
erances and errors chosen are appropriate for detecting gross (≥5%) errors (Figure
4.19).
4.5.2 Application of the analytical model for predicting the
DAVID signal and initial conclusions on its use.
Figure 4.20 shows a suggested paradigm for the algorithm’s use. It is expected
that the implementation of this methodology would catch most major errors that
can occur in radiotherapy. The predictive algorithm developed here was intended
to remove the pre-treatment base-line step. It was able to predict the measured
signals for the whole treatment, and for individual beams. Differences between
the predicted and measured signals at each wire were <5% and <2.5% of the
maximum for each beam and each fraction respectively. It was also shown to be
capable of detecting calibration output errors at the 5% level.
Verification with checking software and signal generation using this algorithm
would detect gross errors on the first treatment fraction, without the time cost of
pre-treatment verification on the LINAC (Figure 4.20). While having the same
tolerance as that typically implemented for IVD diode readings (Section 2.3.1), this
method is 2D and does not require accurate, patient-surface positioning, making
it much more suitable for IMRT deliveries. The suggested method (Figure 4.20)
would detect:
• Errors in treatment planning software – detected by independent checking
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Plan designed
in treatment
planning system
Plan exported
Plan imported
in to treatment-
delivery software
Independent checking
software to check
dose to OARs and
treatment volumes
Dose checking software
independently generates
DAVID signal from
dose-verified plan
Plan delivered to patient,
DAVID signal recorded
Independently-
generated DAVID
signal compared to
measured DAVID signal
Figure 4.20: Suggested paradigm
software
• Errors in DICOM plan export – detected by independent checking software
• Errors in plan transfer, or upload to treatment delivery software (e.g. the
New York incident discussed in Section 2.2.2) – detected by the comparison
of independently-generated and measured DAVID signals. This can be done
in real time allowing the operator to stop the treatment after the first IMRT
beam or, in the case of VMAT, early on in the first fraction.
• Machine errors – detected by the comparison of independently-generated and
measured DAVID signals
4.6 Leaf pair defined segment shape and position
dependence - a possible limitation?
The analytical model has been shown to work with acceptable accuracy for typi-
cal clinical IMRT beams; Section 4.5 shows how it can be implemented in clinical
practice. There is a potential limitation for complex segment shapes. The algo-
rithm, in its current state pays no attention to the shape of the specific segments
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and the relative position of the leaf gaps. The signal is calculated by the convo-
lution of a 1d matrix of leaf separations with the lateral response function. The
position of the leaves relative to each other is important as it dictates the amount
of field that is penumbral and, as a consequence, has a lower fluence. A 10×10
cm square will only have four penumbral regions – one at each side; ten 1×10 cm
strips with alternating 5/-5 offsets will have many penumbral regions resulting in
a lower overall fluence. The effect of this on the DAVID signal was assessed by
recording the signal from two wires for instances where the two wires were covered
with a 1×5 cm strip; in each case however the two strips had a different relative
offset (0 to 5 cm). The results with their respective segment shapes are shown in
Figure 4.21; the most heavily offset segments result in the lowest signals.
Figure 4.21: Segment shapes with their associated DAVID response for a 20MU
delivery along side the predicted response. In each case the predicted response is
the same, this is because the leaf separation matrix used in the algorithm will be
the same in each case. The variation in the measured response is as a consequence
of the varying amount of penumbra in each of the test fields.
4.7 Overall summary and discussion of the need
for more sophisticated modelling approaches.
The analytical algorithm developed and tested in this chapter has only 6 vari-
ables (Table 4.1). Nevertheless is has been shown to be able to import a DICOM
treatment plan and generate a predicted DAVID signal for complex treatments.
The accuracy of the prediction, with the uncertainties discussed, has been demon-
strated to be sufficient to detect gross errors, for example: delivering the wrong
beam or other dose delivery errors greater than 5%. Section 4.5 provides a method
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to implement an error detection workflow using the algorithm in clinical practice,
without any need to have pre-treatment verification measurements. The analytical
model and error-detection workflow has been shown to perform with acceptable
accuracy for typical IMRT beam, although Section 4.6 discussed a potential limita-
tion if the arrangement of the leaves relative to each other is particularly complex.
Should the DAVID have been used as outlined in Figure 4.20 then the severity
of treatment errors discussed in Section 2.2.1 could have been reduced, or maybe
even averted altogether. The algorithm has been published as ”A simple model for
predicting the signal for a head-mounted transmission chamber system, allowing
IMRT in-vivo dosimetry without pre-treatment linac time“ (Johnson et al. 2014)
and can be implemented or used for gross error detection, which is seen by many
as the main purpose of IVD (Section 2.2.3). Maintaining dosimetric confidence of
5% is the minimum needed to ensure clinical objectives are met (Brahme 1984).
However, a dosimetric certainty of 3% is desirable (Brahme 1984). The algorithm
in this chapter lacks the complexity to predict the signal to the extent that the
tolerance on the agreement between measured and predicted signals could detect
3% errors in machine output. This is largely down to the necessary simplifying
assumptions of a limited-parameter analytical model (Figure 4.21) and the uncer-
tainties associated with predicting the out-of-field response (Figure 4.13).
A 2D fluence map contains more information about the delivered field than an
array of leaf separations. Subtleties, like the ones shown in Figure 4.21, will be
included provided the software generating the fluence is suitably complex. The sig-
nal recorded at a wire in the DAVID device is proportional to the energy deposited
in the collection volume. The energy deposited in a volume is proportional to the
radiation passing through it and the stopping power of the medium. A radiation
fluence map across the DAVID area will provide a relative energy distribution map
as the medium is uniformly air. Summing the fluence along the collection volume
of a specific wire and applying a scaling factor will give a prediction of the the
measured signal of that wire (Figure 4.22).
The MU-checking software DIAMOND (PTW, Freiburg) was commissioned
and used to generate fluence maps of IMRT deliveries, the details of this process
are outlined in Appendix B. However, it was evident that specific and accurate
penumbral modelling was not a feature of the algorithm. Also with the out-of-
field area having the fluence set to zero, it was clear that scatter, leaf leakage
and inter-leaf leakage were not considered in the calculation. As a consequence
the fluence maps lacked the accuracy necessary to be used to generate a predicted
signal through the method outlined in Figure 4.22. Attempts were made to modify
the fluence maps and the interaction with the DAVID in an approach similar
to that discussed in Greer et al. (2009), but these were unsuccessful. The idea
of generating a 2D map that could be used to generate the DAVID signal was
not abandoned, though it was clear that a more thorough approach was needed.
Monte Carlo modelling is recognised as the most thorough and accurate way of
simulating linear accelerators and their output (Verhaegen & Seuntjens 2003, Seco
& Verhaegen 2016, AAPM 2007). Monte Carlo algorithms can be used to generate
a dose volume output. Multiplying dose by mass yields energy deposited in a
medium which relates directly to the DAVID response. The subject of the next
chapter is the use of two Monte Carlo techniques to simulate IMRT deliveries
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through the DAVID so that the energy deposited in the collecting volumes of the
wires can be determined and used to predict the signal. It is expected that this
much more sophisticated modelling approach will produce much more accurate
results than those discussed in this chapter and in Appendix B where fluence-
based model lacks detail.
Figure 4.22: The fluence (white) as a result of the MLCs (black) for an IMRT
segment is shown in the top left. Summing the fluence along the collection volume
of the DAVID wires will give the total fluence the volume is exposed to. Applying
a correction factor to this will give a prediction the measured signal.
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Chapter 5
Monte Carlo Modelling of
the DAVID
5.1 Introduction
This chapter is concerned with generating two Monte Carlo models of the DAVID.
One will be generated in Monaco, a commercially available planning system, the
other using EGSnrc. The EGSnrc approach discussed in this chapter is a full MC
model of the linac and DAVID, this thorough approach produces the most accurate
results but at the cost of time in both developing the model and running individual
simulations. The dose calculation in Monaco makes a number of approximations,
this speeds up the calculation considerably, but at the expense of some accuracy.
Assuming that a beam model is already in place, as would be the case in a clinical
department, implementing the Monaco approach to MC modelling of the DAVID
is much easier in terms of both setting up the model and calculating the signal.
It is expected that using Monte Carlo models will enable accurate predictions of
the DAVID signal, and therefore avoid the need to perform pre-treatment mea-
surement on a linac before validating an in-vivo patient measurement. Comparing
the two models is expected to enable evaluation of the performance of the simpler
approach against the fuller EGSnrc approach to consider the Monaco approach’s
accuracy and possible limitations.
5.2 Monte Carlo Modelling
Generally the Monte Carlo (MC) method can be described as a numerical approach
to solving problems based on random number sampling (Seco & Verhaegen 2016).
Take, for example, the value of pi. If we take a circle of radius r and a square of
side length 2r then the ratio of the surface areas will equal pi4 . Let 2r be set to
equal 1 and both shapes drawn so they share a common centre at 0.5,0.5 (Figure
5.1). A random number generator that produces numbers between 0 and 1 can
be used to determine an x and y coordinate, this will define a point that will fall
either inside the area defined by the circle (C) or inside the area defined by the
square (S). The likelihood of a point of falling inside C or S is proportional to
the area of the circle and square respectively. As the number of points increases,
the ratio of the points inside C to those in S tends toward the ratio of the areas.
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If enough points are used it is possible to use the ratio to determine an accurate
value of pi (Figure 5.1).
This example also demonstrates the statistical nature of MC calculations. The
value of pi is not determined analytically, but estimated through a ratio that
changes with N . As N increases, the uncertainty associated with the value re-
duces. This uncertainty, associated with any MC calculation, is unavoidable and
later on in this chapter manifests itself as noise. It can be shown (AAPM 2007,
Feller 2008) that the statistical uncertainty is proportional to 1/
√
N meaning that
statistical noise can be reduced by either increasing N (in the case of EGSnrc
N corresponds to number of histories) or, in the case of voxel-based calculations,
increasing the voxel size so that Nper voxel increases.
Figure 5.1: As the number of randomly-generated points increases, the estimated
value of pi becomes more accurate.
Monte Carlo simulations in medical physics attempt to model nature directly
through the essential dynamics of the system. MC calculations offer a numerical
solution to a problem that can be described as the temporal evolution of particles
based upon their cross sections. Mimicking nature, the interactions are processed
randomly and repeatedly until the numerical results converge on useful means. In
this way MC models offer a solution to a macroscopic problem through simulation
of its microscopic interactions (Seco & Verhaegen 2016).
EGSnrc introduction
There are a number of general-purpose MC codes used throughout medical physics.
PENELOPE (Salvat et al. 2006), MCNP (Briesmeister et al. 2000), GENAT4
(Agostinelli et al. 2003) and EGSnrc (Kawrakow et al. 2000) are the four most
popular with EGSnrc being the most widely used (Rogers 2006). All have various
strengths and weaknesses; however, EGSnrc was used for this work for a number
of reasons:
• Most widely used general-purpose code in radiotherapy physics.
• EGSnrc distribution comes with BEAMnrc - a package designed specifically
to model therapeutic linacs.
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• Of the 4 aforementioned codes, the use of the PRESTA algorithm (Bielajew
& Rogers 1986) for particle boundary crossing in EGSnrc makes it the most
accurate for ion-chamber calculations (Seuntjens et al. 2002).
• Local experience and knowledge of the software.
For the EGSnrc modelling in this chapter, BEAMnrc was used to produce
phase-space files in the plane perpendicular to the beam axis at some distance
outside the linac head (Figure 5.2). From here, the simulation was taken over
by DOSXYZnrc. DOSXYZnrc is, like BEAMnrc, an extension of the EGSnrc
code and is included in the software distribution. It can use the phase-space file
generated by BEAMnrc to simulate the interaction of photons and electrons in
a volume allowing it to score energy deposition in user-specified voxels (Walters
& Rogers 2003). Section 5.3 is concerned with creating an accurate model of the
Figure 5.2: Position of phase space for water tank simulations
Elekta MLCi2 head in using BEAMnrc. Various iterations of different electron
spectra (Section 5.3.1) and beam-shaping geometry (Section 5.3.2) were simulated
and used to create phase-space files. DOSXYZnrc uses these phase-space files as
a particle source for a water tank simulation (Fgiure 5.2). The accuracy of the
BEAMnrc model of the linac was benchmarked by comparing simulations with
water tank measurements made on the physical linac.
Having shown that the BEAMnrc linac model accurately simulates the actual
MLCi2’s output, Section 5.4.1 uses DOSXYZnrc to model the DAVID with and
without the collection wires, assessing the wires’ impact to determine if it is nec-
essary to include them in the model. This is done in a similar way to Asuni et al.
(2011), who assesses the electron contamination from a transmission detector. In
Section 5.4.2 - DOSXYZnrc is used to make a model of the DAVID. Finally, in Sec-
tion 5.5, the DOSXYZnrc model is validated by generating BEAMnrc phase-space
files of clinical VMAT deliveries and using these to predict signal in the DAVID.
These are then compared with equivalent signals collected by the DAVID on the
linac.
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All EGS-based simulations were run on the Linux-based supercomputer - Med-
ical Advanced Research Computer 1 (MARC1). MARC1 is part of the High Per-
formance Computing and Leeds Institute for Data Analytics (LIDA) facilities at
the University of Leeds, UK. This is a large memory node cluster made up of 57
blades each housing one Intel Haswell node. Each node is dual socket with a 10-
core Intel E5-2660v3(2.6GHz) processor per socket (20 cores per node); 256GB of
DDR4 2133MHz memory per node (configured as 16 x 16Gb); a 500Gb hard drive
and QDR Connect-X Infiniband. In total, the 57 blades contain 114 CPUs and
1140 cores. All user traffic is carried over the InfiniBand network (Leeds University
2018).
Monaco Introduction
“The Monte Carlo technique is potentially the most accurate method for the calcu-
lation of dose distributions in treatment planning if radiation sources and patients
are completely modelled and a sufficiently large number of photon and electron his-
tories are simulated”(Fippel 1999, AAPM 2007). At the time of writing, the only
commercially-available MC-based TPS in widespread use was Monaco. Monaco
incorporates the X-ray voxel Monte Carlo (XVMC) algorithm but with a number
of approximations and simplifications to dramatically speed up calculation time.
When benchmarked against EGSnrc calculations, no significant loss in accuracy
has been observed (Kawrakow et al. 1996, Fippel 1999, Semenenko et al. 2008,
Alber & Nu¨sslin 1999). At present, there is no published literature on modelling
a transmission detector in Monaco. However, a TPS-based model of the DAVID
would be much easier to use and would generally be quicker to calculate than one
in EGSnrc. This would allow easier implementation pre-delivery baseline genera-
tion, as it is likely that more people in a radiotherapy department will be familiar
with the TPS than the EGSnrc code. Section 5.4.4 discusses how the model is
designed in Monaco, and it is compared with the EGSnrc-based model in Section
5.5.
5.3 Modelling the MLCi2 head using EGSnrc
The Electron-Gamma-Shower (EGS) software is designed to perform Monte Carlo
simulations of equipment used in radiotherapy and calculate the dose that these
simulations produce in user-defined media. It can simulate the coupled transport
of electrons and photons through a wide range of geometries and materials for
energies from a few keV to hundreds of GeV (Kawrakow et al. 2000). The EGSnrc
code is widely used for radiotherapy simulations because it has been shown to
be accurate, furthermore, its geometries, materials and energy range are tailored
specifically to radiotherapy (Rogers 2006).
BEAMnrc is an extension of the EGSnrc code, specifically tailored to simu-
late radiation produced by therapeutic linear accelerators. The software includes
component modules (CMs) that lend themselves to creating the geometry and
parts integral to a hospital accelerator. In addition to this, a number of variance
reductions tools are included in the software, such as: range rejection, photon
forcing, Bremsstrahlung splitting, Russian Roulette, directional source biasing and
Bremsstrahlung Cross Section Enhancement. All of these are calculation options
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aimed at reducing simulation time with minimal, or unimportant, losses in ac-
curacy. A more in-depth discussion of these options is included in Appendix C.
A linac model, built in BEAMnrc, will consist of a series of component modules,
each dealing with a specific geometry of the beam-delivery system. These are
independent of one another, have a defined material and density and occupy a
horizontal band in space. A BEAMnrc-generated graphic of the primary filter and
flattening filter can be seen in Figure 5.4. In both cases the CM FLATFIL was
used. FLATFIL allows the user to define cones of different width, thickness and
material. In Figure 5.3 FLATFIL is used to make:
1. A single cone, with the bottom radius set to r1, the top radius set to 0 and
the height set to h1
2. Another single cone, but instead of going to a point, a trapezium shape is
defined by using the same settings as 1, but setting the top radius as r2
instead of 0.
3. Two materials are used. The bottom cone, as before, has a radius of r1, but
now has length h2 with a top radius of r3; the other cone starts at height h2
with radius r3 extending h3 to a radius of r4. The two cones, as seen in this
instance, can be defined as being of different materials.
4. Geometry 4 in Figure 5.3 shows that with suitable manipulation of the widths
of cones, different materials (shown here as different colours) can be made
to sit inside each other.
Figure 5.3: Possible geometries using the FLATFIL component module
By exploiting the versatility of the FLATFIL CM, it was possible to create a
variety of shapes that have very different functions in the model. At the time of
writing there are, in total, 25 CMs included in the EGSnrc distribution. A full
description of each is outside the scope of this work, but between them, they can
be used, with suitable manipulation (like that seen for FLATFIL in Figure 5.3)
to define the physical components of a linac in the MC model. The horizontal
banding of the component modules can be seen in Figure 5.5; this shows all the
CMs in the static part of the linac model, labelled with their defined material
(Rogers et al. 1995).
The principal output of the BEAMnrc code is a phase-space file. This contains
the position, direction, energy, charge and history tag (Section 5.4.1) of all the
particles in a user-defined plane. This file can be used as a source for simulations
83
/ calculations by various programs (Rogers et al. 1995) any number of times. This
can reduce the need for repeat simulations of components of the beam-transport
system prior to encountering a component of interest or a dynamic component,
saving time simulating the entire linac for each calculation.
At the time of writing there were no published models of the MLCi2 treatment
head using the EGSnrc code (See Section 5.7). The linac model built in the
BEAMnrc software for this thesis contained 10 CMs. Table 5.1 is a brief description
of each:
Module
Name
Component
Module used
Description
Target FLATFILT Copper rings surrounding a tungsten core
Primary col-
limator
FLATFILT Conical air space flanked by tungsten shield-
ing. See Figure 5.4
Flattening
filter
FLATFILT 6, stacked, steel trapezoids
Monitor
chamber
FLATFILT A complicated 21-layer arrangement using
Mylar, Aluminium and air to define Elekta’s
monitor and output chamber (Figure 5.32)
Backscatter
plate
SLABS SLABS are a simple CM that allow the user
to define the material and relative position of
numerous rectangular blocks. In this case 1
aluminium slab 2.9mm thick was used.
Mirror MIRROR The MIRROR CM is similar to SLABS but
has the extra option to change the angle of
the slab relative to the beam axis; the SLABS
CM keeps this fixed at 90.
MLC SYNCMLC The SYNC modules allow the easy delivery
of multiple-segment plans (IMRT, VMAT and
DMLC) (Lobo & Popescu 2010). The 40
MLC tungsten leaf pairs were defined as hav-
ing rounded tips with a radius of 15.02 cm and
length in the beam-directions of 8.2cm.
Jaws SYNCJAWS Have the same SYNC capabilities as the leaves
and are composed of tungsten.
Mylar SLABS A single, thin mylar sheet.
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Air SLABS Air slab where the phase space is saved. The
length of this slab was modified depending on
the data being collected. For tank-based simu-
lations, it extended to the water’s surface (Fig-
ure 5.2); for DAVID work, it extended to the
DAVID surface.
Table 5.1: The names and descriptions of the CMs used in the
EGSnrc model of the linac
The SYNCMLC and SYNCJAW CMs (Lobo & Popescu 2010) used in the MC
model both require a sequence file that defines the position of the jaws and leaves
in the head. Software was written that took the calibration curves in Section 5.3,
read the leaf / jaw position at isocentre, defined in a GUI, and converted it to
sequence files for the SYNCMLC and SYNCJAW modules. In the case of a single,
static delivery (Figures 5.11 to 5.15), the weight of the segment would be one. The
software was developed further so that it could read a DICOM plan, extract the leaf
positions from each segment, convert them to the position in the head and write
them to a sequence file that could be read by the SYNC modules. This feature was
used for the VMAT plans in Section 5.5. Each segment in the sequence contained
the positions of the leaves / jaws as well as the fraction of the delivery that was
delivered through that segment (segment MU / total MU). The SYNC modules use
the MU weight to define a cumulative probability distribution function (CPDF)
for all the possible leaf positions. For each initial particle history a random number
is generated and used to sample the leaf positions from the sequence file with a
probability determined by the CPDF (Liu et al. 2001). For VMAT simulations,
when the random number falls between two segment indices, the leaf positions are
determined through linear interpolation between the two adjoining segments; for
step-and-shoot deliveries, only even-numbered segments are sampled, and there
is no interpolation (Heath & Seuntjens 2003). SYNC modules not only have the
advantage of allowing an entire VMAT delivery to be done in one go (previously
it was necessary to model each individual segment and sum them at the end), it
is also more accurate, as it models the delivery between the defined segments (Liu
et al. 2001).
The geometry, materials and position of each component module can be set
to match the parameters of the linac to be modelled. In this instance, Elekta
provided a machine specification to work from. Graphics of the flattening filter
and target are shown in Figure 5.4; Figure 5.5 shows the static part of the linac
model.
Having compiled all the CMs to match the specification that Elekta provided
the model was tested by comparing the output with results measured in a plotting
tank. Where necessary the parameters in the model were modified so that it
matched the true linac output (Chibani et al. 2011). The model output was
generated by creating a phase space using BEAMnrc then releasing it through
a dose-scoring medium using DOSXYZnrc. A phase space file contains all the
particles generated by the accelerator as well as their position, energy and direction
of travel. Once generated, the same phase space files can be used any number of
times for any analysis they might be suitable for. Throughout the testing described
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Figure 5.4: Primary collimator (left) and Flattening Filter (right) as modelled by
BEAMnrc
in this chapter, the phase space file was positioned directly after the mylar film
at the end of the linac head. DOSXYZnrc was then used to score the dose of the
field in a water tank simulation. Figure 5.6 shows the DOSXYZnrc arrangements
used to measure the simulated PDDs and profiles.
The simulated profiles were generated by obtaining phase-space files for 20×20,
15×15, 10×10, 5×5, and 3×3cm fields from the BEAMnrc model. 30×109 histo-
ries were used for each delivery, Directional Bremsstrahlung Splitting (DBS) was
used as a variance reduction technique (see Appendix C) and the 700ICRU PEGS
data set was used for particle interactions (Figure 5.5). PEGS is from the original
application for EGSnrc which was in high-energy physics. PEGS4 (Preproces-
sor for EGS) was designed to generate photon cross sections for this purpose.
For radiotherapy applications, the Storm & Israel (1970) data set is used by de-
fault (and throughout this work) for cross-section data, however PEGS4 is still
used for material information, photon threshold energies and some of the electron
data. The EGSnrc distribution includes the material information to provide all
the cross section data for two data sets: 700icru.pegs4dat and 512icru.pegs4dat
(Rogers et al. 2001). The numbers 512 and 700 refer to the energy down to which
the cross sections are calculated, 0.512 and 0.700 MeV respectively. For both the
DOSXYZnrc and BEAMnrc simulations in most of this work, unless stated oth-
erwise, the 700 data set was used, because it gave acceptable accuracy and better
calculation times.
The phase space files for the five field sizes (20×20 to 3×3 cm2) were then
used as sources for DOSXYZnrc simulations of a water tank at 90SSD. For
the DOSXYZnrc simulations, ISMOOTH (see Appendix C) was turned on, the
700ICRU PEGS data was used for particle interactions and 1.5×109 histories were
used for each data set. Profiles were extracted from the DOSXYZnrc .3ddose files
using statdose (included in the EGSnrc distribution package McGowan & Fadde-
gon (2013)). A 10×10cm phase space was also used as a source for DOSXYZnrc to
generate the simulated PDDs in Figures 5.8 to 5.10. The same input criteria and
extraction techniques were used as in the profile data. The DOSXYZnrc water
phantom was simply modified to measure a PDD (Figure 5.6). For all the sim-
ulations, the ECUT and PCUT were set at 0.7 and 0.01 MeV, respectively (see
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Figure 5.5: Static part of the linac model as modelled by BEAMnrc. Materials are
defined by the 700icru.pegs4 data set. The cross-section data in this file is based on
the density corrections contained in the ICRU report 37 (ICRU (1985)) and uses
cross-section data down to 0.7 and 0.01 MeV for electrons and photons, respec-
tively. Both have upper energy limits of 55MeV (Rogers et al. (2001), Kawrakow
et al. (2000)).
Appendix C.2.1).
The water tank data was collected by employing similar techniques described in
Appendix B.2.1; the MP3 PTW water tank and accompanying MePhysto software
were used with semiflex 31010-type chambers as both field and reference detectors
(PTW Freiburg) (Figure B.3). For the profiles, the semiflex field chamber was
orientated in the vertical position, 2mm steps were used for the central part of
the beam and 1mm steps were used in the penumbra. For the PDDs, the semiflex
chamber was in the horizontal orientation and 1mm steps were used throughout.
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Figure 5.6: The voxel arrangement used to collect profiles (left) and PDDs (right).
In the actual simulation there were 250, 0.05cm2 voxels where the dose was scored
5.3.1 Model Spectra and PDD
Modelling approach
To ensure that the dose deposition is simulated correctly, the beam energy in the
model must closely match that of the physical linac. The beam energy is dictated
by the energy spectra of the electrons hitting the target. In a physical linac,
this is controlled by a number of components and the values of their associated
control setting parameters – electron gun, magnetron bending magnets etc. The
BEAMnrc simulation uses a file that contains various electron energies and the
relative abundance of these energies. It has been shown that the central-axis depth-
dose curve is very sensitive to on-target mean electron and energy distribution
(Sheikh-Bagheri & Rogers 2002b, AAPM 2007). Consequently, matching simulated
and measured PDDs implies equivalent on-target electron beams.
Results
Electron spectra are normally described as a Gaussian distribution centred on
the beam energy (Khan 2010). Several Gaussians were tried (Figure 5.7), but
none were found to create a beam that matched the measured data; instead the
spectrum shown in Figure 5.10 was found to work best. Figures 5.8 to 5.10 show
PDDs resulting from mono energetic electron spectrum, Gaussian spectrum and
the final empirical spectrum plotted against the machine-measured PDDs. Figure
5.11 shows the measured and simulated PDDs for 5, 10 and 20cm2 fields using the
final electron spectrum shown in Figure 5.10. Gamma index evaluation (Appendix
A) was used to compare simulated and measured PDDs, 100% of points passed
with the 2D gamma index set to 1% / 1mm. Due to the good match between
measured and simulated PDDs in Figure 5.11, the energy spectrum that generated
them (Figure 5.10) was used for all subsequent simulations. It may be noted that
the noise in the MC simulated PDDs is statistical noise, as discussed in Section
5.2.
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Figure 5.7: Simulated PDDs for low and high energy electron spectra with mea-
sured data; the colour of the PDD (bottom) corresponds to the colour of the
spectrum (top) that was used to simulate it, with the measured data displayed in
green. While it was possible to match the simulated data with measured data in
the build-up region when a higher energy was used, and in the deeper regions when
a lower energy was used; it was not possible to get a PDD match at all depths
using a Gaussian electron energy distribution. All PDDs taken for a 10×10 field
at 90SSD.
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Figure 5.8: Monte-Carlo modelled PDD for a 10×10 field at 90SSD for a mono-
energetic electron beam (top) incident on the target plotted with data measured
using a plotting tank.
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Figure 5.9: Monte-Carlo modelled PDD for a 10×10 field at 90SSD for a Gaussian
electron beam (top) incident on the target plotted with data measured using a
plotting tank.
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Figure 5.10: Monte-Carlo modelled PDD for a 10×10 field at 90SSD for the final
empirically-selected electron beam (top) incident on the target plotted with data
measured using a plotting tank.
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5.3.2 Modelling leaf and jaw positions and Profiles
Modelling approach
The position of the leaves and jaws in the linac model required to create a 3×3,
10×10 and 20×20cm2 square fields were initially determined using geometry and
the supplied schematic. Profiles generated from these field shapes were then com-
pared with measured profiles and minor adjustments made to the model’s leaf and
jaw positions so that the profiles matched. The position of the leaf bank and jaws
in the head were plotted as a function of the isocentric field size for these three
field sizes. The relationship was characterised by a quadratic for both the leaves
and jaws. These scaling equations were then used to determine the leaf and jaw
positions for 5×5 and 15×15cm2 square fields on the central axis as well as 5×5
and 3×3cm2 square fields displaced by 10cm on the X and Y axis.
Results
The X and Y axis profiles from the model and measured results are shown in
Figures 5.12 to 5.15. The X axis profiles were defined by the leaves with the Y
axis profiles being defined by the jaws. All points were found to agree within
the 1.5% / 1mm 2D gamma index acceptance criteria. The quadratics defined by
this process were used to determine the leaf and jaw positions for all subsequent
simulations.
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Figure 5.14: Comparison of measured and simulated X profiles for a 5 and 3cm
field offset from the beam axis by 10cm in both X and Y directions. Agreement
= 100% of points passing 2D 1.5% / 1.5mm gamma index criteria.
Figure 5.15: Comparison of measured and simulated Y profiles for a 5 and 3cm
field offset from the beam axis by 10cm in both X and Y directions. Agreement
= 100% of points passing 2D 1.5% / 1.5mm gamma index criteria.
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5.3.3 Discussion of the linac Monte Carlo Model
Through a combination of vendor-supplied schematics and iterative processes, a
Monte Carlo model of the MLCi2 linac head was made. The model-generated
PDDs and profiles matched the data collected on the linac using the water tank
within the gamma index criteria of 1%/1mm and 1.5% /1mm, respectively. As
this match exceeds what might be deemed necessary to match a clinical treatment
planning system to a linac (Venselaar et al. 2001, Fraass et al. 1998), the model
can be assumed to be good. The linac model, and leaf /jaw position calibrations
discussed in this section will be used for all subsequent EGSnrc simulations.
5.4 Monte Carlo modelling the DAVID
5.4.1 Assessing the impact of the collection wires
The DAVID collection wires have a diameter of 100 micro meters (Poppe et al.
(2006)). Due to their small cross-section, including them in the model of the
DAVID in either EGSnrc or Monaco would be difficult. This section is concerned
with using the EGSnrc software to assess the impact of the collection wires on the
signal and determine if their inclusion on subsequent models is necessary.
To determine the effect the collection wires had on the energy deposited in the
collection volume, the DAVID was modelled in DOSXYZnrc with a single collection
and wire volume (Figure 5.16). It is stated in Poppe et al. (2006) that the cross-
sectional area of the circular collection volume is 0.03cm2, this corresponds to
a diameter of 0.2cm. Circular collection volumes are difficult to model, so the
collection volume was modelled as a square of side length 0.2cm. Modelling the
volume as a square instead of a circle will increase the charge collected, however a
relative effect is being investigated, so provided the volumes are the same in both
wire and non-wire cases, using a square instead of a circle should not matter. The
Figure 5.16: DOSXYZnrc model of the DAVID with a single collection wire and
volume.
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signal measured in the collection volume shown in Figure 5.16 was calculated by
summing the energy deposited in regions 1-9. When modelling the volume without
the wire, the material in regions 1-9 was defined as air. When modelling the wire,
the material in region 5 was defined as tungsten and the dose deposited in the
region was not included in the signal, similar to the approach taken in previous
studies of ionisation chambers with central electrodes (Ma & Nahum 1993, Wulff
et al. 2008, Buckley & Rogers 2006).
BEAMnrc was used with the model described in Section 5.3 to generate phase
space files for three square fields of isocentric side-length 5, 10 and 20cm. For
each phase space file, 1.5×109 histories were used, and DBS (Appendix C.2.4) was
implemented as a variance reduction technique.
Two simulations were run in DOSXYZnrc, using the model of the DAVID
shown in Figure 5.16, for each of the three square-field phase-space sources: one
with the wire, one without, six in total.
For the profile and PDD simulations discussed previously in this chapter (Sec-
tions 5.3.1 and 5.3.2) ∼ 109 histories were used. In this case (Figure 5.16) the vol-
umes were considerably smaller. Consequently, it was necessary to run 1.5× 1011
histories to ensure that there were enough particles to reduce uncertainty of the
dose deposited in the collection volume to < 0.1%.
As discussed previously (Section 5.3), the 700 PEGS data set has been used for
most of the EGSnrc modelling in this work. However for the work in this section,
modelling the small volumes of the wires and collection volumes around them, the
512 PEGS data set has been used. The number 512 refers to the energy down
to which the cross sections are calculated, i.e. it allowed lower ECUT and PCUT
values to be implemented than the 700 set, 0.512 and 0.01MeV respectively. In
the case of DOSXYZnrc calculations this avoided the over deposition of energy
in small voxels adjacent to large voxels. This is thought to arise from tracks of
charged particles having been transported through the large voxel that happen
to end in the small voxel (Walters 2016). Additionally, for both BEAMnrc and
DOSXYZnrc calculation, the decision to use lower PCUT and ECUT values also
meant that the particles were tracked for longer making the position of the dose
deposition more accurate. This all came at the expense of increased calculation
time.
The differences between the energy deposited with and without the wire present
can be seen in Figure 5.17. For each field size, the difference in energy deposition
for the case when the wire was present and when it was not was found to be 3%.
Origin of the increased signal
It is proposed that the increase in signal in the wire simulations was a result of
more secondary particles being created in the high density wire than in the low
density air. To show that this was the case, BEAMnrc’s facility to track a particle’s
origin and history through a simulation using latch filtering was utilised.
Each particle in a phase-space file has a history tag; this is a 32-bit variable that
can be used to record the latch values of the component modules it has interacted
with (bits 1-23) or originated from (bit 0) (Rogers et al. 2001, 1995). By including
the top half of DAVID in the BEAMnrc simulation and assigning a latch value to
the wire / air volume (volume 5 in Figure 5.16) it was possible to apply a filter to
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Figure 5.17: The energy deposited in the collection volume for different field sizes
for instances with and without a wire. The energy deposited is normalised to the
maximum energy deposited (wire 20, 20cm square field). The distances are in cm.
the lower half of the collection volume so that the particles generated in the wire
were captured (Figure 5.18) and extracted using BEAMdp (a phase-space analysis
program included in the EGSnrc distribution (Ma & Rogers 2018)). Figure 5.19
shows the number of particles passing through the bottom three collection volumes
for both the wire and non-wire instances, with and without the latch filter applied.
It can be seen that there is an increase in particles generated when the material
is defined as tungsten (Figure 5.19, top). Applying the latch filter demonstrates
that the increase in signal is a consequence of electrons being produced in the wire
that are not present when the wire is defined as air (Figure 5.19, bottom).
The results shown in Figures 5.18 and 5.19 are from wire 20, the central wire.
Additionally, data was collected for wire 22 for the 5×5cm2 field; wires 22 and
26 for a 10×10cm2 field; wires 22, 27 and 29 for a 20×20cm2 field. All exhibited
equivalent behaviour.
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Figure 5.18: The wire and top collecting volumes were modelled in BEAMnrc
along with the accelerator. The particle and energy fluence entering the bottom
three collection volumes could be extracted from the BEAMnrc-generated phase
space using BEAMdp.
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Figure 5.19: Electron fluence passing through the bottom collection volume (7-9
on Figure 5.16) without latch filtering applied (top) and latch filtered so that only
particles created in the wire volume are scored (bottom).
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5.4.2 Modelling the DAVID with EGSnrc
Materials and dimensions
The DAVID was modelled in DOSXYZnrc as two slabs of Perspex, each 4mm thick,
separated by a 2mm thick air gap (Poppe et al. (2006)). In the plane perpendicular
to the beam axis, the volumes were split into 250×250, 1mm volumes extending
from -125mm to +125mm, the beam axis being at (0,0).
As with Pena et al. (2006) and Liu et al. (2000), energy deposited in the
collection volume was used as a surrogate for the signal. This was calculated
first by extracting the dose from the central air gap using software written by
the author. The dose was summed, at the position of the collection volumes, in
the direction of leaf travel along each 250×1mm scoring volume. These values
were then multiplied by their volume and the density of air (1.2041kg/m3) to give
energy deposited. As the collection volume is 2mm across (Poppe et al. (2006)),
two of these 250×1mm volumes were used to generate the Monte Carlo signal used
to compare against the measured signal.
Calibrating the EGSnrc linac model output
Every quantity scored in an EGSnrc simulation is normalised by the number of
primary histories, in this case, the number of electrons hitting the target. For
BEAMnrc simulations, this number is known to the software; for DOSXYZnrc
simulations, this number is estimated using information in the phase space file
(Rogers et al. 2001, Walters & Rogers 2003). Knowing this, it follows that the
value of any scored quantity should not really depend on the number of histories,
however, increasing the number of histories will reduce the level of uncertainty
associated with the value. For the purposes of this work, it was necessary to convert
the simulated dose to a measured signal. It has been shown that the DAVID
signal is linearly proportional to the MUs for equivalent fields (Section 4.2.2).
This made it possible to define a MU-based scaling factor that could be applied
to the simulated dose so that it could be compared to measured signals. This was
done by delivering 10, 50, 100, 200 and 500 MUs to the DAVID through a static
5×5cm2 open field. The 5×5cm2 field was then simulated in BEAMnrc and the
DAVID signal determined in DOSXYZrnrc. For the simulation, 1.5×109 histories
were used and the values of ECUT and PCUT were 0.7 and 0.1MeV respectively.
The ratio between the DAVID signal and the five different MU deliveries was then
calculated and the linear relationship, shown in Figure 5.20, was used to convert
subsequent simulated signals to predicted measured signals.
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Figure 5.20: Ratio of simulated signal with measured results for 5cm square field
for different MU deliveries.
5.4.3 Modelling the DAVID in MONACO
Introduction
Monaco (Elekta AB) is one of a handful of commercially available TPSs that em-
ploy Monte Carlo techniques to calculate dose. In contrast to EGSnrc, Monaco
necessarily contains features common to all TPSs, namely: patient set-up tools,
beam set-up tools, plan comparison graphics, plan optimising options, patient
contouring tools etc. The calculation options are much more limited and geome-
tries are constrained by what is physically possible. Furthermore, while EGSnrc is
general-purpose code, designed to simulate photons and electrons in a wide range
of materials over the energy range of KeV to GeV, Monaco takes advantage of
the fact that it will only be used to calculate dose over the radiotherapy energy
range (1-30 MeV) for low-Z, tissue-like material with a density range of 0-3gcm3
(Kawrakow et al. 1996). Although the range is small, unlike EGSnrc where the
materials are defined by the user, Monaco has to infer the properties from a CT
scan and, ideally, perform the calculation quickly enough for it to be useful in a
clinical setting.
The beam model
The beam model in MC-based TPSs is either a full MC calculation: Brainlab
(AG) (Ku¨nzler et al. 2009) and ISOgray (DOSIsoft) (Salvat et al. 2006); or model
based: Peregrine (NOMOS corporation) (Siantar et al. 2001) and Monaco (Seco
& Verhaegen 2016). Monaco uses a Virtual Source Model (VSM) that models the
particle / photon energy and fluence distribution at three points in the head: a
photon source at the target (Fippel et al. 2003), a secondary photon source at
the base of the flattening filter (Fippel et al. 2003) and an electron contamination
source, also at the base of the flattening filter (Sikora & Alber 2009). These VSMs
take the form of Gaussian distributions with the parameters derived and verified
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through a combination of MC simulations and measurements taken during the
commissioning process (Sikora et al. 2007). Depth Dose Curves (DDCs) and in-air
measurements are used to determine the energy fluence of the histograms, while
profile measurements dictate the width of the distributions (Fippel et al. 2003,
Sikora & Alber 2009). The VSM takes care of the simulation prior to the patient-
specific beam-shaping modules. This approach has several advantages over full
MC modelling. The particle generation is fast, and the sampling efficiency of the
patient-specific part of the simulation is not limited by the size of the phase space
file. In contrast to a full MC approach, the VSM is numerically light. It can be
defined by a relatively small number of free parameters that can be gathered by
the user (Fippel et al. 2003, Sikora et al. 2007), making it much more practical to
implement in the clinical setting than a full MC model.
While the model-based approach stops at the top of the beam modifiers in
Peregrine, and MC-based particle transport takes over, Monaco use a Transmis-
sion Probability Filter (TPF) to model MLC and Jaw transmission. This analyt-
ical approach taken by Monaco results in a speed increase by about a factor of
100 compared to a full MC simulation of the beam shaping apparatus (Seco &
Verhaegen 2016). The TPF transforms leaf thicknesses into an absorption map.
The number of levels of the TPF a photon has to pass through to get from the
source to the patient determines the cumulative transmission probability. The
TPF is defined by two types of parameters: geometrical and transmission prob-
ability factors. Geometrical factors are the position and shape of the leaves and
jaws. Transmission probability factors are inter-leaf leakage and leaf transmission
(Sikora et al. 2007).
The dose calculation
The combination of the VSM and the TPF create a fluence and energy distribu-
tion at the patient surface that can be sampled by the Monte Carlo algorithm for
the dose calculation inside the patient. The dose calculation is performed by the
X-ray Voxel-based Monte Carlo (XVMC) code (Fippel 1999) which, for electron
transport, uses the Voxel-based Monte Carlo (VMC) electron transport method
described by Kawrakow et al. (1996). The VMC algorithm works by simulating
a single electron history in a homogeneous water environment. The electron scat-
ters through the medium, losing energy through Bremsstrahlung interactions and
scattering events. The cross-sections of these interactions define the properties
of the resulting particles and are discussed at length in Kawrakow et al. (1996).
Electrons produced through these collisions are treated in the same way as the pri-
mary electrons. As the contribution to the final dose from Bremsstrahlung photons
produced from electron interactions is small, time is saved by not tracking their
individual histories. Instead, the Bremsstrahlung histories are immediately termi-
nated and a gamma background applied at the end of the calculation (Kawrakow
et al. 1996). The “water history” is then applied to the heterogeneous CT and the
distances the electron travels scaled according to the density in the voxels. This
process is repeated, and some histories recycled in order to achieve the accuracy
required by the calculation (Fippel 1999, Kawrakow et al. 1996).
Calculations relating to photon transport only consider Compton scattering
and pair production, as other contributions have a negligible effect in the energy
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range of radiotherapy. In both cases, the interaction cross-sections, energies and
angles of the particles produced are treated in the same way as EGSnrc (Kawrakow
et al. 2000, Fippel 1999). Once produced, electrons and positrons are treated the
same and are both subject to the VMC algorithm.
While a DOSXYZnrc simulation allows the user to define the materials in it
from the PEGS data, all that is available in the clinical setting is the patient’s
CT scan. Most MC TPSs map the Hounsfield units to the mass density. This
requires a HU-to-material-density conversion; errors in this can lead to significant
shortcomings in the dose calculation (Seco & Verhaegen 2016). The developers of
the XVMC code opted for the computationally more difficult approach of directly
extracting the interaction probability from the CT number (Vanderstraeten et al.
2007). This is made possible because Equation 5.1, describing material density
as a function of Hounsfield number, matches measured data (ICRU 1992) well
for biological tissue in the range of energies expected in radiotherapy as shown in
Figure 5.21. The mass density can then be used to determine Compton and pair
production cross sections through methods discussed below.
ρ(h′) =

−0.008 + 1.033h′, h′ ≤ 0.895
0.108 + 0.904h′, 0.985 < h′ ≤ 1.1
0.303 + 0.685h′, 1.1 < h′ ≤ 2.381
0.580 + 0.580h′, h′ > 2.381
(5.1)
Figure 5.21: Density as a function of Hounsfield number, for measured data (ICRU
1992) and a fit defined by Equation 5.1. Taken with permission from Kawrakow
et al. (1996)
Electron transport
Electron transport is dictated by the collision stopping powers, radiation stop-
ping powers, plus the scattering power and density of a material (Kawrakow et al.
1996). Figure 5.21 shows that the density can be determined from the Hounsfield
number. The scattering power is defined as: “the mean-square scattering an-
gle per unit thickness of medium due to elastic electron-nucleus Coulomb inter-
actions”(McParland 1989). This, in the VMC code, is determined analytically
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from the density (determined from the Hounsfield number) and known constants
(Kawrakow et al. 1996). Both radiative and mass stopping power can also be de-
scribed by functions that match measured data well for the range of energies used
in radiotherapy and biological tissues (Figure 5.22).
Figure 5.22: Mass collision stopping power normalised to MCS of water as a
function of density (right); Mass radiation stopping power normalised to MRS of
water as a function of density (left). In both cases, the function used by VMC
is plotted along with empirically-derived data from ICRU (1992). Taken with
permission from (Kawrakow et al. 1996)
Compton scatter
It can be shown that, over the range of energies in radiotherapy, the linear atten-
uation coefficient associated with Compton scatter is proportional to the electron
density. The relationship between electron density and density can be described
by Function 5.2 and density can be derived from Hounsfield units (Figure 5.21).
This relationship (Figure 5.23) holds only for natural body tissues (Fippel 1999).
ηe(ρ)
ηwe
=
ρ/ρw, ρ ≤ ρw0.85× ρ/ρw + 0.15, ρ ≥ ρw. (5.2)
Pair production (PP)
Similarly, for the range of energies in radiotherapy, it can be shown that the atten-
uation coefficient of pair production is proportional to a function fr(ρ). The cross-
sections of Bremsstrahlung and electron-positron pair production can be shown to
be equivalent through transformation, or substitution, of their respective Feynman
diagrams (Fippel 1999). The mass radiative stopping power (Figure 5.22) depends
on the Bremsstrahlung cross section; also, the PP mass attenuation coefficient de-
pends on the PP cross section. This means that they have the same material
dependence , so fr(ρ) for PP is the same as mass radiative stopping power (Fippel
1999).
The dosimetric accuracy of the XVMC code has been demonstrated by its creators.
Fippel et al. (2003) demonstrate good agreement between XVMC and EGSnrc, by
comparing PDDs and profiles for both homogeneous and heterogeneous phantoms.
Fippel et al. (1999) take a similar approach, but find good agreement (less than 2%
different) between XVMC and data measured with a pinpoint DIAMOND detec-
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Figure 5.23: Electron density normalised to the electron density of water as a func-
tion of normalised density for tissue materials and aluminium. Tissue (defined by
ICRU (1992)) is well described by Function 5.2. Aluminium is not well described
by this relationship, demonstrating the need to manually enter the electron density
of any metal artefacts when using the XVMC code. Taken with permission from
Fippel (1999)
tor (PTW, Freiburg) (Laub et al. 1999) and Gafchromic film on a linac. Monaco
which combines VSM, TPF and the XVMC dose engine (all discussed above) with
the Hyperion biologically-based treatment optimiser (Alber & Nu¨sslin 1999), has
been tested by numerous groups, but Grofsmid et al. (2010) were one of the first
to test Monaco in a clinical setting. PDDs and profiles calculated in Monaco were
compared to measurements made in a water tank. The PDDs were found to agree
within 1% for all depths apart from the build-up region; this discrepancy was still
less than 2% and attributed to a shortcoming in the VSM that was improved upon
in the Monaco 2.0 release. Measured and calculated in-plane cross-plane profiles of
square and rectangular fields were found to have an average discrepancy of 1%, and
output measurements of offset rectangular fields were shown to agree on average
0.4 +/- 1.1%. Measurements of step-and-shoot IMRT deliveries taken using a lin-
ear array showed excellent agreement between measured and calculated differences,
as did point measurements taken inside the tumour region on an anthropomor-
phic lung phantom. Overall, dose distributions of IMRT fields measured in water
and anthropomorphic phantoms, using the Seven29 array (described in Appendix
B.2.2) and Gafchromic file respectively, were within the 2%/2mm gamma index
criteria and the TPS was deemed fit for clinical use.
5.4.4 Data collection and validation of the Monaco beam
model1
Monaco beam modelling is done by the vendor (Elekta) using data measured on
the specific linac in the clinic and supplied to them, using the model described in
Section 5.4.3. The final model can be tweaked in discussion with local staff. What
1This work was done by many members of the physics team at Leeds Teaching Hospital
(LTH). Though the author was involved in collecting beam data and verifying the beam model,
the work was done for the clinical service and the burden shared throughout the department
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follows is a brief description of the data required. The collection techniques were
the same used in Section B.2.1.
• PDD measurements of 1, 2, 3, 4, 5, 7, 10, 15, 20, 30 and 40 cm square fields
at a SSD of 90cm. Scans extended to 35cm and were in steps of 1mm.
• In-plane and cross-plane profiles of 2, 3, 5, 10, 15, 20, 30 and 40 cm were
measured at depths of dmax, 5 , 10 and 20cm, all with a SSD of 90cm. Scans
were done using 1mm steps in the penumbra and 2mm steps in the field.
Where possible the data collection extended to 6cm outside the field.
• Diagonal scans of a 40cm square field were taken at 45 and 135 degree angles,
at depths of 5 and 10cm. Where possible, the scans extended at least 2cm
beyond the edge of the radiation field, and they were collected at increments
of 3mm. Again, these scans were performed at a SSD of 90cm.
• Absolute dose measurements were taken for 10cm square fields at a depth of
10cm for SSDs of 90 and 100cm.
This data is sufficient to model the virtual sources in the beam model. The post-
modelling adjustment, to refine the parameters entered in to the TPF model and
better characterise the MLC, requires the measurement of 8 fields. The 8 fields
are supplied as part of the Monaco installation; a description of their delivery
and purpose is included in Table 5.2. These fields were measured using the PTW
Seven29 array discussed in Section B.2.2; the results were returned to Elekta who,
in turn, used them to supply LTH with a beam model. The beam model was tested
by a variety of static and step-and-shoot deliveries. The dose for these deliveries
was calculated on a phantom in Monaco and then delivered to the phantom with
a linac. In the case of point measurements, both Farmer and semiflex chambers
were used. For comparisons of dose distributions, the Delta4 was used. The
Delta4 consists of over 1000 diodes spread over two orthogonal planes within a
cylindrical plastic phantom. Dose calculated on a scan of the Delta4 in Monaco
can be compared, using gamma index analysis, with the distribution measured on
the linac. In this way, even after Monaco had been commissioned, the system was
subject to weekly testing through pre-treatment verification. Clinical plans were
subject to Delta4 and point-dose assessment until enough confidence was built up
in the planning and delivery system that they were no longer required.
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Field name Field description Field purpose
10×10 Static. 10×10 delivery Assess calibration of matrix de-
tector.
20×20 Static. 20×20 delivery Assess calibration of matrix de-
tector and assess beam symme-
try.
3ABUT Three 6 cm wide fields.
Step and shoot deliv-
ery.
The fields are meant to abut,
assessment of the position and
width of the junctions evaluates
the MLC calibration and offset.
7SEGA Seven, 2cm wide fields.
Step-and-shoot deliv-
ery
Same as 3ABUT.
FOURL Four L-shaped fields.
Step and shoot deliv-
ery
The L shapes are designed to
abut. Assessment of the posi-
tion and the leakage outside the
field is used to help determine
the leaf offset, MLC transmission
and inter-leaf leakage.
DMLC Dynamic. 10cm sweep
of a 2cm leaf gap.
Tests MLC position and offset
calibration as well as transmis-
sion.
HIMRT Clinical head and neck
plan. Step-and-shoot
delivery.
Evaluation of MLC model in
clinical delivery.
HDMLC Clinical head and neck
plan. Dynamic deliv-
ery.
Evaluation of MLC model in
clinical delivery.
Table 5.2: Field descriptions and their purpose included in the ExpressQA package
used for setting up the Monaco MLC model (Kinsella et al. 2016).
The Monaco DAVID model
Using a similar approach to that discussed in Section 5.4.2, the DAVID was mod-
elled in Monaco (Semenenko et al. (2008)) by creating a thin air gap between two
slabs of Perspex and placing it at an SSD of 63.4cm. A voxel spacing of 0.1cm
was used and the calculation was set to have an uncertainty of 1%. The dose was
extracted by exporting the dose plane from the centre of the air gap. This was
subjected to the same analysis as the dose plane extracted from the DOSXYZnrc-
generated 3ddose file to generate the Monaco-predicted signal.
Unlike the EGSnrc simulation, where the dose is normalised by the number
of primary electrons (Kawrakow et al. 2000), Monaco (being a clinical planning
system) bases its calculation on the intended number of monitor units. This means
that the derived dose should only need a single correction factor that will be the
same for all deliveries. Like the EGSnrc factor, this will include the loss in signal
from the wires not being modelled. By comparing the total measured DAVID
signal of five H&N VMAT deliveries with equivalent Monaco-generated signals,
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this was found to be the case (Table 5.3). A value of 4.32×10-4 was used to
convert the Monaco dose to a DAVID signal.
Delivery
Ratio of Monaco to
measured signal(×10-4)
VMAT1 4.43
VMAT2 4.50
VMAT3 4.04
VMAT4 4.29
VMAT5 4.34
Mean 4.32×10-4
S.Deviation 1.77×10-5
Table 5.3: Ratio of total Monaco-generated signal (dose) to total measured DAVID
signal (arbitrary units proportional to collected charge)
5.4.5 Calibration summary
The EGSnrc and Monaco approaches to predicting the signal generate two different
sorts of 2D dose map. The EGSnrc dose map is normalised to the number of
histories used in the simulation. The Monaco dose map is scaled according to the
number of MU in the plan. A consequence of this difference is that the dose maps
require different treatment in order to convert them to DAVID signal. Both need
a scaling factor, however. The EGSnrc dose maps also need to be scaled by the
delivered MU. The Monaco dose maps do not need the MU to be included.
The EGSnrc scaling factor was determined by comparing a simulated 5cm
square field with the signal measured by delivering different MU through the same
square field (Figure 5.20). The equation defined by this linear relationship was
used to determine the dose-to-signal correction factor for the EGSnrc-generated
dose maps (Equation 5.3).
The Monaco factor was determined by comparing the total Monaco-predicted
dose to the total measured DAVID signal for 5 VMAT plans (Table 5.3). An
average of these ratios was used to determine the dose-to-signal correction factor
for the Monaco-generated dose maps (Equation 5.4).
Signal = EGSnrcdose ×MU(8.91 + 1.51)× 1014 (5.3)
Signal = MONACOdose × 4.32× 10−4 (5.4)
5.5 Comparing VMAT signals
Both EGSnrc (Section 5.4.2) and Monaco (Section 5.4.3) models were used to
generate predicted DAVID signals for individual wires for 5 clinical H&N VMAT
fields. H&N neck treatments were selected as these complicated sites demand
complex, highly-modulated treatment plans that would test the models more rig-
orously than less-modulated deliveries.
For the EGSnrc signals, the BEAMnrc accelerator discussed in Section 5.3 was
used to generate 5 phase-space files - one for each VMAT plan. In each case,
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the plan was exported from the TPS in dicom format; software written for this
work, was used to read the dicom plan and extract the leaf and jaw positions with
associated cumulative monitor units (MU) for each segment. After applying the
calibration factors (derived in Section 5.3) the positions of the jaws and MLCs were
written, with the accumulated MU meterset, to a formatted text file designed to be
read by the SYNCJAW and SYNCMLCE CMs (Lobo & Popescu 2010) included
in the linac model. 1.5×109 histories were used in the generation of each phase
space, and directional bremsstrahlung splitting was used as a variance reduction
technique. The phase space was located 8.5cm from the mylar window (63.39 cm
from the target) on the linac head to account for the space between the linac and
the DAVID.
The DAVID model in DOSXYZnrc was as described in Section 5.4.2. The
Monaco model used was as described in Section 5.4.3
DAVID signals from the two MC approaches were calculated. These were
compared with measured signals; a wire-by-wire comparison can be and can be
seen in Figures 5.24 to 5.28, the uncertainties that dictated the size of the error
bars on these graphs were derived as follows:
EGSnrc: For every volume analysed by DOSXYZnrc both dose and estimated
uncertainty are reported. These values were extracted and used for the error bars.
Monaco: Monaco produces can produce an uncertainty map for all the voxels
where dose is calculated. This map was exported and the uncertainties extracted.
Measured: The plans were delivered three times on two separate days. The
measured signal showed a variation of about +/- 0.5% for all wires, so this was
used for the uncertainty on the measurement.
Table 5.4 summarises the differences on the whole VMAT field delivery. The
biggest difference between a Monaco-generated signal for an entire delivery was
3.1% (VMAT2), whereas the for an EGSnrc this values was -1.45% (VMAT4).
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5.6 Discussion
5.6.1 Spectra
The energy distribution of the electron beam hitting the target shown in Figure
5.10 is reproduced in Figure 5.29. Electron beam energy distributions striking the
target are normally described as Gaussian in nature, and are typically presented
in literature as a nominal energy with accompanying FWHM (Sheikh-Bagheri &
Rogers 2002b, Sheikh-Bagheri et al. 2000, Padilla-Cabal et al. 2015, Fix et al.
2004). Given this, the two low-energy components seen in Figure 5.29 are not
typical. The slalom beam-bending system employed by Elekta linacs acts as an
excellent energy discriminator (Greene & Williams 1997), so it is unlikely any low-
energy electrons that somehow made it to the end of the accelerating waveguide
manage to get to the target. Furthermore, the electron peaks in Figure 5.29 are
too low to be from nuclear relaxations, and a 6MV beam is, strictly speaking,
too low energy to cause nuclear excitations. While too low for nuclear excitations,
they are also too high to correspond to electron relaxations caused by photoelectric
excitations or Compton interactions of material in the linac head by the treatment
beam. However, the excellent match of simulated to measured data for PDDs taken
at both 90 and 100cm SSD, (Figures 5.10 and 5.11) as well as good penumbral
matching of the profiles (Figures 5.12 and 5.13), suggest that the simulated photon
beam is equivalent to the clinical beam. To further show that the electron spectrum
Figure 5.29: The electron spectrum hitting the target for the BEAMnrc simula-
tions.
(Figure 5.29) used was appropriate, the BEAMnrc simulation used to generate
the 10cm2 profiles displayed in Figures 5.12-5.13 was run, but with only 1 million
histories. BEAMdp (Ma & Rogers 2018) was used to extract the photon spectrum.
This can be time consuming if a lot of histories are used to generate the phase
space, hence the comparatively small number used for this investigation. This
photon spectrum (Figure 5.30) was qualitatively compared to equivalent photon
spectra (not graphed here) defined using Monte Carlo (Sheikh-Bagheri & Rogers
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2002a) and analytical techniques (Juste et al. 2008). All three spectra were similar
in character, showing a sharp build up with the peak at about 0.9MeV, followed by
an exponential tail-off with a maximum cut-off at about 6.5MeV. Exact comparison
is not appropriate as the linacs that the two studies used were different to each
other and different to the one that the model, used in this thesis, was matched
to. However, the qualitative likeness between all three suggests that even if the
electron spectra used in this model does not reflect the actual electron fluence,
then at least the photon spectrum it produces is equivalent to ones used in other
works.
Figure 5.30: Histogram showing normalised photon fluence as a function of energy
for a 10×10cm field. Fluence split in to 50 bins with a minimum energy set to
0.1MeV, maximum energy set to 7MeV. The error bars on this graph were defined
using the estimated uncertainty reported in the BEAMdp output file (Ma & Rogers
2018).
5.6.2 Calibration
In Section 5.4.2, a 5×5cm field was used for the calibration of the EGSnrc model.
Calibration graphs, like that seen in Figure 5.20, were derived for 10 and 20cm2
square fields (Figure 5.31). The spread in results seen in Figure 5.31 could possibly
be attributed to backscatter into the monitor chamber. Other groups (Popescu
et al. 2005, Oborn et al. 2014) have incorporated the dose scored in the linac’s
monitor chamber in the MU scaling factor. This approach corrects for the observed
phenomena of smaller fields counting up MUs quicker than larger ones, due to
the increased backscatter from the jaws contributing to the ion chamber signal
(Verhaegen et al. 2000, Popescu et al. 2005, Liu et al. 2000). Popescu et al. (2005)
and (Oborn et al. 2014) both show that backscatter can contribute up to 3%
more dose to the monitor chamber for smaller fields, compared to larger fields.
However, in both cases only Varian linacs are modelled. This effect is investigated
for Philips linacs (models and designs that are the basis for Elekta linacs) by
Hounsell (1998). This work concluded that the backscatter plate, included between
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Figure 5.31: Measured and Monte-Carlo generated signals for different field sizes
for a range of MUs
the monitor chamber and the beam-shaping apparatus, effectively eliminates this
effect, a result backed up by Kairn et al. (2009), where the same effect is shown for a
MLCi2 head. To investigate the backscatter effect in this model, the three volumes
in the monitor chamber were defined as one scoring plane. Elekta linacs have three
monitor chambers, one to count MU, another to verify it and a third for beam-
shape analysis. Although only one of these chambers really determines the output
of the linac, using all three as the same dose scoring volume improves statistics
without affecting relative signal comparison (Popescu et al. 2005). Figure 5.32
shows schematically how the ion chamber was modelled to investigate this effect.
The energy deposited in dose scoring volume is recorded after each BEAMnrc
simulation in a .egslst file. Simulation of 2.5, 5, 10 and 20cm2 square fields showed
that, within error, the results were the same. However, the uncertainty on the
measurements was about of the same order of magnitude as the results (Figure
5.33). In an effort to reduce the uncertainty, the number of histories was increased
by a factor of 20 (from 1.5 × 1015 to 30 × 1016) and BEAMnrc simulations run
for the 20cm and 5cm2 square fields. In accordance with the backscatter effect,
energy deposited in the monitor chamber was seen to be higher in the case of the
5cm field (Figure 5.33). Although this result seems in disagreement with Kairn
et al. (2009) (the only published work on this effect for a Elekta MLCi2 head) if
the uncertainty in both works are considered, the results are just about consistent.
It is possible that this effect is responsible for the spread in the calibration results
seen in Figure 5.31; including this factor would have the effect of reducing this.
Another possibility is that the spread seen in Figure 5.31 is a result of some other
head scatter effect (Kairn et al. 2009). The reason a 5×5cm2 field was used for
the calibration was that it best matched the ratios of the simulated-to-measured
results for the uncalibrated VMAT deliveries (Figure 5.34). This is thought to be
because the smaller square field best matched the scatter / backscatter conditions
of the clinical H&N VMAT segments. For a more accurate, general model that
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Figure 5.32: The ion chamber in BEAMnrc. Blue represents AIR700icru, yel-
low AL700icru and orange ALUMINA700icru. Regions 1, 2 and 3 represent the
segmented ion chamber, the primary MU counter and the backup MU counter re-
spectively; they are separated by MYLAR700icru. Strictly speaking, it is only the
energy deposited in region 2 that contributes to the MU count. However, we are
interested in the relative energy deposited in the chamber, so by assigning regions
1,2 and 3 to be the same scoring volume, the total energy deposited in all three is
calculated and the statistics are better than if just one of the volumes were used
Popescu et al. (2005).
includes larger VMAT segments or even large static fields, this effect is likely to
have a greater impact. Future work could include a more in-depth look at the
source of the spread in calibration factors (Figure 5.31). If the source is found to
be backscatter in to the monitor chamber, then this could be accommodated for
by taking a similar approach to that taken by Popescu et al. (2005). If the source
turns out to be head scatter on to the DAVID, helper volumes in the DOSXYZnrc
model and latch filtering could determine head scatter contributions and the effect
taken into account in this way. For the current work, Figure 5.34 shows that the
calibration determined by 5×5cm2 field was sufficient for the VMAT fields that
were investigated.
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Figure 5.33: Energy deposited in the chamber volumes shown in Figure 5.32 for
different numbers of simulated histories. The uncertainty on the scored dose in
the initial simulations using 1.5 × 1015 histories was too high to show any effect
definitively. The simulations for the 20 and 5cm square fields were rerun using
30×1016 histories and were seen to be distinct even when the uncertainty associated
with the dose was accounted for. The fact that there is more dose deposited in
the chamber for the smaller field is consistent with the backscatter effect.
Figure 5.34: Ratio between signal and EGSnrc-simulated dose for 5cm2 calibration
fields and un-calibrated VMAT deliveries.
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5.6.3 Signal prediction
Figures 5.24 to 5.28 show a good agreement between the measured signals and the
signals predicted by EGSnrc and Monaco. In both cases, the discrepancies between
measured and predicted signals show no particular trend, with the total difference
between the signals always being less than 3.1%. This is, to the knowledge of the
author, the first evidence of the Monaco dose calculation being tested in such a
non-clinical set-up (combination of the position and composition of the DAVID).
Although phantom-based studies have calculated dose in Perspex, it has never been
done at such a low SSD. This provides good evidence that the VSM (Fippel et al.
2003), electron contamination (Sikora & Alber 2009) and leaf transmission (Sikora
et al. 2007) used to define the beam model and determine energy fluence at the
surface of the dose-scoring medium, work well when scaled to non-patient SSDs.
It also shows that the XVMC code models the attenuation and dose deposition in
Perspex and air well, despite these not being human tissue.
Signals generated by EGSnrc matched the measured data marginally better
than the Monaco-generated signals. This can be attributed to assumptions made
in the Monaco dose calculation. These include incomplete Bremsstrahlung mod-
elling, ignoring the photoelectric effect and use of condensed history as a variance
reduction technique, which could all result in minor errors over the small volumes
used in this study. It was good to see that the clinical treatment planning system,
even with a number of approximations, had a performance comparable to the fuller
MC modelling done by EGSnrc.
The Monaco calculations performed in the generation of Figures 5.24 to 5.28
took less than 20 minutes using a 16-core processor. The EGSnrc calculations
took upwards of two hours using 64 cores on the marc1 computer grid. The
Monaco calculation used the pre-existing beam model and could be calculated
inside the TPS with limited user training - calculating on the DAVID signal would
be much like calculating the dose on any QA or verification phantom. The EGSnrc
calculation requires the verification of a new EGSnrc model as well as considerable
computer literacy and resources to run. To summarise, the calculation in Monaco
is easier and quicker and has comparable accuracy.
Generation of the baseline signal, used to compare with the measured signal
on the linac, using the TPS is not as resistant to error as an independent piece of
software calculating the signal. In the case of the field being wrong in Monaco, the
baseline DAVID signal will be wrong and will simply verify that the wrong field has
been delivered. Creation of the baseline signal using the software that checks the
dose is a much more resilient approach (Section 4.5.2). Unfortunately, is has been
shown that the simple algorithms employed by dose-checking software (Appendix
B) may lack sufficient complexity to produce accurate baselines. However, the
next generation of checking software is emerging. These generally include more
complex algorithms with at least one, Prosoma (Medcom, Darmstadt), using MC
techniques (MedCom 2018). Prosoma uses a variation on the XVMC code used by
Monaco. It is likely that this program, and ones like it currently emerging onto the
market, will have sufficient complexity to calculate accurate baselines for DAVID,
and can also be used to independently check the treatment MU / dose. However
this will need to be thoroughly tested. If this is the case, then the work flow
suggested in Section 4.5.2 could be implemented as the shortcomings discussed in
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Appendix B.3 would not be present.
5.7 Conclusion
In this chapter, Monte Carlo algorithms were utilised to better model the DAVID
and its interaction with clinical treatment beams for the purpose of signal pre-
diction. EGSnrc and Monaco were used to model the DAVID; both use Monte
Carlo-based algorithms to calculate dose. In order to use EGSnrc, an accurate
model of the linac had to be constructed. BEAMnrc was used to compile the
vendor-supplied geometry of the linac. Using an iterative approach, minor adjust-
ments were made to the position of the MLCs and jaws so that EGSnrc-generated
profiles matched measured data (Figures 5.12-5.13). A similar approach was taken
with the beam energy (Figures 5.8-5.10).
It was then shown that the presence of the collection wires increases the signal
by a constant 3% (Figure 5.17) and that the source of this increased signal was
extra electrons generated in the wire passing through the collection volume (Figure
5.19). This effect could be accounted for by multiplying any predicted signal by
1.03, though in practice this amplification becomes part of the factor that converts
the Monte Carlo-generated dose to measured signal based on the delivered MU
(Figure 5.20)2. The details of the EGSnrc model were discussed in Section 5.4.2.
Having shown that the effect of the wires can be accounted for with a 3%
correction factor, the DAVID could be modelled in Monaco as two slabs of Perspex,
separated by an appropriate air gap. The details of the Monaco model were
discussed in Section 5.4.3.
Having built two Monte Carlo models, a comparison between the two was made
by using them to predict the DAVID response to five clinical H&N VMAT plans.
The predicted results were, in both cases, compared to measured results. The
measured and predicted results are shown in Figures 5.24 to 5.28. A summary of
the results, showing the difference in total signal between the two predictive ap-
proaches and the measured signals, is shown in Table 5.4. The differences between
predicted and measured signals are all within 3.1%, with the full EGSnrc model
performing marginally better than the Monaco TPS-based model, but the latter
performing acceptably well for clinical use and with significantly less effort to set
up and use.
There are a number of EGSnrc-based models of the Elekta MLCi2 head dealing
specifically with electron beams (Pitcher et al. 2017, 2016); the Elekta MLC head
has been modelled in EGSnrc (De Vlamynck et al. 1999, Van de Walle et al. 2003),
as has the Beam Modulator (Asnaashari et al. 2013, Herwiningsih & Fielding 2016,
Sikora et al. 2007) and the MLCi2 head has been modelled in Geant4 (Fleckenstein
et al. 2013). However, to the authors knowledge there are, at the time of writing,
no MC models of photon beams for the Elekta MLCi2 treatment head using the
EGSnrc code. This makes work outlined in Section 5.3 novel. Furthermore, there
are no MC models of the DAVID and the method of calibrating the model - that
could be generalised to any transmission detector - is not discussed in literature.
It is the intention of the author to publish this work in the near future. It is
2This work was undertaken on MARC1, part of the High Performance Computing and Leeds
Institute for Data Analytics (LIDA) facilities at the University of Leeds, UK.
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intended that the published work will discuss the EGSnrc model of the MLCi2
head as well as the DAVID model and its calibration. The validation of each
model will be reported through comparison of the predicted DAVID signals of the
5 VMAT plans with measured deliveries. Modelling a transmission detector in
Monaco is also novel and the intention is to publish this separately alongside the
work discussed in the next chapter.
Chapter 4 used an analytical approach to predict the DAVID response given a
1D matrix of leaf separations. The model could predict the response to the extent
that 5% delivery errors were detected. The key shortcomings in that model were
the lack of information in the leaf separation matrix about relative separation po-
sitions and penumbral modelling. It was stated at the end of the chapter that a
2D fluence or dose map could offer a solution provided the method of generating
it was sufficiently complex to accurately model these effects. MU-check software
was commissioned and used to generate fluence maps, however, these lacked the
complexity to produce accurate signal predictions. It was decided to use Monte
Carlo techniques to generate dose maps as these are regarded as the most accu-
rate approach to in-silica modelling of the beams generated by theraputic linacs
(AAPM 2007, Seco & Verhaegen 2016, Rogers 2006). The subject of this chapter
was to use two MC codes for the purposes of 2D dose mapping at the level of
the collection volume in the DAVID. The EGSnrc approach had the advantage of
being a complete MC model with the disadvantage of being slower and requiring
more advanced computing skills / equipment. The Monaco dose algorithm makes
a number of approximations but, in practice, generating a DAVID signal would
be quicker and easier to implement than in EGSnrc. Both the MC approaches
performed well and were more accurate than the analytical approach. The three
approaches (analytic, Monaco MC, EGSnrc MC) increase in accuracy, at the same
time as they increase in complexity to both use and implement. The analyti-
cal approach uses a handful of variables and can calculate a predicted response
to a VMAT delivery in less than 30 seconds on a standard PC. Both the MC
approaches require considerable hardware to implement and even then take 15
minutes for a Monaco calculation and over 2 hours for a EGSnrc calculation. For
implementation in the clinic it is desirable to have the quickest approach necessary
to detect clinically relevant errors with sufficient accuracy. The question posed in
the next chapter is how sensitive are these approaches to clinically relevant er-
rors and which, if any, offer a viable solution to routinely predicting an accurate
DAVID response.
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Chapter 6
The performance of the
models in detecting MLC
errors using the DAVID
6.1 Introduction
With traditional 3DCRT deliveries, minor (∼1mm) MLC miscalibrations are only
likely to affect the dose around the periphery of the target. IMRT uses the MLC
to build up non-uniform fluences in order to deliver complex dose distributions.
As a result, the MLC separations can be quite small (∼1cm) and, as is the case
for plans optimised with the Hyperion system used by Monaco, these apertures
can sweep across the target volume during the delivery. As the leaf penumbra
determines the dose at various points in the field, there is a high demand on the
modelling of the leaves in the TPS and the accuracy with which they are moved
to their position by the linac control system (Figure 6.1). It has been shown
that for intensity-modulated deliveries (step-and-shoot IMRT, dynamic IMRT,
and VMAT), even sub-millimetre errors in the MLC position can have clinically-
relevant consequences on the dose distribution across the whole of the irradiated
volume (Rangel & Dunscombe 2009, Heilemann et al. 2013, Oliver et al. 2010,
Nithiyanantham et al. 2015, Bai et al. 2013).
Rangel & Dunscombe (2009), Mu et al. (2007), Bai et al. (2013) and Oliver
et al. (2010) all investigate the impact of systematic and random errors in MLC
position. This was done by applying these errors, with various magnitudes, to
the MLC positions of clinical treatment plans (prostate and H&N), recalculating
the modified plans using the TPS, then looking at the effect they have on target
and OAR Equivalent Uniform Dose (EUD) compared with the un-modified plans.
EUD is a way of reporting dose that accounts for the asymmetries of the TCP
and NTCP curves (Section 1.1) when applied to the non-uniform doses across
target and OAR structures inevitably encountered in practical radiotherapy. It is
thought to be a better single predictor of clinical outcome than mean dose. In the
case of mean dose, a hot spot will mask the effect of a cold spot provided that
they are of equivalent volume and equal displacement from the mean dose (Figure
6.2), whereas in reality, this is not the case (Niemierko 1997).
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Figure 6.1: An IMRT field split into four segments (A) and a 3DCRT field con-
formed to the same target (B). The leaf penumbra clearly makes up more of the
field in the case of the IMRT delivery (a) than it does with (b)
Random errors
LoSasso et al. (2001) cite motor error or fatigue as likely sources of MLC po-
sition error. The effects of motor fatigue/error on leaf velocity could introduce
trailing/leading leaves that may contribute to random errors during dynamic de-
liveries. Although daily variation in MLC position is typically small (0.1 - 0.2mm
(Budgell et al. 2000)), the random errors (Figure 6.3 E) could, in principle, be as
large as the sum of the precision of the control system and accuracy of the cali-
bration (these being 0.1 and 1mm, respectively, for Elekta systems) (Budgell et al.
2000). Oliver et al. (2010), Bai et al. (2013) and Rangel & Dunscombe (2009)
simulated random errors by modifying the original plan’s MLC positions by val-
ues sampled from a Gaussian distribution centred on 0 with a standard deviation
equal to the magnitude of the error being investigated. Mu et al. (2007) randomly
sampled shifts from discrete values of -2.0 mm, -1.0 mm, 0, +1.0 mm and +2.0
mm. In each case it was shown that random errors of up to 2mm in MLC position
had a negligible effect on the calculated EUDs when compared to the original plan
(Figure 6.4). Given this, the effect of random errors is not investigated in this
chapter.
Systematic errors
Systematic errors can be introduced through miscalibration (Figure 6.3 B, C and
D) and gravitational effects (Figure 6.3 D) (Budgell et al. 2000, Oliver et al. 2010).
Again, these errors were investigated by Zhen et al. (2013), Oliver et al. (2010) and
Rangel & Dunscombe (2009) who conducted TPS-based studies. In the studies
conducted by Oliver et al. (2010) and Rangel & Dunscombe (2009), leaf positions
were modified in the DICOM RT files. These were recalculated in the TPS and
compared to the unmodified plan doses. Zhen et al. (2013) planned the treatments
using a “golden beam model”, then recalculated the dose using a modified beam
model. All three showed that type B and type C shifts (Figure 6.3) produced er-
rors of equal magnitude and opposite sign. A type B shift of xmm will increase the
dose to the target volume by d% and a type C shift of xmm will decrease the dose
to the target volume by d%. Given this, the results were presented in % change per
mm shift. For RapidArc H&N plans, Oliver et al. (2010) reported error gradient
of 3.2%mm-1, Zhen et al. (2013) reported 1.2%mm-1 and Rangel & Dunscombe
(2009) reported 5.6 %mm-1 for CTVs. Oliver et al. (2010) and Rangel & Dun-
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Figure 6.2: For the case where the the dose is perfectly homogeneous, the EUD
matches the mean dose, introducing inhomogeneities moves away from this. For
example: if two equally-sized volumes of equivalently high and low dose are intro-
duced to an otherwise homogeneous distribution (right), the mean dose will be the
same as the mean dose of the homogeneous distribution (left). However, the loss
in TCP from the low-dose region will not be fully compensated for by the increase
in TCP gained by the high-dose region. This is due to the asymmetry in the TCP
curve around the treatment dose. This is why, traditionally, uniform and precise
dose delivery is one of the corner stones of accurate radiation therapy (Brahme
1984). EUD is an attempt to account for inhomogeneities like this when reporting
tumour doses.
scombe (2009) used Eclipse (Varian Medical Systems, Palo Alto, USA), whereas
Zhen et al. (2013) used Pinnacle3 (Philips Radiation Oncology Systems, Fitch-
burg, WI), all three use collapsed cone algorithms to calculate dose, but the range
of results could be due to the different planning systems in each study generating
plans with different modulations, though there is no clear evidence to support this.
Typically, OARs are equally (Zhen et al. 2013), or less (Oliver et al. 2010, Rangel
& Dunscombe 2009) sensitive and Rangel & Dunscombe (2009) showed that H&N
plans were more sensitive to leaf errors than prostate plans, attributing this to the
higher degree of modulation (Figure 6.5). Zhen et al. (2013) noted little difference
in sensitivity between prostate and H&N cases.
The findings reported by Rangel & Dunscombe (2009) and Heilemann et al.
(2013) showed that current approaches to pre-treatment verification (Alber et al.
2008, Stathakis et al. 2013, Ezzell et al. 2003, AAPM 2018) using either the Oc-
tavius and (Appendix B.2.3) or the Delta 41 (Scaniddos), and applying 3%/3mm
gamma index analysis (Appendix A) were not sufficient to detect clinically-relevant
leaf bank errors. In order to detect clinically-relevant leaf bank errors, a more ad-
vanced approach is needed. A similar conclusion was reached by Zhen et al. (2013),
whose in-silica approach used gamma index analysis to compare plans made with
and without a faulty beam model. By doing this, they demonstrated that gamma
index analysis pass rates were not a good surrogate for TCP/NTCP changes for
identifying TPS or machine errors. Instead, Zhen et al. (2013) propose metrics
based upon DVHs. This concept was used by (Nithiyanantham et al. 2015), who
demonstrated that the MatrixX (Sun Nuclear) device (a head-mounted detector
array) could be used to record dose, then back-project this through a CT and
structure data set to determine the delivered dose. This approach was shown to
1Another widely-used, pre-treatment verification device consisting of two orthogonal diode
arrays (Feygelman et al. 2010)
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Figure 6.3: MLC errors. A. Baseline B. Systematic growth C. Systematic shrink
(if leaves overlap due to the shrink, then they are set to minimal separation) D.
Systematic shift E. Random errors. (Oliver et al. 2010). The errors drawn here
are much larger than would be expected in reality, the effect has been exaggerated
for illustrative purposes.
be sensitive to minor leaf errors.
The DAVID does not contain an inclinometer, so this sort of analysis is not
possible. However, it has been shown to be sensitive to small (∼ 1mm) changes
in leaf position when compared to a baseline measured on the linac (Poppe et al.
2006). In this chapter, it will be shown how sensitive the predictive algorithms
developed in previous chapters are to leaf errors; also, given the uncertainty in the
predictions, whether they are capable of detecting these errors.
6.2 Materials and method
Five clinical H&N plans were selected and were delivered by an Elekta Synergy
linac with a MLCi2 head (Crawley, UK) with the DAVID mounted on the head.
The measured signals were compared to the signals predicted by the Basic Algo-
rithm (Chapter 4, (Johnson et al. 2014)), the Monaco model (Section 5.4.3) and
the EGSnrc model (Section 5.4.2). The DICOM RT files were then modified for
each plan so that the leaves were moved +/- 2, +/- 1 and +/- 0.5 mm, where pos-
itive displacements indicate a move of opposing leaf banks away from the central
axis (Figure 6.3, B) and negative displacements indicate a movement of opposing
leaf banks towards the central axis (Figure 6.3, C) creating larger and smaller
fields respectively. Predicted signals were generated for each of the 6 modified
plans using each of the three models for all 5 VMAT plans. In the case of the
basic algorithm, the same variables were used to calculate the predicted response
as those determined in Section 4.3. In the case of the the Monaco and EGSnrc
predictions, the same simulation parameters were used as those outlined in Section
5.4.
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Figure 6.4: Effect of random and systematic MLC errors on cumulative DVHs for
a H&N plan. Taken with permission from Rangel & Dunscombe (2009)
Figure 6.5: Change in dose as a function of MLC error for prostate and H&N
plans. Taken with permission from Rangel & Dunscombe (2009)
6.3 Results
Figures 6.7 to 6.11 each show the results for a VMAT plan. Each figure con-
tains three graphs, one for each approach - Basic Algorithm (Chapter 4), Monaco
(Section 5.4.3) and EGSnrc (Section 5.4.2). Each of the three graphs show the dif-
ference between the signals from the 6 modified plans and the unmodified plan in
addition to the difference between the unmodified plan and the measured signal.
The measured signal was taken as an average of the signals taken from repeat-
ing the deliveries on 3 different days using two different linacs. The process of
generating Figures 6.7 to 6.11 was as follows:
1. The predicted signal for the VMAT plan was generated using one of the
three approaches.
2. 6 RT plan files were generated with leaf errors of +/- 0.5, +/- 1 and +/-
2mm (boxed legends in Figures 6.7 to 6.11).
3. Using the same approach as step 1, a predictive signal was generated for
each of these 6 plans.
4. The signal generated in step 1 was deducted from each of the 6 plans gener-
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ated in step 3.
5. This difference in signal calculated in step 3 was plotted as a function of
position on the DAVID for all 6 modified plans.
6. The difference between the measured signal and the signal generated in step
1 was calculated and displayed on the same axis.
A graphic outlining the process of creating these graphs is shown in Figure 6.6.
The total signal for all the measured, modified and unmodified plans was
calculated by summing the response for each wire for each plan. The difference
between the total measured signal and the un-modified predicted signal are shown
in Tables 6.1 to 6.3. Additionally the difference between the unmodified predicted
signal and the modified plans are also displayed.
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Figure 6.7: Results for all three approaches for VMAT1
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Figure 6.8: Results for all three approaches for VMAT2
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Figure 6.9: Results for all three approaches for VMAT3
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Figure 6.10: Results for all three approaches for VMAT4
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Figure 6.11: Results for all three approaches for VMAT5
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Meas
- Pred
Difference between predicted
with no shifts and with shifts
+2mm +1mm +0.5mm -0.5mm -1mm -2mm
VMAT1 -2% 13% 7% 3% -4% -10% -18%
VMAT2 11% 11% 6% 3% -3% -7% -13%
VMAT3 -16% 14% 7% 4% -4% -12% -21%
VMAT4 -7% 14% 7% 4% -4% -10% -20%
VMAT5 -4% 12% 6% 3% -4% -9% -17%
Table 6.1: Basic Algorithm results
Meas
- Pred
Difference between predicted
with no shifts and with shifts
+2mm +1mm +0.5mm -0.5mm -1mm -2mm
VMAT1 0.2% 14.0% 7.0% 3.4% -3.9% -7.4% -15.7%
VMAT2 3.1% 12.0% 6.0% 3.0% -3.0% -6.0% -13.0%
VMAT3 0.9% 14.7% 7.6% 3.9% -4.9% -8.1% -16.7%
VMAT4 -2.7% 15.2% 7.9% 3.9% -4.2% -8.5% -17.5%
VMAT5 -0.9% 13.6% 7.1% 3.5% -4.3% -7.3% -15.0%
Table 6.2: Monaco results
Meas
- Pred
Difference between predicted
with no shifts and with shifts
+2mm +1mm +0.5mm -0.5mm -1mm -2mm
VMAT1 0.1% 14.6% 7.1% 3.4% -3.4% -6.5% -12.7%
VMAT2 0.7% 12.3% 6.0% 3.0% -2.8% -5.6% -10.9%
VMAT3 1.0% 15.4% 7.5% 3.8% -3.7% -7.0% -13.6%
VMAT4 -1.5% 16.2% 7.9% 3.8% -3.6% -7.3% -14.0%
VMAT5 -0.1% 13.9% 6.9% 3.3% -3.2% -6.4% -12.3%
Table 6.3: EGSnrc results
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6.4 Discussion
6.4.1 General observations
It is interesting to see that the same shifts had different effects on different plans.
In the plus 2mm column in Table 6.3 the total signal from VMAT4 has a 16.2%
change from the no-shifts signal compared to 12.3% for VMAT2. As discussed
later in this section, the EGSnrc model has the least difference between measured
and predicted signals - so for the purposes of this discussion, it will be the only
one of the three models considered. To try and explain the varying sensitivity
of the different plans to equivalent leaf-bank shifts, the plans were delivered to a
phantom in Monaco. The total dose deposited in the phantom was calculated for
the no-shifts plans and the +2mm plans. The difference in total DAVID signal
using the EGSnrc model (Table 6.3, column +2mm), was plotted as a function of
the difference in the total dose delivered to the phantom; these results are shown
in Figure 6.12. It can be seen that the difference in DAVID signal correlates with
the difference in beam output - not an unexpected result as the DAVID signal has
been shown to correlate to delivered dose (Section 3.1.1). However, this still does
not explain what it is about the plans that causes this difference.
Figure 6.12: Change in EGSnrc-simulated total DAVID signal between original
plans and plans with a +2mm leaf bank shift plotted as a function of the change
in Monaco phantom dose.
To try and determine why different plans responded differently to equivalent
leaf bank shifts, software was written that calculated the area of each segment in
the isocentric plane. The average segment area was calculated for each unmodified
plan and plotted against the difference in signal seen from a 2mm shift (Figure
6.13). It can be seen that the smaller the average segment area, the greater the
effect a leaf bank shift had on the DAVID signal (and, given the results in Figure
6.12, the delivered dose). This result makes sense as the same leaf bank shift
will have a proportionally higher change on smaller segments in agreement with
LoSasso et al. (1998).
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Figure 6.13: Change in EGSnrc-simulated total DAVID signal between original
plans and plans with a +2mm leaf bank shift plotted as a function of average
segment area.
The graphs shown in Figures 6.7 to 6.11 are an indication of how good each
approach is for picking up errors for that specific plan. The smaller the deviations
of the red line from zero, the better the prediction matches the actual results.
Where the red line crosses a difference line it demonstrates that, in this region,
the prediction is not accurate enough to pick up the shift associated with the
difference line. Qualitatively it is evident that the Basic Algorithm is the worst of
the three as it has the largest spread of the red line in each plan and crosses the
most difference lines. Both the Monaco and EGSnrc approaches are considerably
better - a narrower spread on the red line, crossing fewer difference lines. A
more quantitative assessment is shown Tables 6.1 to 6.3 where the accuracy of the
approach is shown in the first column; the lower the magnitude of these values, the
better the prediction. The difference between the values in the first column and the
other values in the row demonstrates the error-catching ability of the approach - in
the case where the error caused by a leaf movement is greater than the difference
between the measured and unmodified plans, the uncertainty on the prediction
is greater than the difference caused by the simulated error. It has been shown
that leaf bank shifts ∼ 1mm can have clinically relevant effects on the delivered
dose distribution (Section 6.1, (Rangel & Dunscombe 2009, Nithiyanantham et al.
2015, Oliver et al. 2010)). With the large errors in the first column of Table 6.1 it
is evident that the basic algorithm lacks the accuracy to pick up clinically-relevant
leaf errors.
6.4.2 Determining tolerances for routine use
Figure 6.14 is an example of two deliveries. The green lines represent the difference
between measured and predicted signal, the red lines represent the pass / fail
tolerance. The delivery in Case A is inside the red lines, so would pass; the delivery
in Case B goes outside the red lines, so would fail. The results seen in Case B could
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be brought about either through an output miscalibration or a leaf bank offset.
Determining the position of the tolerance lines is crucial for appropriate use of
the device as outlined in Figure 6.16. If the tolerances are too tight, there will be
too many false positives and the physics staff will spend time investigating alerts
that do not correspond to an actual fault, or faults with no clinical impact. If the
tolerances are too slack then errors that may affect the outcome of the treatment
may be missed. The other key factor in determining the position of the tolerance
line is the accuracy of the predictive technique. The less accurate the predictive
technique, the wider the tolerances need to be set so that false positives do not
occur too regularly.
The differences between the measured and predicted signals displayed in Fig-
ures 6.7 - 6.11 were collected for each predictive approach and are displayed in
Figure 6.15. It can be seen that the Basic Algorithm would need considerably
higher tolerances than the two MC approaches. Setting the tolerance limits at
+/- 2 standard deviations should ensure that 95% of predicted - measured points
pass for normal deliveries. By doing this for the results displayed in Figure 6.15
the tolerance limits for the Basic Algorithm were found to be +/- 10% whereas
the two MC approaches allowed for a tighter tolerance of +/- 3%.
Looking at the results displayed in Figures 6.7 - 6.11 it is apparent that a
tolerance of +/- 10% is not appropriate as leaf bank errors up to 2mm would not
trigger an alert. Therefore, while the Basic Algorithm can be used to detect gross
errors, it is not accurate enough in its prediction of the signal to be used to detect
leaf errors of 2mm. A tolerance of +/- 3% is sufficient to detect leaf bank errors
of 1mm and even some 0.5mm errors. Consequently, both MC approaches could
be used routinely for the assessment of VMAT deliveries to give confidence that
the treatments are being delivered with sufficient accuracy to ensure that clinical
objectives are maintained.
Figure 6.14: An example of two deliveries where the difference between the pre-
dicted signal and the measured signal is shown in green; the pass/fail tolerances
are shown in red.
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Figure 6.15: Difference between measured and predicted signals for 5 VMAT de-
liverers for each predictive approach.
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Plan designed
in treatment
planning system
Plan exported
Plan imported
in to treatment-
delivery software
Independent checking
software to check
dose to OARs and
treatment volumes
Dose checking software
independently generates
DAVID signal from
dose-verified plan
Plan delivered to patient,
DAVID signal recorded
Independently-
generated DAVID
signal compared to
measured DAVID signal
Figure 6.16: Suggested paradigm, reproduced from Chapter 4
6.5 Conclusion
The work in this chapter has demonstrated that the Basic Algorithm is not ac-
curate enough to produce a baseline with sufficiently small uncertainty to detect
leaf bank errors that could have an adverse clinical effect. The EGSnrc approach
produces the predicted signals with the lowest levels of uncertainty, however the
calculation is CPU intensive. Without a computing grid of at least 64 cores, the
calculation will take more than two hours and is not really conducive to the efficient
day-to-day running of a clinical department.
The Monaco model is easy to set up and quick to run. However, using the TPS
to generate its own checking baseline is not a particularly robust approach as it
lacks independence and is susceptible to generating false negatives. Not only is it
not sensitive to systematic errors in data collection, but it is conceivable that the
TPS could generate an erroneous plan and simply generate a correspondingly erro-
neous baseline. As outlined in Section 4.5.2 the best way of generating a baseline
is the use of third-party software that also checks the dose using independently-
collected beam data (Figure 6.16).
While EGSnrc could potentially fulfil this role, it is too complex and CPU /
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staff-time demanding. Basic checking programs could easily have simple baseline
calculations added on, however, this approach lacks the complexity to generate
sufficiently accurate signals (Appendix B). It is the opinion of the author that
the solution lies in the new generation of checking software. These use more ad-
vanced algorithms to check the dose generated by the TPS, in the case of Prosoma
a Monte Carlo approach is used that, like Monaco, implements the XVMC (Sec-
tion 5.4.3) code. Having shown that Monaco can generate accurate baselines, it
is suspected that Prosoma could too as, fundamentally, they use the same cal-
culation algorithm. Implementing Prosoma, or an equivalently complex checking
program, to check the dose and generate the DAVID baseline signal would retain
the independence of third party software. If set up with appropriate diligence,
the accuracy of the baseline signal should allow tolerances to be placed on it that
would detect clinically relevant MLC errors without too many false positives.
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Chapter 7
Conclusions and future work
An outline of the key points from each chapter and how they led to work in
subsequent chapters is given in Figure 7.1.
Chapter 3 - Preliminary work for predictive algorithms. The DAVID
is shown to be a stable device; two algorithms are devised that
predict the DAVID response for limited cases. The linear-fit al-
gorithm comfortably outperforms the look-up table approach.
Chapter 4 - An analytical model for predicting the DAVID signal. The
linear-fit algorithm is developed so that it can predict the response to any
field shape for any number of MUs, this allows it to be used to predict the
DAVID response to IMRT deliveries. The algorithm is shown to be able
to predict the response accurately enough so that output errors >5% are
detected and gross errors (delivering the wrong field) are easily detectable.
Ideally the device should be able to pick up errors of 3%. It is postu-
lated that a 2D dose map could provide sufficient information to do this.
Chapter 5 - Monte Carlo Modelling of the DAVID. An EGSnrc Monte Carlo
model of a MLCi2 head is developed and tested then used to show that the
effect of the collection wires can be taken into account in a multiplicative
correction factor. The DAVID is modelled as two, 4mm slabs of perspex
separated by an air gap of 2mm in both EGSnrc and Monaco. The 2D dose
map produced in the air gap is exported and used for signal prediction.
Both models are used to predict the response to 5 clinical VMAT deliver-
ies. When compared to measured signals both approaches perform well.
Chapter 6 - The performance of the models in detecting MLC errors us-
ing the DAVID. All three approaches to predicting the signal are tested
in the context of clinically relevant leaf errors. The simple algorithm
is found to lack the necessary accuracy in predicting the response to
impose working tolerances that could detect these errors. Both the
MC approaches are shown to produce predicted responses accurately
enough so that a working tolerance would detect 1mm leaf errors.
Figure 7.1: Flow of the thesis
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7.1 Overview
Chapter 3 demonstrates that the DAVID has a stable and predictable response.
This work was built on in chapter 4, where a simple predictive algorithm was devel-
oped based on the lateral response function (Figure 4.4) and penumbral modelling
(Figure 4.7). The simple algorithm was used to predict the DAVID response for
IMRT (Section 4.5.1) and VMAT (Section 6.3) plans. The algorithm was accurate
enough to detect gross output errors (Section 4.5.1). However, it lacked the com-
plexity to detect leaf bank offsets ∼ 2mm (Table 6.1) that have been shown to have
clinically significant effects on delivered dose distributions for IMRT deliveries as
discussed in Sections 1.4 and 6.1.
Figure 4.21 demonstrated that relative leaf position, not just leaf separation,
was a factor in the DAVID response to a field. It was postulated that the extra
information available in an accurate fluence / dose map would model this effect as
well as improving the penumbral modelling (thought to be another shortcoming of
the model). An attempt was made to use MU check software to produce fluence
maps at the level of the DAVID, these lacked sufficient complexity to accurately
predict the DAVID response (Appendix B). So the decision was made to use Monte
Carlo methods to produce 2D dose maps for the purposes of signal prediction.
Monte Carlo techniques given sufficient time / computing resources can accu-
rately model coupled photon-electron transport (Rogers 2006, Seco & Verhaegen
2016) and were employed in Chapter 5 to generate a DAVID response. Two mod-
els were created, one using the EGSnrc code (Section 5.4.2) and the other using
the Monaco treatment planning system (Section 5.4.3). In order to model the
DAVID using the EGSnrc code, it was first necessary to build a working model of
the MLCi2 linac head (Section 5.3). Once this had been completed, it was shown
that the collection wires in the DAVID could be ignored in specific modelling, since
their effect was demonstrated to change the response by a constant percentage cor-
rection factor. The multiplicative correction, to account for the wires, was built in
to the correction factor applied to the simulated dose values to convert them to a
predicted signal (Section 5.4.1). This allowed the DAVID model, in both EGSnrc
and Monaco, to be modelled as two slabs of Perspex with the signal proportional
to the dose measured in the air gap. The two models were verified by comparing
the simulated response to five H&N VMAT fields with measured signals (Section
5.5).
Chapter 6 uses the three methods (Basic algorithm, EGSnrc and Monaco) to
predict the DAVID response to five complex H&N VMAT plans. The difference
between the measured and predicted signal is compared to the predicted signal
generated by each method for the same plans with known errors introduced. The
Monte Carlo techniques are shown to be capable of predicting the signal accurately
enough to distinguish between plans with no errors and and ones with leaf bank
errors <1mm. If the signal measured by the DAVID during a delivery matches
that predicted by one of the Monte Carlo techniques, then it is implicit that leaf
separation is accurate to within 1mm, ensuring appropriate dosimetric accuracy
as recommended by IPEM (2018), AAPM (2009), Thwaites (2013), Smith et al.
(2017).
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7.2 Vendor and beam specificity
The practical work for this thesis was conducted exclusively on an Elekta Syn-
ergy linac using a MLCi2 head to deliver flattened 6MV treatment beams. All
the parameters in all the models were tailored specifically for this beam, being
delivered by this treatment unit. During the time when the work for this thesis
was conducted, there were no other treatment units available for research and
only the 6MV beams were being used to deliver advanced treatments. Both 6MV
flattened and 6MV unflattened beams were being used to deliver IMRT, however,
the decision was made to limit the work in this thesis to investigations concerning
flattened beams. The models and techniques outlined in this thesis are expected
to be broadly applicable to to all modern linacs provided that there is due con-
sideration of a few key points. The following is a qualitative discussion on this
topic.
Unflattened beams
The flattening filter (First discussed in Section 1.2.2, EGSnrc component module
displayed in Figure 5.4) is a conical beam attenuater, made of a medium or high Z
material, located in the treatment head below the primary collimator. The purpose
of the flattening filter is to correct for the forward bias of the photon beam that is
produced from the target, so that the beam is approximately flat at some depth
(normally 10cm). Historically this feature of the beam was useful as it made dose
calculations considerably easier when computers were not available or when only
simple dose algorithms could be implemented (Georg et al. 2011, Budgell et al.
2016). Removing the flattening filter produces a non-uniform forward-peaked (con-
ical) treatment beam, however, the more advanced algorithms that are currently
employed in radiotherapy planning can produce plans with unflattened beams
that are equivalent to flattened-beam plans. Removing the flattening filter brings
additional advantages:
• Increased dose rate (normally 2 to 3 times higher) resulting in shorter treat-
ment times
• Reduced extra-focal scattered radiation
• Reduced electron contamination in the primary beam
• Reduced leakage from the treatment head
• Reduced susceptibility to beam-steering errors.
Consequently, the number of Flattening Filter Free (FFF) treatments is rapidly
increasing (Budgell et al. 2016). What are the consequences for the application
of the work in this thesis? The first one is positive: one of the criticisms of the
DAVID is that it is insensitive to unilateral leaf bank offsets. If both leaf banks were
displaced by the same amount, the apertures would be the same size, so the DAVID
response would be approximately the same. Although unilateral shifts have been
shown to have limited clinical impact (See section 6.3), the ability to detect them
would offer a more complete solution. For beams having a conical dose profile,
the DAVID becomes sensitive to these errors as a unilateral offset would result
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in a significant change in radiation fluence incident on the detector. Investigation
of the DAVID’s sensitivity to unilateral offsets in FFF treatment beams could be
an interesting topic for future work. The predictive models discussed in this work
could potentially take this in to account too.
The basic algorithm discussed in Chapter 4 and published by (Johnson et al.
2014) could be adapted to include a beam profile factor, this would be a function
that matched the beam profile and would be applied to wires according to their
position in the beam. FFF beam models exist for both EGSnrc (Kajaria et al.
2017, Mishra et al. 2018) and Monaco (Valdenaire et al. 2016, Georg et al. 2011).
Once the beams have been set up, including a DAVID model would be the same
process as that discussed in Section 5.4.
Different units, vendors and energies
Different treatment units to the ones discussed in this work, either from Elekta
or Varian will obviously require different EGSnrc models in order for them to be
used to accurately predict the DAVID signal through the methodology discussed
in Section 5.4.2. In the case of Elekta units, the deviation from the model archi-
tecture discussed in Section 5.3 will be less than modelling Varian linacs. There is
published work on EGSnrc models for the flagship linacs from both Varian (Cheng
et al. 2016, Song et al. 2012) and Elekta (Gholampourkashi et al. 2019, Oderinde
& du Plessis 2016), demonstrating that both are possible. Once a linac unit has
been verified at one energy, creating a model for another energy on the same unit
will require a new electron spectrum that can be validated through comparison of
PDDs, similar to the methodology in Section 5.3.1. If the MLCs and jaws have
energy-dependent settings it will also be necessary to determine new beam-shaping
scaling factors that can be validated through profile measurements (See Section
5.3.2).
Provided the EGSnrc MC model of the linac is well matched to the treatment
beam then the DAVID model discussed in Section 5.4 should work well. A new
calibration would need to be determined following the process described in Section
5.4.2. Having done this, extracting the dose and converting it to signal would be
the same, the only difference being the location of the collection volumes would
need to match those of the DAVID designed for the linac associated with the beam
model.
The same can be applied to the Monaco MC model. If the TPS’s beam model
for the new linac / beam is suitably validated, and a new calibration factor deter-
mined (Section 5.4.4) then the DAVID model, and the conversion of dose to signal
should work well.
The analytical algorithm discussed in Chapter 4 uses a small number of free
parameters. For any new treatment unit / beam these would need to be reestab-
lished. Provided work is done to get sufficiently good estimates of these values
(Following a similar workflow to that outlined in Sections 4.2.2 to 4.2.5) then the
values could be tuned as described in Section 4.3 to improve the accuracy of the
prediction.
Differences in delivery technique, for example Varian RapidArc treatments
can either be delivered with static or dynamic jaws (Feng et al. 2015, Wu et al.
2016, Mani et al. 2017), should be accounted for in all models as they base their
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prediction on the DICOM plan file. The position of the beam-shaping apparatus
is read for each segment and included in the model. In the case of the EGSnrc
approach, the leaf and jaw positions are converted into sequence files for the SYNC
modules to read (Lobo & Popescu 2010). The Monaco model retains the leaf and
jaw positions and uses them when the plan is recalculated on the DAVID model.
The analytical approach uses the DICOM values to determine the leaf separation
matrix and where to apply the leaf-leakage factor (Section 4.2.4). In the case of
static jaws, this factor will then be applied at the same wires for each segment;
for dynamic jaws, it will be applied to different wires.
7.3 Basic Algorithm
The only other published work on predicting the signal of a transmission detec-
tor with a simple, analytical algorithm was published by Islam et al. (2009) and
discussed in Section 2.4.2. Before the work in Chapter 4 there was no published
literature on predicting the DAVID signal, nor was there any published work pre-
dicting the signal of a head-mounted transmission detector. This makes the con-
tent of Chapter 4, the posters displayed at ESTRO 2011 (Appendix D), ESTRO
2012 (Appendix E), ESTRO 2013 (Appendix G) and the publication that this
contributed to (Johnson et al. 2014) original. Ultimately the algorithm devised
in Chapter 4 is accurate enough to detect gross errors of the magnitude of those
discussed in Section 2.2.1, but as demonstrated in Chapter 6 the approach is not
accurate enough to predict small (∼ 1mm) leaf errors that have been shown to
have a clinical impact on IMRT deliveries (Section 6.1).
In the follow up work to Islam et al. (2009), Pasler et al. (2017) made no
mention of predicting the response of the device. It may be that they too found
modelling the response of a device to VMAT fields requires the inclusion of more
parameters than either model contained.
It is the opinion of the author that an analytical model is capable of predict-
ing the response of a transmission detector to a VMAT field. Inclusion of more
parameters could be the subject of future work. It is likely that the algorithm
presented in Chapter 4 would benefit from improved penumbral modelling and an
approach that accounted for the relative position of the leaves (not just the sepa-
ration) therefore reducing the discrepancy between predicted and measured signal
seen in Figure 4.19. The advantage of such an algorithm would be that the signal
could be predicted quickly, with minimal computing power and would require the
entry of only a small number of free parameters specific to the linac the device
would be used on.
7.4 Monte Carlo models
As stated in Section 5.7, there are a number of EGSnrc-based models of the Elekta
MLCi2 head dealing specifically with electron beams (Pitcher et al. 2017, 2016);
the Elekta MLC head has been modelled in EGSnrc (De Vlamynck et al. 1999,
Van de Walle et al. 2003), as has the Beam Modulator (Asnaashari et al. 2013,
Herwiningsih & Fielding 2016, Sikora et al. 2007) and the MLCi2 head has been
modelled in Geant4 (Fleckenstein et al. 2013). However, to the author’s knowledge
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there are, at the time of writing, no published MC models of photon beams for the
Elekta MLCi2 treatment head using the EGSnrc code. This makes work outlined
in Section 5.3 novel.
While EGSnrc has been used to model transmission detectors (Asuni et al.
2011), this was only to investigate containment electrons. To the author’s knowl-
edge a Monte Carlo model of the DAVID has not been produced and there is
currently no published literature on predicting the response of a head-mounted
transmission detector to a VMAT plan using Monte Carlo techniques. This makes
the DAVID models presented in Chapter 5 and displayed as a poster at ESTRO
2016 (Appendix H) completely novel.
In showing that the effect of the collection wires in the DAVID would be ac-
counted for in a general dose-to-signal conversion factor (Section 5.4.1), it allowed
a simple two-slab approach to be used in both EGSnrc and Monaco DAVID mod-
els. EGSnrc is a full Monte Carlo approach so an accurate model was anticipated.
Monaco, however, uses the XVMC code that implements a number of approxi-
mations to speed up the simulations for calculating dose in tissue (Section 5.4.3).
It is interesting to see that these approximations hold for simulating dose in the
distinctly non-clinical conditions (positioning, geometry and materials) of a trans-
mission detector.
While there have been several publications that discuss calibrated Monte Carlo
models of linacs (Popescu et al. 2005, Oborn et al. 2014), they tend to focus on cor-
relating the dose scored in the monitor chamber to the linac’s output. It appears
that the relatively simple approach of generating a calibration curve outlined in
Section 5.4.2 has not been published previously and although there are shortcom-
ings to it (Section 5.6.2), the results it yields are accurate. Not only is this novel
and useful for future work on Monte Carlo modelling of transmission detectors, it
has the potential to be useful whenever a calibrated Monte Carlo linac model is
required. It is the author’s intention to publish this work in the near future.
By showing that Monaco can predict the DAVID response to VMAT deliveries,
it is implicit that the XVMC dose engine is also capable of calculating an accurate
baseline signal for the DAVID. The XVMC code is freely available; the subject of
future work could be the packaging of software that uses the XVMC code to cal-
culate patient dose and DAVID response to a treatment plan. The software would
require a beam model, the data for this would have to be collected independently
of the TPS data. Provided the beam model was accurate, if the software was
implemented in the way outlined in Figure 7.2 it would provide a robust approach
to ensuring that VMAT treatments were delivered with the precision required to
deliver the dose accurately (discussed in Section 4.5.1) without the need to acquire
a pre-treatment DAVID baseline on the linac.
7.5 Summary
In summary, the work was intended to investigate the characteristics of the novel
2-D transmission detector, the DAVID, with the intention of being able to predict
its response to radiotherapy deliveries. The aim was to eliminate the need to
collect a pre-treatment baseline signal for the device on the linac. The approach
was to directly predict signal for individual treatment deliveries. This would make
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Plan designed
in treatment
planning system
Plan exported
Plan imported
in to treatment-
delivery software
Independent checking
software to check
dose to OARs and
treatment volumes
Dose checking software
independently generates
DAVID signal from
dose-verified plan
Plan delivered to patient,
DAVID signal recorded
Independently-
generated DAVID
signal compared to
measured DAVID signal
Figure 7.2: Suggested paradigm, reproduced from Chapter 4
individual patient QA and treatment verification faster and more efficient, as well
as independent and therefore safer. By developing and testing predictive models
of increasing complexity and creating an appropriate methodology to use this
practically, this aim was clearly met. A robust approach to ensuring that advanced
and complex treatments, e.g. VMAT, are delivered with the precision required to
deliver the dose accurately without the need to acquire a pre-treatment DAVID
baseline on the linac was demonstrated.The Monte-Carlo based models perform
well in identifying leaf errors within tolerances of ∼ 1mm; one of these techniques
works with the relatively widely-used MC-based TPS, Monaco making it easy
to implement in the clinic. In addition the work presents a suggested clinical
workflow for application in daily use to monitor patient treatment. This work
can provide the basis of fast and efficient intra-fraction monitoring of complex
radiotherapy delivery, that can be further developed for appropriate workflows to
support adaptive radiotherapy verification and QA.
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Appendix A
Gamma analysis
A.1 Introduction
Gamma analysis is a popular tool that allows the comparison between two, 3D or
2D dose distributions; the original paper describing the technique (Low et al. 1998)
has, at the time of writing, been cited over 2000 times. Although the approach has
been criticised for not picking up some clinically relevant dose discrepancies (Zhen
et al. 2011, Kim et al. 2014, Ohira et al. 2017, Caivano et al. 2014), some form
of gamma analysis a feature on most commercial verification analysis software
platforms (Hussein et al. 2013b) and it remains in widespread use throughout
radiotherapy departments (Hussein et al. 2017).
A.2 Methodology
Gamma analysis compares a reference dose distribution with an evaluated dose
distribution in terms of both geometric distance and dose difference between equiv-
alent points. Taking the example of 2D gamma analysis, the reference dose point
can be thought of as being at the centre of an “acceptance ellipsoid”. Gamma cri-
teria is normally given in terms of δD%/δSmm where δs is the distance between
reference and evaluated dose points, δD is the dose difference as a percentage of
some value. In the case of global analysis this value is normally the maximum
dose, if it is local analysis it will be the reference point. The acceptance ellipsoid
is centred on a Cartesian coordinate system, its origin at the reference dose point
with spatial dimensions for the x and y axis and dose on the z axis. The gamma
criteria determines the shape of the acceptance ellipsoid (Figure A.1), when com-
paring a reference and evaluated dose point, a gamma index of <1 is assigned if
the evaluated point is inside the acceptance ellipsoid and >1 if it is outside. This
is repeated for all points in the evaluated distribution and the result is normally
quoted as the percentage of points with a gamma index <1 along with the gamma
criteria, for example, at James Cook university Hospital the passing criteria for
pre-treatment verification is 98% at 3%/2mm.
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Figure A.1: Acceptance gamma ellipsoid around a reference point. 2D gamma
analysis compares the two dose distributions in the xy plane.
More quantitatively, the gamma index between a reference point (rR) and an
evaluation point (rE) is given by
γ(rR, rE) =
√
∆r2(rR, rE)
δr2
+
∆D2(rR, rE)
δD2
(A.1)
Where δr and δD are the distance and dose criterion respectively. ∆D is can
be defined for local gamma analysis (Equation A.1) or global gamma analysis
(Equation A.2).
∆D(rR, rE) = DE(rE)−DR(rR) (A.2)
∆D(rR, rE) =
DE(rE)−DR(rR)
Dmax
(A.3)
(Low et al. 1998, Hussein et al. 2017)
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Appendix B
DIAMOND software
evaluation
B.1 MU checking software
There have been a number of documented radiotherapy errors, these have ranged
in severity and consequence. Although these are terrible events and often, in
retrospect, better risk management could have avoided them, they give us the op-
portunity to learn. From such errors, we can develop better strategies for avoiding
risk in the department. For example, in 2000 physicists in Panama calculated
the MUs for several treatments using a TPS. At the time, the centre was using
apertures created from drilled holes in lead. Unfortunately, due to a glitch, the
software interpreted what was meant to be an aperture as lead, assigning it the
wrong density. Consequently, the number of monitor units calculated was much
higher than required. Twenty-eight people were over-exposed. At the time the re-
port was published, five people had died and it was expected that 15 more would
“develop serious complications, which in some cases may ultimately prove fatal”
(Vatnitsky et al. 2001).
The report into the incident made three recommendations. The first was:
“ensuring that the procedures require independent (manual) verification of the
monitor units (or irradiation time) and doses to the prescription points as calcu-
lated by the TPS for each individual patient, before the first treatment starts”
(Vatnitsky et al. 2001).
In the UK the practice of checking monitor units is now recommended, “For
plans generated by treatment planning computers (producing isodose distributions
resulting from the combination of two or more beams), calculation of the monitor
units and dose to the reference point must be independently checked either by
hand using tabulated data or by using another computer program” (BIR 2007).
The check is in place to ensure that the planning system has calculated the dose
correctly. Traditionally for 3DCRT where, typically, <7 beams were used this,
could be done by hand. The dose checker - normally a medical physicist – would
use information like the field size, beam energy and the depth of the treatment to
determine a number of correction factors from look-up tables, based on indepen-
dently measured linac data. The correction factors would be used in conjunction
with the beam MU to determine the dose in the patient for that beam. Due to
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the different calculation methods, some difference between the TPS and check-
ing method of dose calculation is to be expected (AAPM 2011, BIR 2007). It is
recommended that in the event of the difference in dose being >2%, the data is
rechecked. In the case of the difference being >5%, an alert is raised (BIR 2007).
In the cases of more advanced treatments – IMRT and VMAT – where a
single beam could be made up of a number of small segments, hand calculations
became infeasible due to the time it would take to perform them. Predictably,
with radiotherapy moving increasingly towards advanced treatments, a number
of commercially available checking programs started to appear (Radcalc (Lifeline
Software Inc., Tyler TX), Diamond (PTW-Freiburg), IMSure (Standard Imaging,
Middleton, WI), and Mucheck (Oncology Data Systems, Inc), to name a few).
These programs typically consist of a method to import dicom plans and a simple
dose calculation algorithm (AAPM 2011, 2014, Tuazon et al. 2018). The user
is able to import a plan and patient structure set, and where necessary, assign
densities to the structures and calculate the dose at a point of their choosing.
They can then compare the dose at this point to the dose calculated by the TPS.
While designed to make dose checks on advanced plans feasible in the radiotherapy
department, these programs can also be applied to 3DP and can save a lot of time.
On account of this, it is hardly surprising that some sort of checking program is now
a standard feature of UK radiotherapy centres (IPEM 2008) and recommended by
international bodies too ICRP (2009).
DIAMOND is a checking algorithm owned by PTW and supplied for the pur-
poses of this work. DIAMOND is not only capable of calculating the dose at a
point, but it can also generate and export fluence maps of the treatment. It was
hoped that, after commissioning the software, the fluence map could be used to
determine the DAVID signal, thereby improving the accuracy of the algorithm
discussed in Chapter 4 by addressing the problems outlined in Section 4.6.
B.2 Commissioning DIAMOND
B.2.1 Data collection
Introduction
DIAMOND calculates dose based on a modified Clarkson algorithm; this approach
determines the scatter at a point using sector integration. Figure B.1 shows a
irregular radiation field (A), this can be split up in to n segments; one of these is
shown in red. The dose due to scatter at point P can be said to be equal to the
scatter contribution from the n segments. The scatter dose from one segment can
be calculated as follows:
The scatter-air ratio (d,rd) at depth d and radius rd can be described by the tissue-
air ratio T(d,rd), with contributions from both scatter and primary radiation minus
the primary contribution T(d,0)1 (Equation B.1). Values of (d,rd) are tabulated
and stored for reference.
S(d, rd) = T (d, rd)− T (d, 0) (B.1)
1primary contribution in this instance is defined at zero field size - where there is no scatter,
this can be determined by taking measurements with increasing smaller field sizes and extrapo-
lating back to zero.
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The contribution of segment r1,θ in Figure B.1 is simply the ratio of its area to
the area of the circle (r1), multiplied by the S(d,rd) of circle (r1) (Equation B.2).
This can be read, or interpolated, from the tabulated data.
S(d, ri, θi)segment =
θi
2pi
× S(d, ri) (B.2)
The scattered dose at point P (Dscatter) from the sector is simply the scatter-air
ratio multiplied by the dose at that point in air DA (Equation B.3) that can be
determined from the SAD, air output factor and collimator scatter factors.
Dscatter(θi) = DA(d, ri, θ)× S(d, ri, θ) (B.3)
Making total scatter dose:
Dscatter = DA(d, ri, θ)×
∑
i
θi
2pi
× S(d, ri) (B.4)
Primary dose is calculated using Equation B.5, where DA is, as above, the dose in
Figure B.1: The scatter-air-ratio of the segment at point P is equal to the scatter-
air ratio of a circle of equal radius multiplied my the area ratio of the segment and
circle (Cunningham et al. 1972).
air, T(d,0) is the tissue-air ratio for the case where there is no scatter and f(x,y) is
a off-axis factor that corrects for changes in the beam profile (Khan 2010, Mayles
et al. 2007, Cunningham et al. 1972).
Dprimary = DA)× T (d, 0)× f(x, y) (B.5)
This approach of primary-scatter separation provides a computationally lite ap-
proach to dose calculation. It was developed further to be used with 3D data
sets and cope with tissue inhomogeneities (Sontag & Cunningham 1978, Redpath
& Thwaites 1991), providing a useful tool for calculating the dose at a point for
irregular fields. The advent of IMRT made meant that the assumption made with
sector-integration, that the dose was homogeneous was no longer valid. However,
Kung et al. (2000) developed a modified Clarkson algorithm relying on annular
integration. Three equally-sized apertures, with equal MU, at different points on
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a circle around a central axis will contribute equally to the dose measured at that
point. This concept can be extended further: instead of considering an IMRT field
as a complicated fluence distribution on a Cartesian axis, it can can be though of
as a set of concentric intensities centred on the CAX (Figure B.2). The intensity
of each concentric ring is the azimuthal average of the intensity at each radius.
The dose is calculated in a equation analogous to Equation B.4. However, instead
of summing over 2pi sectors, the sum is between 0 and R annular sectors. Varying
surface contours can be accommodated for by applying attenuation corrections to
incident fluences, and tissue inhomogeneities can be accounted for by using radi-
ological depths in the place of geometrical depths (Kung et al. 2000).
This algorithm, employed by DIAMOND and RadCalc, uses patient data, the
Figure B.2: An IMRT fluence distribution on the left can be converted to an
annular distribution (right) with the intensity of each ring equalling the average
intensity at distance R in Cartesian space(Kung et al. 2000)
treatment plan (MU, MLC positions, gantry angle etc.) and beam data to calcu-
late the dose at a point. The patient data is in the form of structures that are
outlined on the CT images in the TPS and imported with the treatment plan. The
beam data needs to be collected from the linac. To ensure that the dose check is
completely independent, the data was, in accordance with recommendations (Na-
tional Cancer Peer Review Programme 2014, BIR 2007, AAPM 2011), collected
separately from the TPS data.
Method
Depth dose data Figure B.3 shows the water tank; this was filled with water,
levelled and moved to 100cm SSD. The semi flex chamber (31010, PTW-Freiburg,
Germany) was mounted, in the horizontal position (Figure B.3), on the arm and
centred on the beam axis. PDDs were taken for a range of field sizes between
1×1cm and 40×40cm. For field sizes 5cm2 and below, the data was re-collected
with the photon diode (T60012, PTW-Freiburg, Germany). Below field sizes of
4cm2, the larger semi flex chamber suffers from volume-averaging effects, making
the much-smaller diode a better device for small fields (AAMP (2008), Griessbach
et al. (2005), Das et al. (2008)). By taking 4cm2 and 5cm2 PDDs with both
chambers, where volume-averaging effects suffered by the semi flex would not
have an effect and the fields were not big enough to adversely affect the diode’s
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performance, it was shown that the PDDs were equivalent. Having shown the
equivalence of the diode and semi flex, the diode was used to collect the data for
field sizes less than ≤ 4cm2. The PDDs used in the software are shown in Figure
B.4
Figure B.3: The PTW water tank set up for data collection with a semi flex being
used as the reference chamber and the diode being used as the field chamber. Top
right: semi flex chamber, bottom right photon diode.
Off axis data. This data was taken using the plotting tank at an SSD of 100cm.
A semi flex chamber, in the vertical position, was used to measure a 40×40cm
profile at depths of 1.6cm, 5cm, 10cm, 20cm and 30cm in 1mm steps (Figure B.5 ).
MLC data. This was collected with a semi flex chamber in the vertical
position, the chamber was moved in 1mm steps across a 4×4cm field in the
direction of the MLC movement (Figure B.6).
Head scatter. The SCP and SC values were collected in a water tank
and in a mini phantom, respectively (IPEM 2018). All values were collected
with an isocentric (SAD) set up with the detector at a depth of 10cm (SSD =
90cm)(Figure B.7)
Leaf transmission. A value of 2% was used – the same as the planning
system (AAMP (2008)).
Results
159
Figure B.4: PDDs for a range of field sizes.
Figure B.5: 40×40cm profiles in measured in the direction perpendicular to leaf
travel for a range of depths.
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Figure B.6: Profile of a 4×4cm field in the direction of MLC travel.
Figure B.7: SC and SP values for a range of field sizes extrapolated back to 0cm2.
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B.2.2 Array Calibration
Introduction
To benchmark the DIAMOND software against measured dose (Section B.2.3),
planer measurements of plans delivered on the linac were taken. This was done
using the OCTAVIUS phantom (PTW Fireburg-Germany) with the Seven29 2D
array inserted into it. The Seven29 array consists of a plane matrix of 27× 27 cubic,
air-filled ion chambers. The vented plane-parallel ion chambers are 5×5×5mm3 in
size with a centre-to-centre spacing of 10mm. The upper electrode layer sits below
a 0.5cm a PMMA build-up layer, whereas the lower electrode layer lies on top of
a 0.2cm thick electrode plate, which itself is mounted on a 1cm PMMA base plate
(Bohsung et al. 2004, PTW 2010, Hussein et al. 2013a, Van Esch et al. 2007). The
Seven29 array has been shown to give reproducible results in the short, medium
and long term with a response that is linearly proportional to energy and dose,
showing that it can be considered an accurate and sensitive QA tool (Spezi et al.
2005). The Seven29 array has a varying angular sensitivity - this is because of the
increased attenuation from the electronics behind the chambers that is not present
on the front of the device. When used in conjunction with the Octavius phantom,
this is effect accommodated for by an open void in the PMMA behind the array
(Figure B.8). The drop in attenuation from the void compensates for the blocking
of the beam by the electronics. The combination of the Octavius phantom and the
Seven29 array has been shown to be a useful and appropriate tool for performing
pre-treatment verifications on arc-style deliveries (Van Esch et al. 2007).
Figure B.8: Schematic of the Octavius phantom with transaxial CT slice as inset.
Polystyrene = physical density 1.04 g/cm3, relative electron density 1.00, width
and length: 32cm (Van Esch et al. 2007)
Method
In an approach similar to Van Esch et al. (2007), the array was placed on the couch
and centred on the beam axis. Increasing amounts of solid water were placed on
top of it, dropping the couch each time to maintain a constant SSD. In this way, a
PDD was measured with the central chamber. This procedure was repeated, but
in place of the array, a farmer chamber was used. The farmer chamber was a field
chamber with a traceable calibration (Lillicrap et al. 1990), so the measured dose
could be calculated. The procedure was repeated three times for both the array
and the chamber. The resulting PDDs were compared, and a factor applied to shift
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the array measurements so that they matched the chamber measurements (Figure
B.9). This factor was applied to subsequent array measurements, converting them
to measured dose.
As both the farmer chamber and the 2D array chambers are vented, tempera-
ture and pressure corrections were applied to all readings.
Results
After applying the calibration factor, the chamber and array PDDs were seen to
match well (Figure B.9), showing the process to be appropriate. The calibration
factor was found to be:
2D array calibration factor = 1.0105
Although the Seven29 array is issued by the manufacturer in a calibrated
state, meaning that the calibration factor should be unity, some drift is expected.
A change in calibration factor of about 1% is consistent with the evaluation
performed by Spezi et al. (2005).
Figure B.9: PDDs from a chamber, post-calibration array PDD and pre-calibration
array PDD – the discrepancy between the pre- and post-calibration PDDS has been
exaggerated to illustrate the process.
B.2.3 Testing
Introduction
To test the DIAMOND software, the dose it calculated was compared with mea-
sured dose and dose calculated by two other systems. Having access to Monaco
as a TPS provided the opportunity to compare the DIAMOND calculation to a
Monte Carlo algorithm (Section 5.2). RadCalc is the checking software currently
used in the department. Like DIAMOND, it uses a Clarkson-based algorithm to
calculate dose; comparison between the two will benchmark DIAMOND against a
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piece of software with an equivalent role and approach. Finally, the dose will be
measured on the linac using the Seven29 array (Section B.2.2).
Method
To compare measured and calculated doses, a similar process to pre-treatment
patient-specific QA (Alber et al. 2008, Stathakis et al. 2013, Ezzell et al. 2003,
AAPM 2018) was followed. The OCTAVIUS phantom with the Seven29 array in-
serted (Figure B.10), was imaged on the CT scanner. This image set was imported
into the TPS, an external contour was drawn around the image of the phantom
and the electron density forced to 1. A treatment plan was then imported and the
dose calculated on the phantom. Typically, for pre-treatment verification, com-
mercial software is used to compare the dose plane at the level of the detectors
calculated in the TPS to the dose measured by the detectors, normally using a 2D
gamma analysis with a locally decided passing criteria (Alber et al. 2008). How-
ever, in this instance, the software being tested can only calculate dose at a point.
So, in the dose calculated in the TPS, four points in the plane of the detectors
were recorded - the position of these points is shown in Figure B.11. The plan and
structures were exported to DIAMOND and RadCalc, and the dose was calculated
at the same four points in each.
The plan was then delivered to the phantom / array on the linac and the dose
measured at the four points was recorded. The TPS, RadCalc, DIAMOND and
measured doses for all four points were compared for 10, clinical, step-and-shoot
IMRT plans.
Figure B.10: The OCTAVIUS structure set in DIAMOND and The OCATAVIUS
phantom with the 2darray inserted on the linac couch.
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Figure B.11: Dose measurement points in the plane of the detector / coronal plane
of the plan. Distances are in cm.
B.2.4 Results
Figure B.12 shows the absolute values determined by the four techniques. Figure
B.13 shows the difference between the dose calculated by Monaco and the three
other techniques. The differences are typically within 5% and the DIAMOND
results are equivalent the clinically used RadCalc. This is consistent with the data
published by Tuazon et al. (2018) and can be attributed to the simplistic nature of
the Clarkson dose-calculation algorithm. In some cases, the differences are greater
then 5%. This can be ascribed to the arbitrary selection of measurement point
in fields with high dose gradients. The points were the same for all plans; in the
event of performing these calculations in the clinic, the checker would choose a
point with a low dose gradient eliminating the errors that this causes.
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B.3 Fluence from DIAMOND
Showing that the DIAMOND software calculated point doses with the same level
of accuracy as RadCalc demonstrated that the software was working and that
the data that had been entered was correct. To predict the DAVID signal using
DIAMOND, its function to generate normalised fluence maps was utilised. Ten
fluence maps of IMRT deliveries were generated and exported as matrices in .txt
format. Software was written to import the fluence maps, extract predicted signals
(Figure B.14) and compare them to the normalised DAVID responses measured
on the linac (Figure B.15).
The results shown in Figure B.15 are typical of the results derived by the
DIAMOND-generated fluence technique – notably poor. Using processes similar
to those discussed in Section 4.3 efforts were made to enhance the predicted signal
with iteratively derived factors, but little improvement was made and the derived
factors were of the same order of magnitude as the factors themselves, so not
deemed appropriate.
Figure B.14: Normalised fluence map of VMAT delivery.
Further investigation showed the fluence maps to be of quite a poor standard.
Figure B.16 shows a 10 × 10cm2 fluence map with the accompanying cross-plane
profile. With the in-field normalised fluence equalling one and the penumbral
region (in both in-plane and cross-plane directions) equalling 0.5, it is evident
that specific and accurate penumbral modelling was not a feature of the algorithm.
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Figure B.15: Comparison of signal generated by DIAMOND’s normalised fluence
map and measured data.
Also with the out-of-field area equalling zero, it is clear that scatter, leaf leakage
and inter-leaf leakage were not considered in the calculation. Attempts were made
to modify the fluence maps and the interaction with the DAVID in an approach
similar to that discussed in Greer et al. (2009), but these were unsuccessful.
With this in mind, it was decided to abandon DIAMOND as a potential source
of usable fluence maps and move on to a different method – dose maps generated
from Monte-Carlo modelling of the linear accelerator and DAVID. This is the
subject of the next chapter.
169
Figure B.16: DIAMOND-generated square field fluence and profile
170
Appendix C
Efficiency enhancing
methods in EGSnrc
C.1 Introduction
Monte Carlo programming is regarded as the most accurate way of calculating dose
delivered by linear accelerators Fragoso et al. (2009), the cost of this accuracy is
computing time. Even with multi-core computers the sheer number of calculations
that need to be made to individually simulate the histories of millions of particles
means that computation time needed to provide accurate doses can often be hours.
To try and reduce the computation time, a number of efficiency enhancing have
been developed; a number of these are included in the EGSnrc distribution and
are discussed in this section.
Broadly speaking, efficiency enhancing techniques can be split in to two types:
Approximate Efficiency Improving Techniques (AEITs and Variance Reduction
Techniques (VRTs). AEITS make approximations about particles and their his-
tory and ignore particles that are not going to make a meaningful contribution to
the regions of interest. When using AEITs it is important to select ones with ap-
propriate parameters that will not bias the results by ignoring important particles.
AEITs included in the EGS distribution include charged particle Range Rejection
(RR), photon and electron transport cut-off energies and the condensed history
technique. VRTs do not change the the physics so should not bias the results.
VRTs available with the EGS distribution are bremsstrahlung photon splitting,
Russian roulette and photon interaction forcing.
C.2 Description of efficiency enhancing options
C.2.1 Range Rejection and energy cut off
This technique uses the MXRNGE subroutine compute the residual ranges in each
medium as a function of electron energy up until the user-defined electron-energy
cutoff before the simulation begins. If and electron enters a medium without
sufficient energy to escape, its history is terminated Rogers et al. (1995). Range
rejection means that time is not wasted on interactions that are not going to affect
the total energy deposition and has been shown save considerable time in electron
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calculations Rogers et al. (1990).
Range rejection was turned on for most of the calculations in the thesis as
the highly accurate determination energy deposition by low energy electrons was
not necessary and would be time consuming . However, in section 5.4.1 when
the effect of the wire was being determined and the energy deposition in small
volumes was being determined it was turned off so because the small volume
meant that it was necessary to know the particles position with more precision.
ECUT is the electron transport cut off energy, a user-defined variable be-
low which electron interactions are no longer calculated and the dose is energy
is assumed deposited in the medium its in. For most detailed work ECUT =
0.7MeV is acceptable (Rogers et al. (2001)) however, in cases where the energy
deposition in small volumes of interest is important, smaller values can be used.
ECUT = 0.511 was used in Section 5.4.1.
PCUT is the photon transport cut off energy, in the event of a photon’s energy
dropping below this value, the particle tracking is terminated and it is assumed
that the energy is deposited in the current medium. Having a low value of PCUT
does not incur a big calculation-time penalty and it is recommend that a value of
0.01MeV is generally used (Rogers et al. (2001)).
C.2.2 Photon Forcing
For thin or low density materials, the likelihood of a photon interacting can be
quite low, simulation statistics can be improved by forcing photons to interact.
Photons that are forced to interact are split in to a scattered photon and a photon
continuing as if the interaction had not occurred. The weight of the scattered
photon is equal to the probability of the interaction taking place, the unscattered
photon take the rest of the weight Rogers et al. (2001). The unscattered photon
cannot be forced to interact again in the forcing CM, the scattered photon can,
however, be forced to interact as many times as the user specifies. Photon forcing
is useful for improving Bremsstrahlung statistics and can be particularly useful
when used with Bremsstrahlung splitting Rogers et al. (2001), Mohammed et al.
(2016)
C.2.3 Russian Roulette
In the case of Bremsstrahlung splitting, Russian Roulette (RR) can be turned
on, this essentially eliminates some higher order charged particles and distributes
their weight to the surviving charged particles. This removes charged particles,
and their associated computational-time penalty, from the calculation and retains
the bremsstrahlung photons. Rogers et al. (2001) Kawrakow et al. (2004).
C.2.4 Bremsstrahlung Splitting
Bremsstrahlung-generated photons are often often the most relevant consequence
of an interaction, unfortunately the physical process of generating these photons is
inherently inefficient. The variance associated with the resulting Bremsstrahlung
spectrum can be reduced by artificially enhancing the number of photons produced
at each Bremsstrahlung event. The electron path and energy is normally, for first
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generation particles, unimportant, so splitting algorithms do not generally modify
path of the photon-generating electron.In order to avoid biasing the results, the
statical weight of each of these particles is reduced by the reciprocal of the Number
of Bremsstrahlung SPLitting photons (NBSPL) produced Meurant (2012) Bielajew
et al. (1989), this is a user-defined value normally between 20 and 100 Kawrakow
et al. (2004). There are three types of Bremsstrahlung splitting associated with
the EGSnrc code1:
• Uniform Bremsstrahlung Splitting (UBS) where the the NBSPL is applied
to all Bremsstrahlung photons
• Selective Bremsstrahlung Splitting (SRS) where the NBRSPL is modified to
enhance the Bremsstrahlung spectrum in the direction of the field, this saves
time calculating histories for photons that will not reach the field of interest.
• Directional Bremsstrahlung Splitting (DBS) which is an improvement on the
SBS approach. This was used for all BEAMnrc simulations and is discussed
below.
Statistics in a field of interest generated with SBS turned on are compromised by
the variable splitting number producing a large range of photon weights. Also,
some photons aimed away from the field of view can, through “chance events”
still create particles that will get to the field of interest, as the progenitor photons
for these particles wont have been split, the particles and photons generated from
them will have a high weight and adversely affect statistics (Figure C.2). The effect
of these chance-event particles was ameliorated in the SBS code by a “background-
splitting” subroutine, but this is at the expense of CPU time. DBS eliminates the
need for the background-splitting and ensures that all the photons in the field of
view have the same weight, the overall effect of this being a factor 6 and 20 increase
in efficiency when DBS is used instead of SRS and UBS respectively Kawrakow
et al. (2004).
In general, DBS handles Bremsstrahlung events initiated by fat2 particles
by splitting them NBRSPL times, the resultant photons will all have weight
NBRSPL-1. The resulting photons that are aimed at the field of view are kept, the
ones aimed away from it are subject to RR, those surviving RR have their weight
increased and making them “fat”. Different interactions are handled slightly differ-
ently, but the result is that all photons inside the target field will be non-fat, each
having a weight NBRSPL-1, all those outside the target field will be fat, having a
weight of 1 Kawrakow et al. (2004). DBS is largely concerned with photons, the
electrons that are involved in the production of these photons are subject to RR
meaning that the small amount (small compared to the DBS-amplified number of
photons) reaching the target field will all be fat. So, although photon statistics
will be good, containment electron statistics will be poor, this problem is overcome
using the electron-splitting technique Kawrakow et al. (2004) Rogers et al. (2001).
Electron splitting, when used in conjunction with DBS requires a splitting
plane, in addition to the RR plane needed for DBS. Both planes are typically
1UBS and DBS are available with the current distribution, SBS has been discontinued Rogers
et al. (2001)
2fat particles are ones with high weight, all primary particles will be fat, fat particles can be
left over from splitting algorithms and, in some cases generated by them
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in the flattening filter, with the splitting plane being below the RR plane. The
idea behind this being that electrons in the upper part of the head are unlikely to
get to the target plane, whereas electrons in the lower part of the head are. Fat
electrons crossing the splitting plane are split NBRSPL times each having their
weight reduced by NBRSPL-1. Non-fat charged particles can go on to interact
and produce non-fat photons, of these photons, the ones not directed at the field
of view will be subject to RR as described DBS process above Kawrakow et al.
(2004)
There is a finite possibility that fat electrons will get to the target plan. In
Figure C.1 the dose deposition should be symmetric about the centre, the increased
dose to the right of centre in the top plot is likely to be from a fat photon as a
result of DBS. While the fat photon increases the dose deposited in a voxel, it also
increases the uncertainty associated with the dose - this is reflected in the error bar
associated with the volume. The uncertainty used to determine the size of the error
bars on the graph was extracted the BEAMdp output file - these values calculated
from the uncertainties contained with in the phase-space file. For the phase-space
uncertainties to be calculated correctly the parameters in the model need to be
entered correctly (Rogers et al. 2001, Ma & Rogers 2018, Walters et al. 2002).
The distribution in this figure should be symmetric and is if the uncertainties
are taken in to account. This demonstrates that the parameters in the model
are appropriate and the code written by the author to extract them worked as
intended. The phase space was regenerated using different random number seeds.
The result of the same analysis is seen in the bottom of the figure. Due to the
random nature of MC calculations in general and fat photon contamination in
particular the fat photon was not present in this run.
In the BEAMnrc simulations performed for this work, electron splitting plane
was put just below the RR plane and both were in the flattening filter as rec-
ommend by Kawrakow et al. (2004) Rogers et al. (2001). the behaviour efficiency
improvements relation to NBRSPL was has been shown to be independent of place-
ment and the optimal number has been shown to be 1000 Kawrakow et al. (2004),
so this was used throughout.
C.2.5 ISMOOTH
ISMOOTH is as DOSXYZnrc option to redistribute particles in a phase-space
source file symmetrically about the central axes. This option is only used when the
phase-space file is recycled multiple times. It has the effect of reducing statistical
uncertainties (mainly in surface dose) associated with repeatedly using the same
phase-space file during a single DOSXYZnrc simulation. This option should only
be used for symmetrical fields, in the case of asymmetric fields, particle fluence
could potentially be created where there is none and vice versa Figure C.3
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Figure C.1: Taken from Chapter 5, here Electron fluence passing through the
bottom collection volume (7–9 on Figure 5.16) extracted using beamdp phase-
space analysis tool (Ma & Rogers 2018).
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Figure C.2: The figure shows an electron beam striking a target, three electrons
are produced, e-1 and e
-
2 produce Bremsstrahlung photons each with a weight
NBRSPL-1, e-3 is not thought to produce particles or photons that will hit the
field of interest, however, an unlikely chance event causes a photon to be directed
to the plain of interest, without the back-ground splitting subroutine, this photon,
having not come from a splitting event, will have considerably higher statistic le
weight than the other photons adversely affecting the photon statistics in the plain
of interest
Figure C.3: 5×5 field offset in the xdirection. Only difference between the two
plots is that one was generated with ISMOOTH on and the other with ISMOOTH
off.
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Appendix D
ESTRO 2011
Figure D.1: Poster accepted for ESTRO 2011
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Appendix E
ESTRO 2012
Figure E.1: Poster accepted for ESTRO 2012
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Appendix F
ESTRO 2012
Figure F.1: Poster accepted for ESTRO 2012
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Appendix G
ESTRO 2013
Figure G.1: Poster accepted for ESTRO 2013
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Appendix H
ESTRO 2016
Figure H.1: Poster accepted for ESTRO 2016
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Appendix I
BEAMnrc input file for
MLCi2 linac
#!GUI1.0
AIR700ICRU
0, 0, 0, 0, 0, 2, 0, IWATCH ETC.
1500000000.0, 33, 97, 2, 2, 1000, 0, 0, NCASE ETC.
10, 63.31, 3, 4, 1, 15.1, DIRECTIONAL BREM OPTIONS
-1, 19, -0.2, 0, 0, 1, 1.35, -0.24, 0.0, 0.0, IQIN, ISOURCE + OPTIONS
1, SPECTRUM
nobackup umdj EGSnrc HEN HOUSE spectra Elekta UFFF 5.spectrum
1
0, 0, 0.7, 0.1, 0, 1, 2, 0 , ECUT,PCUT,IREJCT,ESAVE
0, 0, 0, 0, 0, PHOTON FORCING
1, 10, SCORING INPUT
0,0
0, DOSE COMPONENTS
-0.35, Z TO FRONT FACE
*********** start of CM FLATFILT with identifier target ***********
3, RMAX
Target
-0.35, ZMIN
3, NUMBER OF LAYERS
1, 0.261, # CONES, ZTHICK OF LAYER 1
0.28,
0.28,
1, 0.089, # CONES, ZTHICK OF LAYER 2
0.28,
0.28,
1, 1, # CONES, ZTHICK OF LAYER 3
2.9,
2.9,
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
CU700ICRU
0, 0, 0, 0,
WRE700
0, 0, 0, 0,
CU700ICRU
0, 0, 0, 0,
CU700ICRU
0, 0, 0, 0,
CU700ICRU
*********** start of CM FLATFILT with identifier pricol ***********
4, RMAX
Primary collimator
1.5, ZMIN
1, NUMBER OF LAYERS
1, 10.1, # CONES, ZTHICK OF LAYER 1
0.645,
3.14,
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
W700ICRU
*********** start of CM FLATFILT with identifier Flatten ***********
4.65, RMAX
6MV Flattening Filter
13.3, ZMIN
7, NUMBER OF LAYERS
1, 0.1, # CONES, ZTHICK OF LAYER 1
0.0,
0.26,
1, 0.49, # CONES, ZTHICK OF LAYER 2
0.26,
0.9,
1, 0.49, # CONES, ZTHICK OF LAYER 3
0.9,
1.45,
1, 0.55, # CONES, ZTHICK OF LAYER 4
1.45,
2.25,
1, 0.56, # CONES, ZTHICK OF LAYER 5
2.25,
3.25,
1, 0.2, # CONES, ZTHICK OF LAYER 6
4.65,
4.65,
1, 0.2, # CONES, ZTHICK OF LAYER 7
4.65,
4.65,
0.7, 0.01, 0, 0,
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STEEL700ICRU
0.7, 0.01, 0, 0,
AIR700ICRU
0.7, 0.01, 0, 0,
STEEL700ICRU
0.7, 0.01, 0, 0,
AIR700ICRU
0.7, 0.01, 0, 0,
STEEL700ICRU
0.7, 0.01, 0, 0,
AIR700ICRU
0.7, 0.01, 0, 0,
STEEL700ICRU
0.7, 0.01, 0, 0,
AIR700ICRU
0.7, 0.01, 0, 0,
STEEL700ICRU
0.7, 0.01, 0, 0,
AIR700ICRU
0.7, 0.01, 0, 0,
STEEL700ICRU
0.7, 0.01, 0, 0,
AIR700ICRU
0.7, 0.01, 0, 0,
AL700ICRU
0.7, 0.01, 0, 0,
AIR700ICRU
*********** start of CM FLATFILT with identifier chamber ***********
7.4, RMAX
Chamber
16.44, ZMIN
21, NUMBER OF LAYERS
1, 0.0012, # CONES, ZTHICK OF LAYER 1
7.3,
7.3,
1, 0.1, # CONES, ZTHICK OF LAYER 2
4.5,
4.5,
1, 0.0012, # CONES, ZTHICK OF LAYER 3
7.3,
7.3,
3, 0.1, # CONES, ZTHICK OF LAYER 4
4.5, 5.4, 6.625,
4.5, 5.4, 6.625,
2, 0.0012, # CONES, ZTHICK OF LAYER 5
5.4, 6.625,
5.4, 6.625,
3, 0.22, # CONES, ZTHICK OF LAYER 6
4.5, 5.4, 6.625,
4.5, 5.4, 6.625,
2, 0.0012, # CONES, ZTHICK OF LAYER 7
5.4, 6.625,
5.4, 6.625,
3, 0.1, # CONES, ZTHICK OF LAYER 8
4.5, 5.4, 6.625,
4.5, 5.4, 6.625,
2, 0.0012, # CONES, ZTHICK OF LAYER 9
5.4, 6.625,
5.4, 6.625,
3, 0.1, # CONES, ZTHICK OF LAYER 10
4.5, 5.4, 6.625,
4.5, 5.4, 6.625,
2, 0.0012, # CONES, ZTHICK OF LAYER 11
5.4, 6.625,
5.4, 6.625,
3, 0.1, # CONES, ZTHICK OF LAYER 12
4.5, 5.4, 6.625,
4.5, 5.4, 6.625,
2, 0.0012, # CONES, ZTHICK OF LAYER 13
5.4, 6.625,
5.4, 6.625,
3, 0.1, # CONES, ZTHICK OF LAYER 14
4.5, 5.4, 6.625,
4.5, 5.4, 6.625,
2, 0.0012, # CONES, ZTHICK OF LAYER 15
5.4, 6.625,
5.4, 6.625,
3, 0.1, # CONES, ZTHICK OF LAYER 16
4.5, 5.4, 6.625,
4.5, 5.4, 6.625,
2, 0.0012, # CONES, ZTHICK OF LAYER 17
5.4, 6.625,
5.4, 6.625,
1, 0.31, # CONES, ZTHICK OF LAYER 18
6.625,
6.625,
1, 0.0012, # CONES, ZTHICK OF LAYER 19
6.625,
6.625,
1, 0.0676, # CONES, ZTHICK OF LAYER 20
4.5,
4.5,
1, 0.0012, # CONES, ZTHICK OF LAYER 21
7.3,
7.3,
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
ALUMINA700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
ALUMINA700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
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0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
ALUMINA700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
ALUMINA700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
ALUMINA700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
MYLAR700ICRU
0, 0, 0, 0,
MYLAR700ICRU
*********** start of CM SLABS with identifier bkplt ***********
6, RMAX
Back scatter plate
1, NSLABS
18.25, ZMIN
0.29, 0, 0, 0, 0, 0
AL700ICRU
*********** start of CM MIRROR with identifier mirror ***********
5.18, RMAX
mirror
18.54, 7.94, ZMIN, ZTHICK
5.18, -5.19, XFMIN, XBMIN
2, # LAYERS
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0.0012, thickness of layer 1
3e-5, thickness of layer 2
0, 0, 0, 0,
POLYETH700ICRU
0, 0, 0, 0,
AL700ICRU
0, 0, 0, 0,
AIR700ICRU
0, 0, 0, 0,
AIR700ICRU
*********** start of CM SYNCMLCE with identifier MLC ***********
26, RMAX
MLCi2 leaf bank
0, 2, ORIENT, MODE
40, NUM LEAF
29.3, 37.5, ZMIN, ZMAX
35, 34, ZSTEPL, ZSTEPR
0.0, TGW
0.14315, 0.18395, X3, X4
1.0, 100, SPACE, SSD
0, LBROT
0, ENDTYPE
15.02, 32.836, LEAFRADIUS, CIL
nobackup umdj EGSnrc egs home BEAM MLCi2 Match 1010MLC
0.7, 0.01, 0, 0,
AIR700ICRU
0.7, 0.01, 0, 0,
WRE700
*********** start of CM SYNCJAWS with identifier Jaws ***********
30, RMAX
Y backup and X jaws
2, 2, # PAIRED BARS OR JAWS, field type
Y
X
nobackup umdj EGSnrc egs home BEAM MLCi2 Match 1010JAW
0.7, 0.01, 0, 0,
0.7, 0.1, 0, 0,
WRE700
0.7, 0.1, 0, 0,
WRE700
*********** start of CM SLABS with identifier MylWin ***********
30, RMAX
Mylar window
1, NSLABS
54.8, ZMIN
0.01, 0.7, 0.1, 0, 0, 0
MYLAR700ICRU
*********** start of CM SLABS with identifier Airslab ***********
50, RMAX
8.5cm to DAVID
1, NSLABS
54.81, ZMIN
8.5, 0.7, 0.1, 1, 0, 0
AIR700ICRU
*********************end of all CMs*****************************
#########################
:Start MC Transport Parameter:
Global ECUT= 0.7
Global PCUT= 0.1
Global SMAX= 5
ESTEPE= 0.25
XIMAX= 0.5
Boundary crossing algorithm= EXACT
Skin depth for BCA= 0
Electron-step algorithm= PRESTA-II
Spin effects= On
Brems angular sampling= Simple
Brems cross sections= BH
Bound Compton scattering= Off
Compton cross sections= default
Pair angular sampling= Simple
Pair cross sections= BH
Photoelectron angular sampling= Off
Rayleigh scattering= Off
Atomic relaxations= Off
Electron impact ionization= Off
Photon cross sections= si
Photon cross-sections output= Off
:Stop MC Transport Parameter:
#########################
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